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Abstract 
 
 
 
Assessment of risk in the development of pressure ulcers is an essential tool 
to prevent and therefore, reduce the incidence of pressure damage. Pressure 
damage has been shown to be preventable in 95% of cases (Chan et al., 
2009). The economic and social ramifications of pressure damage are vast. 
They can drastically impair quality of life and cause considerable suffering for 
the individual. Clinicians are advised to employ the use of a validated risk 
assessment tool in their practice to aid the prevention of pressure damage 
(EPUAP, 2014). There are over forty validated risk assessment tools being 
used across the world at present (Kottner et al., 2010). The questionable 
validity of these tools has been debated in current research. The purpose of 
this study was to determine the relationship between current risk assessment 
tools and a new method of risk assessment, sub-epidermal moisture 
measurement in an effort to determine which tool will provide the clinician 
with the most accurate assessment of risk. A quantitative, prospective, non-
experimental design was used. The study found similar issues regarding 
predictive validity of risk assessment tools as seen in previous research. The 
limitations of these tools must be emphasized and caution practiced with their 
use. The study found promise in the use of sub-epidermal moisture 
measurement however further research is needed to confirm these results. 
This is clinically relevant as limitations can be seen in the current methods of 
risk assessment. If sub-epidermal moisture measurement can perform in 
clinical practice as it has in research, it could be a valuable tool to aid 
clinicians in reducing pressure ulcer incidence. 
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Chapter One - Introduction 
1.1 Introduction 
The incidence of pressure ulcers is a worldwide healthcare issue (Coleman 
et al., 2012). The European Pressure Ulcer Advisory Panel (EPUAP, 2014) 
defines a pressure ulcer as: 
“A localized injury to the skin and/or underlying tissue usually over a 
bony prominence, as a result of pressure, or pressure in combination 
with shear.” 
Pressure ulcers can be categorised into six grades ranging in severity from 
non-blanching erythema or redness to full thickness tissue loss involving 
skin, fat and muscle, occasionally involving bone (EPUAP, 2014). Pressure 
ulcers are also referred to as pressure sores, bedsores and decubitus ulcers, 
all of which result in pain, reduced independence and poor quality of life 
(Gorecki et al., 2009, Spilsbury et al., 2007, Bouten et al., 2003). They also 
add further economic burden to the healthcare sector due to treatment costs 
and extended hospital stays (Dealey et al., 2012, Chaves et al., 2010, 
Whiteing 2009, Bennett et al., 2008). Pressure ulcers are a preventable 
healthcare complication. Indeed, pressure damage is believed to be 
preventable in 95% of cases (Garcia-Fernandez et al., 2013 and Chan et al., 
2009). Therefore, the prevalence of such an injury is a valuable indicator of 
quality care delivery (Department of Health and Children, 2008).  
 
Worldwide pressure ulcer prevalence is reported to range between 7% and 
54% (Kim et al., 2012, Page et al., 2011, Chaves et al., 2010, Sayer et al., 
2008), with Irish studies citing prevalence at an alarming rate between 12-
38% (Gallagher et al., 2008, Gethin et al., 2005, Moore et al., 2000). 
Internationally, large portions of health expenditure are needed to fund the 
treatment of pressure ulcers. Research suggests that the cost of managing 
pressure ulcers is substantial with the treatment of a single ulcer ranging 
from £1,000 to £10,000 per person, depending on the severity of the ulcer 
(Whiteing, 2009). Furthermore, the personal cost of pressure ulcers cannot 
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be underestimated. People suffering from pressure ulcers have described the 
substantial burden of this debilitating injury noting mental, physical, emotional 
and social impacts on their quality of life (Spilsbury et al, 2007). Therefore it 
is imperative to evaluate every individual’s risk of pressure ulcer development 
and provide preventative measures as needed (EPUAP, 2014). 
 
Pressure ulcer risk assessment is the process in which each person is 
screened for common risk factors for pressure ulcer development in an effort 
to determine those at risk as a precursor to the initiation of preventative 
measures (Moore et al, 2008).International guidelines recommend the use of 
a validated risk assessment tool (EPUAP, 2014). Several different tools have 
been developed to analyse the risk to each individual, two of the most 
commonly used are the Waterlow and Braden scales (Guy, 2012 and 
O’Tuathail et al, 2011). Each scale provides a list of common risk factors to 
help assess the patient and identify those at risk of pressure ulcer 
development. These risk factors include but are not limited to age, weight, 
mobility, nutrition and continence status. The tool provides the practitioner 
with a score which indicates a low, medium or high risk of pressure ulcer 
development. Preventative measures should then be initiated in the form of a 
care plan, as appropriate to the perceived risk.  
 
Preventative measures include regular patient repositioning, skin inspection, 
pressure relieving devices such as mattresses and cushions, nutritional 
advice such as supplementation and continence management. These 
preventative measures have been recommended by the National Quality 
Improvement Programme in their SSKIN collaborative (HSE, 2014). This 
collaborative was implemented to reduce the incidence of avoidable pressure 
ulcers. 
 
A study by Kottner et al., (2010) found that there are more than 40 validated 
risk assessment tools in use today. Two of the most frequently used are the 
Waterlow and Braden scales (Guy, 2012 and O’Tuathail et al, 2011). 
However, despite the use of these validated tools, increasing pressure ulcer 
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prevalence continues to be a major healthcare issue with one study citing an 
80% increase in pressure ulcer prevalence in the last twenty years (Cox, 
2012).  
 
Studies regarding the use of risk assessment tools have cited many 
problems with their use. Their shortcomings include poor predictive validity, 
issues with inter-rater reliability, low sensitivity and low specificity. Due to 
these shortcomings, clinicians are provided with invalid risk assessments. 
Over prediction of risk will lead to unnecessary and costly preventative 
intervention. Under prediction of risk leads to increasing prevalence and 
increasing treatment costs (Chan et al., 2009). Due to such issues in the use 
of risk assessment tools, there has been a growing interest in other methods 
of risk assessment. 
 
Sub-epidermal moisture is a biophysical marker of the level of moisture 
contained within the skin (Guihan et al., 2012). The World Health 
Organisation (2001) has described a biophysical marker as a measurable 
process in the body which can predict the incidence of an outcome. Sub-
epidermal moisture measurement is the process in which the level of 
moisture in the skin is calculated through the use of a hand held scanner. 
Elevated sub-epidermal moisture content has been shown to be a reliable 
indicator of tissue damage due to the natural inflammatory response of the 
body (Guihan et al., 2012, Bates-Jensen et al., 2007). When tissue damage 
occurs, a healing response is triggered, beginning with an initial inflammatory 
reaction. This inflammatory phase causes oedema and therefore an increase 
in tissue moisture (Sussman and Bates-Jensen, 2012).This is relevant to 
pressure ulcer risk assessment as the presence of increased sub-epidermal 
moisture is a marker of inflammation and therefore, an indicator of impending 
more severe tissue damage (Sussman and Bates-Jensen, 2012). If sub-
epidermal moisture can be measured, the presence or absence of very early 
tissue damage can be established and appropriate preventative measures 
introduced.  
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1.2 Background 
The first risk assessment tool was devised in 1962 by Doreen Norton (Bell, 
2005). The Norton scale was specifically designed to provide pressure ulcer 
risk assessment in a care of the elderly environment. It was developed with 
this population in mind, focusing on factors which contribute to pressure 
damage in the elderly. Five subscales were created; activity, mobility, 
continence, physical condition and mental condition (Norton, 1962). Several 
variations of this tool have since been created to cater to varying specialties 
and populations. 
 
According to Kottner et al., (2010) there are more than 40 validated risk 
assessment tools in use today. Yet despite the use of these validated tools, 
pressure ulcer development and increasing prevalence continue to be a 
major healthcare issue with one study citing an 80% increase in pressure 
ulcer prevalence in the last twenty years (Cox, 2012).  
 
There are several issues of importance in the use of risk assessment tools 
such as: 
1. Predictive validity: The ability of the tool to accurately determine the 
outcome for the individual (Chan et al., 2009). A high level of 
predictive validity is vital as preventative measures will be 
implemented based upon the outcome of the risk assessment. Poor 
predictive validity can lead to an over prediction of risk resulting in 
unnecessary use of preventative interventions and a poor use of finite 
healthcare resources. Similarly, poor predictive validity can also 
under-predict risk which will lead to increased prevalence (Chan et al., 
2009). 
2. Inter-rater reliability: The degree to which different raters or clinicians 
agree in their assessment of pressure ulcer risk (Wang et al, 2014). As 
risk assessment scales are subjective tools, inter-rater reliability is 
essential to ensure continuity in risk assessment. 
3. Sensitivity: This refers to the tools ability to accurately identify those 
who are at risk (Wang et al., 2014). 
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4. Specificity: This refers to the tools ability to accurately identify those 
who are not at risk (Wang et al., 2014). 
 
Sensitivity and specificity are used to determine the predictive validity of a 
risk assessment tool (Tannen et al., 2010). Ideally, each tool should have 
high sensitivity and specificity to provide the most valid risk assessment 
(Kottner et al., 2010) however few studies have demonstrated an appropriate 
level of both sensitivity and specificity among risk assessment tools (Webster 
et al., 2010).  
 
Hyun et al., (2013) conducted a study to evaluate the predictive validity of the 
Braden scale in an intensive care environment (n=7790). The results showed 
high sensitivity but low specificity, 0.954 (95% confidence interval: 0.936-
0.967) and 0.207 (95% confidence interval: 0.197-0.216) respectively. The 
author noted positive predictive value of 0.114 and negative predictive value 
of 0.977; however, the effect of preventative intervention on predictive values 
has not been mentioned. This would affect the predictive values of the study. 
Cho et al., (2009) provided similar results from their assessment of the 
Braden scale in an intensive care environment (n=715) with a high level of 
sensitivity and low specificity, 0.759 and 0.473 respectively. Poor positive 
and negative predictive value was noted, 0.181 and 0.928 respectively. The 
author has not discussed the effect of preventative measures on predictive 
value.  
 
Poor predictive validity was also noted in an assessment of the Waterlow 
scale in an acute care environment (n=274). Webster et al., (2010) found that 
sensitivity was 0.67 (95% confidence interval: 0.35-0.88) and specificity was 
0.79 (95% confidence interval: 0.73- 0.85). Positive predictive value was 0.13 
(95% confidence interval: 0.07-0.24) and negative predictive value was 0.98 
(95% confidence interval: 0.94-0.99). As in Hyun et al., (2013) and Cho et al., 
(2009), preventative intervention is not discussed in relation to poor 
predictive validity. Conversely, Tannen et al., (2010) found high predictive 
validity in the use of the Braden scale in an acute care environment (n=1053) 
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with sensitivity and specificity of 84.8% and 74.5% respectively. Similarly, 
Iranmanesh et al., (2011) found good predictive validity in the use of the 
Braden scale in an intensive care environment (n=82) however, analysis was 
completed based upon individual subscales and not on the Braden scale as a 
whole. Mean Braden scores of patients with pressure ulcer was 10.3, mean 
score of those without pressure ulcer was 13.9. An independent T-test 
verified a statistical significance between the two figures. Therefore, a lower 
Braden score suggests a higher risk of pressure damage. Significantly, as 
the study has been broken down to analyse the validity of specific subscales, 
it is important to note the added value of including age and level of 
consciousness into the Braden subscales to improve the predictive validity of 
the scale.  
 
Each of the five studies mentioned were conducted in either intensive care or 
acute care environments. Webster et al., (2010) and Iranmanesh et al., 
(2011) used prospective, descriptive designs. A cross-sectional, 
observational design was employed by Tannen et al., (2010). Prospective 
and cross-sectional designs are ideal when researching pressure damage as 
participants can be followed for a defined period of time. Over this time, 
changes in skin condition can be monitored and assessed according to the 
tool the researcher has used. Cho et al., (2009) and Hyun et al., (2013) used 
retrospective reviews of electronic medical records to collect study data 
which limits the validity of results as the researcher is dependent on accurate 
and complete documentation in order to assess the population. Regrettably, 
Iranmanesh et al., (2011) small sample size (n=82) reduces its applicability to 
other environments. Conversely, Tannen et al., (2010) and Hyun et al., 
(2013) large sample sizes, 1,053 and 7,790 respectively, are more applicable 
to the wider population.  
 
Issues in the predictive validity of current tools have prompted researchers to 
explore the modification of these tools. For example, Chan et al., (2009) 
conducted a study in a surgical orthopaedic ward which compared the 
Braden scale with a modified Braden scale. This modified scale substituted 
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subscales of body mass index and skin type with the current nutrition 
subscale. The sensitivity and specificity of the standard Braden scale was 
67% and 64% respectively. The modified Braden scale showed 89% 
sensitivity and 62% specificity. Therefore, the modified Braden scale 
provided a more appropriate predictor of validity in this environment. 
 
Another important aspect of risk assessment discussed in the literature is the 
use of clinical judgement. Clinical judgement is the processes in which a 
healthcare professional assesses the needs or concerns of a patient and 
intervenes where appropriate (Tanner, 2006). In regards to risk assessment 
in pressure damage, clinical judgement is employed by a clinician to 
determine the risk of each individual. Factors such as medical history, weight 
and skin condition will be taken into consideration however this is not a 
formal method of assessment and therefore, will differ between clinicians. 
Johansen et al., (2014) and Saleh et al., (2009) conducted studies to assess 
the impact of risk assessment in the development of pressure damage. 
These studies compared the use of clinical judgement against current risk 
assessment tools.  
 
Saleh et al., (2009) conducted their pre-test/post-test comparative study in an 
acute care setting, recruiting 719 participants from various medical and 
surgical settings. Participants were randomly allocated to three groups, a 
control group (Group C) with no intervention, a group using only clinical 
judgement (Group B) and a group using clinical judgement and the Braden 
scale (Group A). Group A and group B showed an incidence of 22% post 
intervention whereas Group C had an incidence of 15%. Reductions in 
prevalence were noted in all three groups post-intervention (A=10%, B=8%, 
C=17%) however the largest reduction was found in the control group which 
applied no intervention. This indicates that there was no advantage to using a 
formal risk assessment tool, such as the Braden scale, or the use of clinical 
judgement over the current risk methods employed by the study site.  
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Johansen et al., (2014) compiled a qualitative study in an effort to determine 
healthcare workers opinion of the validity of risk assessment scales. 
Fourteen healthcare workers in Norway and Ireland were recruited. 
Interestingly, the Norwegian health system does not recommend the use of a 
risk assessment tool, therefore all healthcare workers rely on clinical 
judgement alone. While in Ireland, the use of a formal risk assessment tool is 
strongly recommended. The study found that there was no difference 
between the use of clinical judgement and the use of a risk assessment tool 
in detecting those at risk. 
 
Both Johansen et al., (2014) and Saleh et al., (2009) found no significant 
difference in the evaluation of risk when comparing clinical judgement to risk 
assessment scales. This would suggest that there is no benefit to using 
clinical judgement as opposed to a risk assessment tool. Significantly, the 
high incidence of 22% in Saleh et al., (2009) study would indicate the need 
for a method of risk assessment that would identify those at risk more 
accurately and most importantly, more swiftly. The use of a qualitative design 
by Johansen et al., (2014) is a limitation as results will not be applicable to 
other environments. Although Saleh et al., (2009) reported that there was no 
benefit in the use of risk assessment tools or clinical judgement, a reduction 
in prevalence can be seen in all groups, most notably in the control group. It 
is likely that this is an example of the Hawthorn effect whereby the 
awareness of the study increased staff awareness and therefore promoted 
intervention. This is a limitation of the study as results cannot be directly 
related to study intervention.  
 
The current risk assessment methods, whether using clinical judgement or a 
risk assessment tool, involve a visual inspection of the skin to identify the 
presence or absence of tissue damage. According to the EPUAP (2014) 
guidelines there are six grades of tissue damage beginning with non-
blanching erythema or redness. This red marking on the skin indicates the 
presence of tissue damage. Unfortunately, the use of a visual skin 
assessment cannot provide clinicians with evidence of tissue damage until 
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after the damage has been done. Due to this, there is a growing interest in 
the use of clinical biomarkers to determine the risk of pressure ulcer 
development.  
 
The World Health Organisation (2001) defines a biomarker as a 
characteristic that can be objectively measured within the body, which can 
serve as an indicator of a biological process. When pressure damage first 
occurs, the body initiates a four phased healing response, the first of which is 
an inflammatory phase (Sussman and Bates-Jensen, 2012). This phase 
consists of a brief period of vasoconstriction, followed by vasodilation, 
oedema formation and cell migration, specifically neutrophils and 
macrophages to fight infection and begin wound healing. This oedema and 
migration of cells causes an increased level of moisture in the sub-epidermal 
tissue. Therefore, the level of sub-epidermal moisture is a biomarker of the 
inflammatory process. If sub-epidermal moisture is elevated, inflammation is 
present, therefore tissue damage has occurred. This enhanced method of 
risk assessment is valuable to clinicians as existing practice relies on visual 
skin assessment. By the time non-blanching erythema is visible on the 
surface of the skin, tissue damage has already occurred (Bates-Jensen et al, 
2008).  
 
Traditionally, pressure ulcers were considered to be caused by a prolonged 
lack of oxygen to the tissues (Daniel et al., 1982 and Hermann et al., 1999). 
This impaired oxygenation of tissue is a result of prolonged pressure which 
occluded blood vessels and therefore prevented the delivery of oxygen to the 
tissues. This poor oxygenation or ischemia results in the death of cells and 
the beginning of a pressure ulcer (Oomens et al., 2014). When this tissue 
death occurs in the superficial layers of the skin such as the dermis and 
epidermis, damage to the skin is apparent as it can be visualised (Bethall, 
2003). Recently, the European Pressure Ulcer Advisory Panel (2014) have 
altered their pressure ulcer classification system. This new system involves 
two further grades; unstageable damage which can be described as full 
thickness tissue loss or unknown depth and suspected deep tissue injury 
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which is a purple or maroon area of discoloured yet intact skin. Unstageable 
damage is often caused by slough or eschar covering the extent of the 
wound therefore, the depth cannot be verified (EPUAP, 2014). However, 
suspected deep tissue injuries have intact dermal layers yet show 
discoloration. This is due to the fact that deep tissue injuries arise in the 
muscle layers directly adjacent to a bony prominence. Currently, their 
presence can only be determined after the damage evolves to the superficial 
layers of the skin, at which time severe damage has already occurred 
(Stekelenburg et al., 2008). For this reason, the use of sub-epidermal 
measurement could be highly beneficial in determining the condition of the 
sub-epidermal layers. 
 
A study conducted regarding visual assessment of pressure damage and the 
use of sub-epidermal moisture (SEM) measurement found that higher SEM 
readings correlated with a greater likelihood of the development of grade I 
damage within one week (Bates-Jensen et al., 2009). Participants with 
elevated sub-epidermal readings were shown to be between 8-10 times more 
likely to develop visible pressure damage the following week. Therefore, 
inflammatory changes could be identified between 3-10 days prior to visible 
skin breakdown meaning sub-epidermal moisture measurement has the 
ability to detect pressure damage up to 10 days before current methods. The 
discovery and use of these biomarkers enables practitioners to determine the 
presence of pressure damage before it is visibly evident, which is otherwise 
not detectable through traditional risk assessment processes (Bates-Jenson 
et al, 2009).  
 
One method of detection of biomarkers is through the use of a hand-held 
scanner. This scanner sends low amplitude signals from electrode structures 
placed on the surface of the skin. These low amplitude signals use surface 
electrical capacitance to assess the level of oedema in the epidermal and 
sub-epidermal tissues (Bates-Jensen et al., 2008). The level of moisture in 
the skin is determined by dermal phase units. These units increase with an 
increase in moisture content (Harrow et al., 2014). 
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Previous trials of sub-epidermal moisture measurement have been 
promising. In Bates-Jensen et al., (2007) pilot study of nursing home 
residents (n=35), sub-epidermal moisture measurements were found to 
predict grade 1 pressure damage one week before visual cues were evident 
(odds ratio = 1.26 for every 100 Dermal Phase Units (DPU)  increase in 
SEM, p=.04). Similar results were reported in their cohort study of nursing 
home residents (n=31). Higher SEM predicted greater possibility of non-
blanching erythema/grade I pressure damage the following week (odds 
ratio=1.32 for every 100 DPU increase, p=0.03) (Bates-Jensen et al., 2008). 
A similar study conducted by Guihan et al., (2012) assessed the feasibility of 
using sub-epidermal moisture to predict early pressure damage in persons 
with a spinal cord injury. This study was conducted in two spinal cord injury 
centres with the inclusion of thirty-four participants. Changes in sub-
epidermal values were found to correlate with tissue damage with values 
increasing between normal skin (39.3 DPU, standard deviation=12.6) and 
erythematous/grade I visual damage (40.8 DPU, standard deviation 10.4). 
Sub-epidermal moisture measurement was also found to be useful in 
assessing darker skin tones (Bates-Jensen et al., 2009).  
 
Traditionally, there have been issues in identifying early tissue damage in 
darker skin tones as erythema is not easily visible. This means that people 
with darker skin tones may not provide the visual cues needed to alert the 
clinician that tissue damage is occurring. This is evident when reviewing 
prevalence of grade 1 pressure ulcers among Caucasian and African 
American skin which were 48% and 20% respectively (Baumgarten et al., 
2004). Grade I pressure damage is not easily identifiable in darker skin tones 
as the clinician is attempting to detect colour changes in darkly pigmented 
skin. Bates-Jensen et al., (2009) has documented similar results to 
previously mentioned studies. Elevated SEM readings correlated with the 
development of erythema/stage I and stage II pressure damage in persons 
with darker skin tones the following week (OR=1.88 for every 100 DPU 
increase in SEM, p=0.004).  
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As discussed above, there appears to be many issues in the use of risk 
assessment tools. There seems to be inconsistency in the consensus 
regarding the sensitivity and specificity of risk assessment tools. The studies 
discussed (Hyun et al., 2013, Iranmanesh et al., 2011, Tannen et al., 2010, 
Webster et al., 2010 and Cho et al., 2009) have suggested differing results 
despite containing a similar study population and setting. Each of the studies 
determined the validity of the tools through the use of positive and negative 
predictive values yet none of the studies mentioned the effect of preventative 
measures on predictive value. Preventative measures will alter predictive 
values as they will reduce the possibility of pressure damage therefore, 
reducing prevalence.  
 
Issues in validity of risk assessment tools have prompted researchers to 
modify existing tools to suit a specific specialty (Chan et al., 2009). This tool 
modification appears to improve validity; however, in order to modify a tool, 
specific risk factors must be determined for each speciality. Research in 
establishing predominant risk factors suggests a broad range of risks; 
therefore, selection of the most appropriate risk factors would be problematic. 
The use of clinical judgement in risk assessment was discussed in two 
studies (Johansen et al., 2014 and Saleh et al., 2009). Neither study found 
clinical judgement to be a more valid method of risk assessment when 
compared to current risk assessment tools. Issues in visual skin inspection 
have prompted interest in sub-epidermal measurement. As seen in studies of 
sub-epidermal measurement, pressure damage can be seen up to ten days 
before it is visibly evident on the skin (Guihan et al., 2012, Bates-Jensen et 
al., 2009, Bates-Jensen et al., 2008, Bates-Jensen et al., 2007). Therefore, 
using sub-epidermal measurement would facilitate faster recognition of early 
inflammation and therefore enable a greater targeting of prevention 
strategies. 
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1.3 Significance of the study 
Universally, the prevalence of pressure ulcers continues to burden the 
healthcare sector (Coleman et al, 2012). To date, efforts to reduce pressure 
ulcer prevalence have not been significant (Garcia-Fernandez, et al., 2013, 
Bouten et al., 2003). In fact, global prevalence almost doubled between 2001 
and 2009 (Garcia-Fernandez et al., 2013). 
 
According to Chaves et al., (2010), a study conducted in Belgium, Italy, 
Portugal, Sweden and the United Kingdom showed that European pressure 
ulcer prevalence is 18%. In Australia the rate is 12% and in the United States 
prevalence is reported to be 10% (Page et al., 2011). Pressure ulcer 
prevalence in South Korea is between 10.5% and 45.5% according to Kim et 
al., (2012). Turkish prevalence is stated to be between 7.2% and 54.8% 
(Sayer et al., 2008). Irish prevalence rates are reported to be between 9-38% 
(Moore and Cowman, 2011, Gallagher et al., 2008, Gethin et al., 2005 and 
Moore and Pitman, 2000).  
 
The cost of pressure ulcer prevention and healing is very high. Indeed, 
almost 4% of the UK health expenditure is used in the prevention and care of 
pressure ulcers (Chaves et al., 2010). Bennett et al., (2008) estimate that 2- 
8% of global health care budgets are used to treat pressure ulcers annually. 
Each year in the United States, 1.6 million people develop pressure ulcers at 
a cost of $2.2-$3.6 million annually (Sayer et al., 2008). Whiteing (2009) has 
suggested that the cost of treating a grade 1 pressure ulcer is £1,064 and the 
treatment of a grade 4 ulcer can cost up to £10,551. These figures do not 
include wounds with further complication such as wound infection or 
osteomyelitis which can cost up to £24,000 for treatment. Dealey et al (2012) 
estimate that hospital stays are lengthened by 5-8 days per pressure ulcer. 
This will accumulate between 3000 and 4800 excess bed-days per year not 
to mention the excess nursing and medical cost of these unnecessary days.  
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Pressure ulcers can affect people physically, mentally, socially and financially 
with the main problems being pain, immobility, anxiety, low mood, a sense of 
social isolation and increased absence from the workplace (Gorecki et al, 
2009). Gorecki et al., (2009) and Spilsbury et al., (2007) have discussed the 
impact of pressure ulcers on the individual’s self-image with many people 
citing poor self-image due to the appearance and smell of their ulcer. It has 
been noted that the mortality of patients with pressure ulcers is higher than 
the patients without pressure ulcers (Bo et al., 2003). It is evident that they 
have a significant negative impact on quality of life of the individual (Bouten 
et al., 2003). 
 
Another important point to consider is the aging demographic of our society. 
Studies have shown that advancing age is an important risk factor in the 
development of pressure damage (Moore et al 2013, Shanin et al 2008 and 
Nixon et al 2006). Chan et al., (2009) estimate that older persons will 
represent 17% of global population by 2050, compared with only 7% in 2002. 
Subsequently, as our population ages, our pressure ulcer prevalence will 
increase therefore increasing healthcare costs and negatively affecting 
individual quality of life. Consequently, appropriate risk assessment is 
essential to every healthcare sector in the world as it will provide invaluable 
information regarding individual probability of developing pressure damage. 
Preventative measures can then be implemented as necessary to prevent 
prevalence thereby reducing human and economic cost. 
 
1.3.1 Purpose of the Study 
The purpose of the study is to ascertain the best method of risk assessment 
for use in clinical practice. Assessing the risk of pressure ulcer development 
is essential in determining which patients will need preventative intervention. 
By defining those at risk and providing them with the appropriate preventative 
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care, pressure ulcer prevalence can be reduced, increasing quality of care 
and reducing healthcare costs.  
 
1.3.2 Research Question 
The research question for this study is: What is relationship between the 
Braden scale, Waterlow score and sub-epidermal moisture measurement? 
 
1.3.3 Research Aim 
The aim of this research is to assess three methods of risk assessment, 
namely the Braden scale, Waterlow score and sub-epidermal measurement 
and determine the relationship, if any, between them. 
 
 
 
1.4 Summary 
Pressure ulcers are one of the most prevalent health related complications 
worldwide, causing significant distress for the patient and cost to the 
healthcare system (Gardiner et al, 2008). The growing prevalence of 
pressure ulcers is a discredit to the healthcare sector as they are preventable 
(Garcia-Fernandez et al., 2013 and Chan et al., 2009). Therefore, the 
presence of pressure damage is often used as an indicator of quality care 
(Department of Health and Children, 2008). Pressure ulcer prevalence rates 
in Ireland are as high as 38% and the cost of treating such injuries is very 
high from both an economic and human perspective. In times of economic 
instability, prevention of health related complications need to be at the 
forefront of health professionals’ minds.  
 
Currently, the gold-standard in risk assessment is the use of risk assessment 
tool such as the Waterlow and Braden scales. Risk assessment scales have 
been advocated for use in international guidelines however, it is evident 
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through the literature that their efficacy in their current form is questionable. 
However, the research available on the use of sub-epidermal moisture 
measurement as a proxy for early pressure damage shows promise. If sub-
epidermal moisture measurement can be definitively verified, current issues 
with risk assessment tools could be redefined, yielding greater accuracy in 
predicting risk. 
Reducing the prevalence of pressure ulcers will have a positive impact on the 
health service in many ways. Quality of care will improve, length of hospital 
stay will decrease and nursing time spent caring for such wounds can be 
used in other areas. Appropriate risk assessment is a valuable tool in aiding 
health professionals to attain this goal. 
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Chapter Two – Literature Review 
2.1 Introduction 
The aim of the study was to determine the relationship between two risk 
assessment scales, the Braden scale and the Waterlow score, and sub-
epidermal measurement. Risk assessment is the process in which each 
person is screened for common risk factors for pressure ulcer development in 
an effort to determine those at risk as a precursor to the initiation of 
preventative measures (Moore et al, 2008). Risk assessment is often 
performed through the use of a risk assessment tool which is a numeric scale 
to provide the clinician with an estimated risk value for each individual. There 
are reported to be over forty risk assessment scales in use today (Kottner et 
al., 2010) each including different risk factors.  
 
Research regarding the most prominent risk factors in pressure ulcer 
development indicates a wide and varying range of factors for clinicians to 
consider when performing risk assessment. Mobility is often cited as the most 
prominent factor in determining risk however no consensus has been 
reached regarding other contributing factors. As the use of risk assessment 
tools is advocated by the European Pressure Ulcer Advisory Panel (2014) is 
it important to determine the validity of these tools. Therefore, a search was 
conducted to discover research relating to risk assessment in pressure 
damage. A review of the research has indicated several areas of importance, 
predictive validity of risk assessment tools, modification of risk assessment 
tools and the use of clinical judgement in risk assessment and each of these 
areas will be discussed.  
 
Reported issues in the use of risk assessment tools have prompted an 
interest in other methods of risk assessment such as sub-epidermal 
measurement. If sub-epidermal measurement can be shown to be a 
satisfactory predictor of pressure damage, then issues in the use of risk 
assessment tools could be eliminated. A search was conducted to review all 
articles related to the use and validity of sub-epidermal measurement and 
these articles are included in the literature review. 
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2.2 The Concept of Risk Assessment  
Pressure ulcer risk assessment is the process in which each person is 
screened for common risk factors for pressure ulcer development in an effort 
to determine those at risk as a precursor to the initiation of preventative 
measures (Moore et al, 2008). The first risk assessment tool, the Norton 
scale, was established in 1962 in response to growing concern regarding the 
development of pressure damage. By monitoring the patients that developed 
pressure damage, Norton noted several factors of influence (Bell, 2005). 
These factors were combined into a numeric tool to provide assistance to 
clinicians in determining those at risk. The tool was devised to measure 
several factors; activity, mobility, continence, physical condition and mental 
condition.  
 
Since the creation of the Norton scale, an abundance of research has been 
conducted regarding predominant risk factors in tissue damage however, we 
have yet to understand the combination of factors that best predict risk 
(Benoit et al, 2012). Bouten et al (2003) discuss sustained mechanical 
loading as the prevailing factor in pressure ulcer development mainly related 
to immobility such as paralysis and orthopaedic prosthesis. Lahmann et al 
(2011) agree that reduced mobility is the main risk factor but also include 
friction and shear as important factors to consider in the intensive care 
environment. Non-blanching erythema and older age profile are discussed as 
important risk factors in the geriatric population (Nixon et al, 2006). Shahin et 
al (2008) agreed that these two factors were the most common in the 
intensive care environment.  
 
Moore et al (2013) have compiled a research review regarding risk factors for 
pressure ulcer development with mobility, extended length of admission and 
older age as the most common factors for pressure ulcer development. Sayer 
et al (2008) cited incontinence and malnutrition as important risk factors. A 
study conducted in a critical care environment found that pressure ulcer 
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development occurred in overweight individuals which are in direct contrast 
with other studies. They also found that the mean age for pressure ulcer 
development was 51 years. This also contradicts previous studies (Alderden 
et al, 2011).  
 
Coleman et al (2013) conducted a systematic review of risk factors in 
pressure ulcer development and found mobility and poor tissue perfusion to 
be the prevalent risk factors however diabetes and previous pressure 
damage were also reliable indicators of risk. According to these studies, 
mobility appears to be the most commonly cited risk factor in pressure ulcer 
development. However, a multitude of risk factors appear to contribute to this 
issue. With so many risk factors to consider, clinicians would struggle to 
assess their patients. Research suggests that different risk factors should be 
considered depending on the speciality and population being assessed. For 
this reason, several risk assessment scales have been created, based upon 
risk factor research, to suit defined specialities and populations. 
 
Currently, over forty validated risk assessment scales are in use (Kottner et 
al., 2010). Two of the most commonly used risk assessment tools are the 
Waterlow and Braden scales (Guy, 2012 and O’Tuathail et al, 2011). Both of 
these scales were modelled on the original Norton scale however, subscales 
have been changed in accordance with the speciality of the population and 
risk factor research. The Braden scale is composed of six risk factors; 
sensory perception, moisture, activity, mobility, nutrition and friction/shear. 
Patients are assessed using each subscale and their score determines their 
level of risk. This scale was devised for use in a residential environment 
therefore, subscales were determined based upon common risks in this 
population. The Waterlow scale is composed of ten risk factors; body mass 
index, continence, skin type, mobility, sex, age malnutrition screening tool, 
tissue malnutrition, neurological deficit and major surgery/trauma. This scale 
was devised for an acute care setting; therefore, the subscales include risk 
factors common to an acute or surgical population. 
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The European Pressure Ulcer Advisory Panel (2014) advocates the use of a 
validated risk assessment tool. For this reason, the writer has chosen to 
focus on the use of the Braden and Waterlow scales in the review of 
literature. 
 
2.2.1 Search Strategy 
The Cumulative Index to Nursing and Allied Health Literature (CINAHL) plus 
with full text, Dynamed, PubMed and Cochrane databases were searched for 
relevant literature between October and November 2014. 
The search terms were as follows: 
 Risk assessment AND tool AND pressure ulcer OR pressure sore. 
 Risk assessment AND efficacy AND pressure ulcer OR pressure sore. 
 Risk assessment AND pressure damage. 
 Risk assessment AND pressure ulcer AND Waterlow OR Braden. 
 Predictive validity AND pressure sore OR pressure ulcer OR decubitus 
ulcer. 
 Predictive validity AND Waterlow OR Braden. 
 Inter-rater reliability AND Waterlow OR Braden. 
 Inter-rater reliability AND pressure sore OR pressure ulcer OR 
decubitus ulcer. 
All search terms had the same limitations applied; English language, peer 
reviewed, research articles. Abstracts of relevant titles were read by the 
author and relevant articles were read in detail. 
 
17 articles were appraised in total, which comprised of 13 studies relating to 
the use of risk assessment scales such as the Waterlow and Braden scores 
in clinical practice. Two literature reviews and two systematic reviews of 
current risk assessment scales were also included in the review. Of the 13 
studies reviewed, 12 were quantitative and one was qualitative. The 
qualitative study was conducted by engaging healthcare workers from 
several different care settings such as community care, nursing homes and 
acute care (Johansen et al., 2014). Eleven of the quantitative studies were 
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undertaken in an acute setting and the remaining study was conducted in a 
care of the elderly setting. The acute care settings comprised of a variety of 
specialties including five critical care, one orthopaedic and one general 
surgical study. The remaining studies were conducted throughout the study 
author hospital therefore several varying specialties were involved. The 
studies were from a broad range of countries including Germany, Iceland, 
Norway, Iran, Australia, two South Korean studies, two Chinese studies, two 
Irish studies and five studies from the United States. 
 
There were three reoccurring themes in the literature; Predictive validity of 
risk assessment scales, modification of risk assessment subscales to 
improve use in specialist areas and the comparison of clinical judgement and 
risk assessment scales. 
 
2.2.2 Predictive Validity of Risk Assessment Scales 
Eight studies were found that discussed the predictive validity of risk 
assessment tools. Three studies were comparative assessments of the 
predictive validity of multiple risk assessment tools (Jackson et al., 2011, 
Tannen et al., 2010 and Kim et al., 2009). The other five studies assessed 
the predictive validity of a single tool, with four studies evaluating the Braden 
scale (Hyun et al., 2013, Tschannen et al., 2012, Iranmanesh et al., 2011 and 
Cho et al., 2009) and the final study evaluating the Waterlow score (Webster 
et al., 2010). 
 
Kim et al., (2009) conducted a comparative study in South Korea to assess 
the best predictive tool for risk assessment in a surgical intensive care 
population. Three tools were compared; Braden, Song and Choi, and Cubbin 
and Jackson. These three risk assessment tools are the most commonly 
used tools in South Korea. This non-experimental, prospective study enrolled 
219 participants over a 10 month period. Participants’ skin was assessed 
daily and all three risk assessments completed until discharge. The 
sensitivity and specificity of each tool was calculated. Each tool showed 
adequate sensitivity and specificity; however the Cubbin and Jackson scale 
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provided the best values of 95% and 81.5% respectively. Interestingly, 
despite the adequate sensitivity and specificity for all three tools, positive 
predictive value was low, between 40.6% - 53.5%. The author states that all 
three tools overestimated the risk of pressure damage and this may lead to 
unnecessary preventative intervention and cost. The author has not 
mentioned the effect preventative strategies will have on predictive value. As 
stated by Moore and Cowman (2013) accurate predictive value is very 
difficult to determine as preventative interventions will alter the identified risk 
status. The reliance on predictive values is a limitation of the study as 
prevention will interfere with results. 
 
Similarly, Tannen et al., (2010) completed a study to compare risk 
assessment tools however the Braden, Waterlow and Care Dependency 
Scales were studied. Three risk assessment tools and a skin inspection were 
performed on each of the 1,053 patients in the study. Both the Braden and 
Care Dependency scales reached sufficient sensitivity and specificity levels. 
The Braden scale showed sensitivity of 84.8% and specificity of 74.5%, 
sensitivity of the Care Dependency Scale were 84.8% and 72% respectively. 
However, the sensitivity and specificity of the Waterlow score were too poor 
to prove adequate validity (72.7% and 4.2% respectively). The Braden and 
the Care Dependency scales showed high association with the incidence of 
pressure damage. However, the author states that the Care Dependency 
scale is already used in the hospital as a generic nursing assessment tool. 
Considering the sensitivity and specificity shown in the study, the Care 
Dependency scale could be used to assess risk for pressure damage and 
this would reduce nursing assessment activities. The author did not mention 
the inconsistency in the high association between the Braden and Care 
Dependency Score, and the incidence of pressure ulcers. If both of these 
tools are providing clinicians with high risk scores and intervention is being 
performed, why is damage occurring? If preventative measures are used as 
determined by the risk assessment score then pressure damage should not 
occur. This could be caused by two factors. Either preventative measures are 
not performed despite a high risk score or these tools are not providing 
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clinicians with appropriately specific risk assessments therefore, inadequately 
determining risk. 
 
Jackson et al., (2011) compared a locally developed risk assessment tool 
with the Braden scale. In this study, 41,840 participants were recruited into 
this retrospective study of risk assessment in an acute care facility. Patient 
medical records were reviewed and relevant data extracted. The authors 
noted that when using the Braden scale, 9.49 of 1,000 admissions developed 
pressure damage. When the locally developed risk assessment tool was 
used, 8.08 of 1,000 admissions developed pressure damage. The authors 
found that the difference in predictive validity between the two scales were 
not statistically significant. Therefore, there was no increased value in using 
the Braden scale over the hospitals current locally developed tool. The use of 
retrospective chart analysis is a limitation of the study as the author is reliant 
on adequate documentation to gather study data. As noted by Moore and 
Pitman (2000) nursing documentation regarding pressure area care is often 
inadequate. In their survey of documentation practices of nurses, it was 
found that prevention was not always performed despite the knowledge of 
pressure risk and the presence of a care plan. In fact, some patients who 
were defined as ‘at risk’ of pressure damage had no care plan in place. Also, 
care plans were not routinely updated meaning the patients risk status did 
not change according to changes in their condition. This will affect study 
results as the author has gathered data based upon documentation, which 
may not be reliable, as opposed to gathering data directly from the study 
population. Similarly to Tannen et al., (2010), the author has not mentioned 
the inconsistency between the risk assessment tool and the incidence of 
pressure ulcers. If the risk assessment tool is adequate and preventative 
intervention is performed there should be no incidence of pressure ulcers. 
The use of retrospective data collection could have contributed to the 
inconsistent results as the documentation may not have been accurate. If the 
risk assessment tools were not updated as the participants condition 
changed, this would provide inaccurate risk status and therefore, inaccurate 
24 
 
prevention. This could lead to pressure ulcer incidence despite 
documentation stating that prevention occurred. 
 
The comparison of several risk assessment tools is useful as it contrasts and 
compares strengths and weaknesses of the various tools. Two studies found 
the Braden scale to be a good predictor of risk; however, there was no added 
benefit in using the Braden scale over the study author’s current risk 
assessment tool. The third study encouraged the use of the Braden scale 
due to its high levels of sensitivity and specificity, yet the author notes that 
the low level of positive predictive value indicates that the tool is likely to 
overestimate risk leading to unnecessary preventative measures. As 
previously noted, predictive value is not an accurate measurement of the 
validity of the tool as preventative measures will interfere with the incidence 
of pressure ulcers. 
 
Both Tannen et al., (2010) and Jackson et al., (2011) used large sample 
sizes meaning the results could be representative to the wider population 
(Polit and Beck, 2012). The use of a retrospective method of data collection 
in Jackson et al., (2011) study is a limitation as it is dependent on accurate 
documentation (Polit and Beck, 2012). Quality control reports used to report 
pressure damage may not be a reliable indicator of prevalence as it is 
dependent on staff reporting. As pressure damage is an adverse incident, 
staff may be reluctant to report incidences. The final limitation this author has 
noted throughout the studies is the reliance on predictive values. No study 
mentioned the effect of prevention on predictive value. Also, studies noted 
incidence of pressure ulcers despite the use of risk assessment tools failed to 
mention this in their conclusions. 
 
Webster et al., (2010) conducted a longitudinal cohort study of 274 inpatients 
in an acute care setting. Waterlow score and skin assessments were 
completed every second day. Results showed moderate sensitivity and 
specificity, 0.67 (95% confidence interval; 0.35-0.88) and 0.79 (95% 
confidence interval; 0.73-0.85) respectively. The author also reported a low 
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positive predictive value, 0.13 (95% confidence interval; 0.94-0.99). For this 
reason, the author has reported poor predictive validity of the Waterlow score 
and advised an urgent randomised controlled trial to ascertain the clinical 
efficacy of the Waterlow score. Again, no discussion has been included 
regarding the impact of prevention on predictive values and this is a study 
limitation. 
 
The final four studies discussed the predictive validity of the Braden scale. 
Two were prospective cohort studies, Hyun et al., (2013) and Tschannen et 
al., (2012) with 7790 and 3225 participants respectively. Both studies 
conducted medical record reviews of inpatients, one in an acute care setting 
(Tschannen et al., 2012) and the other in intensive care (Hyun et al., 2013). 
The intensive care study showed moderate sensitivity and specificity, 0.954 
(95% confidence interval; 0.936-0.967) and 0.207 (95% confidence interval; 
0.197-0.216) respectively, but low positive predictive value 0.114 (95% 
confidence interval; 0.106-0.122). Therefore, the author does not recommend 
the use of the Braden scale in an intensive care environment isn’t advised 
due to its low predictive validity. 
 
Contrastingly, Tschannen et al., (2012) found the Braden scale to be a useful 
predictor in risk assessment. Braden scale scores at admission were found to 
be significant predictors of risk through logistic regression analysis. Logistic 
regression analysis is the analysis of one variable to determine the 
probability of the success of another variable (Polit and Beck, 2012). For 
example, Tschannen et al., (2012) used the incidence of pressure ulcers 
(12%, n=383) to determine risk factors could be used to identify those at risk. 
They found that Braden score at admission was a predictor of risk (odds ratio 
0.89; 95% confidence interval 0.86-0.93, p <.001). 
 
Similarly, the study of Iranmanesh et al., (2011) indicated the clinical 
usefulness of the Braden scale in predicting risk. This prospective study of 82 
intensive care patients used a daily Braden scale score and skin assessment 
to gather data. However, the Braden scale was not assessed as a whole, 
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instead it was broken down to its subscales and the subscales were 
assessed individually. The results were as follows; sensory perception (r = 
0.873, p < 0.01), moisture (r = 0.574, p < 0.01), activity (r = 0.83, p < 0.01), 
mobility (r = 0.644, p < 0.01), nutrition (r = -0.046, p < 0.01), friction and 
shear (r = 0.582, p < 0.01). Therefore, each subscale was shown to be 
statistically significant in the prediction of pressure damage. 
 
Cho et al., (2010) conducted a retrospective analysis of 715 patient records 
from an intensive care setting. The author found similar results to the Kim et 
al., (2009) study, sensitivity was 75%, specificity was 47% and positive 
predictive value was 18%. Once again, the effect of prevention on predictive 
value has not been mentioned by the author and this is a study limitation. 
 
Some limitations of the above studies include small sample size (Iranmanesh 
et al., 2011), retrospective analysis (Cho et al., 2009) and the use of medical 
records (Hyun et al., 2013, Tschannen et al., 2012 and Cho et al., 2009). 
Small sample size limits the generalizability of the study results as the small 
sample will not be representative of the wider population (Polit and Beck, 
2012). A retrospective analysis of medical records relies on accurate 
documentation. Results may not be representative if the documentation is 
incomplete (Polit and Beck, 2012). The same issue applies to the use of 
medical records. Obtaining data from medical records alone, without direct 
patient contact, creates the possibility for missed or incorrect data. 
 
Systematic and literature reviews regarding risk assessment scales have 
found similar issues to those discussed previously. Garcia-Fernandez et al., 
(2013) reviewed the research regarding risk assessment in intensive care. 
Sixteen scales were identified as developed specifically for the critical care 
environment. Of these, only 7 have been validated for use. Of these seven 
studies, only the Cubbin-Jackson scale offers adequate levels of sensitivity 
and specificity, 85% and 73% respectively. The positive predictive value of 
this scale was 58%. However, the authors (Garcia-Fernandez et al., 2013) 
state that due to the limited research regarding Cubbin-Jackson in an 
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intensive care environment (only three studies have been conducted) further 
validation is required. The author recommends the use of the Braden scale 
despite a specificity rating of 38%. This is accompanied by a low positive 
predictive value of 48%. Again, the low positive predictive value has been 
noted as a limitation of the Braden scale however, the effect of prevention on 
predictive value has not been considered.  
 
Kottner et al., (2010) found little evidence to support the validity of risk 
assessment scales. The study cites the large number of risk factors involved 
in risk assessment and the inconsistencies regarding their importance. 
Therefore, weighting of risk factors is a concern as many tools have equal 
scores for each subscale. In reality, some subscales have more clinical 
relevance to the development of pressure sores than others. Risk factors are 
patient and specialty specific meaning the most predictive risk factors will 
vary in every clinical setting (Henoch, 2003). As mentioned previously, 
mobility appears to be the most commonly cited risk factor in pressure ulcer 
development (Coleman et al., 2013, Moore et al., 2013, Lahmann et al., 2011 
and Bouten et al., 2003). However, research shows that other contributing 
factors vary widely depending on the population and speciality. 
 
Moore et al’s. (2014) Cochrane systematic review discussed two studies 
regarding risk assessment tools for the prevention of pressure damage. 
Saleh et al’s. (2009) randomised controlled trial had three intervention 
groups. Group A used the Braden scale risk assessment and were provided 
with educational training regarding the development and prevention of 
pressure damage. Group B received educational training alone and Group C 
used clinical judgement alone. No statistical difference was found in pressure 
ulcer incidence between these three groups. The second study, a 
randomised controlled trial by Webster et al (2011), compared three 
intervention groups. Group A received assessment using the Waterlow scale, 
Group B were assessed using the Ramstadius screening tool and Group C 
were assessed using clinical judgement alone. There was no statistical 
significance regarding the incidence of pressure damage between the three 
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groups or methods. Therefore, the systematic review concludes that there is 
no evidence to support the use of risk assessment tools in the reduction of 
pressure ulcer incidence. 
 
2.2.3 Modification of Risk Assessment Subscales 
The questionable predictive validity of current risk assessment scales has led 
many authors to discuss modification of existing scales, specifically devising 
new subscales. Current risk assessment scales comprise varying subscales. 
For instance, the Braden scale is composed of six risk factors; sensory 
perception, moisture, activity, mobility, nutrition and friction/shear. The 
Waterlow scale is composed of ten risk factors; body mass index, 
continence, skin type, mobility, sex, age, malnutrition screening tool, tissue 
malnutrition, neurological deficit and major surgery/trauma. Research has 
suggested that risk assessment tools, in their current form, are insufficient for 
all environments or specialities. The research surrounding the modification of 
risk assessment tools is outlined below. 
 
Chan et al., (2009) completed a study to assess the predictive validity of the 
modified Braden scale in an orthopaedic environment. This modified scale 
was based upon previous studies conducted in Hong Kong which suggested 
the most appropriate subscales for risk assessment. The Braden scale was 
found to be the most accurate of three tools, however it did not account for 
skin type and body mass index. The Braden also included a nutrition 
subscale which was removed due to the irregularity in its measurement. This 
prospective, cohort study recruited 197 patients from an orthopaedic ward in 
Hong Kong. Daily risk assessments of the Braden scale and modified Braden 
were completed to determine efficacy. The modified Braden scale was found 
to have higher predictive validity than the Braden scale noting sensitivity and 
specificity to be 89% and 62% respectively however the sensitivity and 
specificity of the Braden scale was 67% and 64% respectively. The moderate 
sensitivity and specificity of the Braden scale provide a wide margin of error 
in the risk assessment of patients. Of note, the subscales of sensory 
perception (r = 0.214, 95% confidence interval; 0.061-0.746) body mass 
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index (r = 0.470, 95% confidence interval; 0.238-0.929) and skin type (r = 
0.217, 95% confidence interval 0.084-0.561) were found to be significant 
predictors of risk using regression analysis. Statistical significance was noted 
for all subscales (p = 0.016, 0.030 and 0.002 respectively). However, the 
study environment is a limiting factor. The mean age of participants was 79.4 
meaning this sample will not be representative of the wider population. 
Further research is needed to confirm the predictive power of the modified 
Braden scale. 
 
Cox (2011) compiled a study to examine the predictors of pressure ulcers in 
critical care, specifically the most prominent risk factors. The Braden 
subscales of mobility, activity, sensory perception, moisture, nutrition and 
friction/shear were analysed. Further subscales of age, blood pressure, 
length of stay, administration of vasopressors and comorbid conditions were 
also analysed. A retrospective, correlational design was used to observe 347 
patients in a surgical intensive care unit. Risk factors were assessed to 
determine the most accurate predictors of pressure ulcers. The Braden scale 
was found to over predict risk with 75% of participants deemed to be at risk 
but remaining ulcer free. The author has not mentioned the effect of 
intervention on predictive validity. When subscales were individually 
assessed, mobility and friction/shear were found to be reliable indictors of 
risk (r = 0.439, 95% confidence interval; 0.21-0.95 and r = 5.715, 95% 
confidence interval; 1.423-22.950 respectively). Other predictive factors 
included age (r = 1.033, 95% confidence interval; 1.003-1.064), length of stay 
(r = 1.008, 95% confidence interval; 1.004-1.012), use of vasopressors (r = 
1.017, 95% confidence interval; 1.001-1.033) and cardiovascular disease (r = 
3.380, 95% confidence interval; 1.223-9.347). The author suggests the 
development of a new risk assessment tool, which comprises these factors, 
for use in the critical care environment. The retrospective nature of this study 
is a limitation as the author was reliant on documentation to extract data. 
Poor documentation could provide inaccurate results. Further assessment of 
risk factors in a critical care environment is needed to confirm these findings. 
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Several other authors cite the need for modified tools due to poor predictive 
validity (Gadd et al., 2014, Wang et al., 2014, Hyun et al., 2013, Tschannen 
et al., 2012 and Iranmanesh et al., 2011) however further research is needed 
to determine the most predictive subscales of each risk assessment tool. 
 
2.2.4 Clinical Judgement and Risk Assessment Scales 
Clinical judgement is the processes in which a healthcare professional 
assesses the needs or concerns of a patient and intervenes where 
appropriate (Tanner, 2006). In regards to risk assessment in pressure 
damage, clinical judgement is employed by a clinician to determine the risk of 
each individual. Factors such as medical history, weight and skin condition 
will be taken into consideration however this is not a formal method of 
assessment and therefore, will differ between clinicians. For this reason, it is 
not possible to standardise this method of assessment. This is a limitation as 
assessment will differ from clinician to clinician therefore providing irregular 
risk assessment. Nevertheless, clinical judgement is still regarded as 
beneficial in risk assessment (Johansen et al., 2014, Balzer et al., 2013 and 
Saleh et al., 2009). 
 
Two studies compared the use of clinical judgement and the current risk 
assessment scales. Johansen et al., (2014) conducted a descriptive, 
qualitative study to explore nursing opinion on risk assessment and 
preventative practice. Fourteen healthcare workers from Norway and Ireland 
were interviewed by the researchers and participated in two focus groups. 
These two groups were chosen as Irish healthcare workers use a structured 
risk assessment scale while Norwegians use clinical judgement alone in 
assessing risk. The authors found that participants accurately identified risk 
factors irrespective of their method of risk assessment. Therefore clinical 
judgement can play a valid role in risk assessment. Saleh et al., (2009) 
conducted a similar study to evaluate the impact of risk assessment methods 
on patient outcomes. Three groups were formed, one to assess using the 
Braden scale, one to receive education about the Braden scale but continue 
using clinical judgement alone and a control group which had no intervention. 
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The authors found that there was no statistical significance between the 
Braden scale and the use of clinical judgement as seen in the post-test 
incidence rates of 22% and 15% respectively. The authors advocate using 
clinical judgement over the use of the Braden scale. The training of the 
clinical judgement group in the use of the Braden scale is a limitation of the 
study. If this group were not to use the scale, there was no reason to educate 
them on its use. Results pertaining to the efficacy of clinical judgement may 
have been altered by changes in practice post Braden education. 
 
2.3 Sub-epidermal moisture measurement 
2.3.1 Introduction 
Assessment of the skin is a vital component of risk assessment in pressure 
damage prevention (EPAUP, 2014). It is advised that skin assessment 
should be used as part of pressure risk assessment and should be included 
in the screening policy of all healthcare organisations (EPUAP, 2014). There 
are two types of pressure ulcer, superficial and deep (Bouten et al., 2003). 
Superficial damage is evident to clinicians as it is near the surface of the skin 
however, deep tissue damage cannot be visualised and this is problematic in 
skin assessment. For this reason, the writer is interested in evaluating the 
use of sub-epidermal measurement in the assessment of pressure damage. 
Current research on the use and validity of sub-epidermal measurement is 
discussed below. 
 
2.3.2 Skin Assessment 
Assessment of the skin is a vital component of risk assessment in pressure 
damage prevention (EPAUP, 2014). It is advised that skin assessment 
should be used as part of pressure risk assessment and should be included 
in the screening policy of all healthcare organisations (EPUAP, 2014). Four 
factors are noted in correct skin assessment; Discoloration of the skin, 
increased skin temperature, oedema and a change in tissue consistency 
(EPUAP, 2014). When noting skin discoloration it is important to distinguish 
between blanching and non-blanching erythema. Blanching erythema is an 
area of red or erythematous tissue that loses all redness when pressed. 
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Therefore, non-blanching erythema is tissue that remains red when pressed 
(Bethnell, 2003). Non-blanching erythema is the most important symptom of 
grade I pressure damage (EPUAP, 2014). It has been shown to be the first 
sign of tissue reaction to prolonged pressure and can be reversed if pressure 
is relieved (Halfens et al., 2001, Smith, 1995 and Maklebust, 1987).  
 
There are two methods used to determine the presence of non-blanching 
erythema, the finger method and the transparent disk method (Vanderwee et 
al., 2006). Both methods involve pressing the tissue lightly to test for 
blanching of the skin. According to Bouten et al., (2003), there are two types 
of pressure ulcer; superficial and deep. Superficial pressure damage affects 
the layers of the skin near the epidermal tissue and is therefore visible to the 
naked eye (Linder-Ganz et al., 2006). Thus, superficial damage can be 
visualised and assessed using either the finger or transparent disk method. 
However, deep tissue injury cannot be seen as it is below the epidermal 
layer. This is a serious concern for clinicians as visual skin assessment is not 
capable of identifying the presence of deep pressure damage. The writer is 
interested in exploring the use of sub-epidermal moisture measurement as 
this could be a worthy method of determining the presence of deep tissue 
damage. 
 
2.3.3 Search Strategy 
The Cumulative Index to Nursing and Allied Health Literature (CINAHL) plus 
with full text, Dynamed, PubMed and Cochrane databases were searched for 
relevant literature between October and November 2014. 
The search terms were as follows: 
 Sub-epidermal AND moisture. 
 Sub-epidermal moisture AND pressure damage. 
 Biophysical marker AND pressure damage. 
 Biophysical marker AND skin. 
 Biophysical measure AND skin. 
 Surface electrical capacitance. 
 Tissue water content AND epidermis AND pressure damage. 
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 Pressure damage AND skin capacitance. 
All search terms had the same limitations applied; English language, peer 
reviewed, research articles. Abstracts of relevant titles were read by the 
author and relevant articles were read in detail. 
 
Six studies were found based upon the use of sub-epidermal moisture in risk 
assessment of tissue damage. Three studies were conducted in care of the 
elderly settings and two studies in a spinal care injury centre. The final study 
evaluated the inter-device and inter-reliability of sub-epidermal measurement. 
This was not conducted in a clinical setting instead volunteers were used to 
determine reliability. All six studies were quantitative and were completed in 
the United States. Three studies  were descriptive, cohort designs (Bates-
Jensen et al., 2009, Bates-Jensen et al., 2008 and Bates-Jensen et al., 2007) 
and three studies used a prospective, observational design (Guihan et al., 
2012 and Harrow et al., 2014). Sample sizes in all six studies were similar, 
recruiting between 16 and 66 participants. 
 
The first sub-epidermal moisture study by Bates-Jensen et al., (2007) was a 
pilot study to ascertain the relationship between sub-epidermal moisture 
measurement and visual skin inspection on non-blanching erythema or grade 
I tissue damage. The sample group were predominantly non-Hispanic white 
(80%) females (83%) with cognitive and functional impairment and at risk of 
pressure ulcer development as defined by their current Braden scale score. 
Among this cohort of 35 nursing home residents, the authors identified a 
statistically significant relationship between elevated sub-epidermal moisture 
measurement and higher grades of skin damage (r = 1.26 for every 100 DPU 
increase in SEM, p = 0.04). This relationship existed across all anatomical 
sites (Sacrum, trochanters, ischials and buttocks).  
 
Concurrent visual assessments and sub-epidermal readings were taken at 
each anatomical site weekly for fifty-two weeks. Sub-epidermal moisture was 
measured using a dermal phase meter with higher dermal phase 
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measurements indicating great sub-epidermal moisture. Sub-epidermal 
moisture measurement was also responsive to visual changes in the skin, 
increasing as tissue damage became evident and decreasing as tissue 
damage improved. Most importantly, high sub-epidermal moisture readings 
were found when tissue damage was not visible; however visible tissue 
damage developed the following week. The authors found that 26% of all 
visual erythema or grade I pressure damage had been predicted the week 
before it was visible on the surface of the skin.  
The following year, Bates-Jensen et al., (2008), completed the follow up to 
their pilot study. Thirty-one nursing home residents were recruited to the 
study. This provided similar yet more comprehensive results to the pilot 
study. They have shown that sub-epidermal moisture measurement is 
concurrent with visual assessment in four levels of risk; no damage, 
blanching erythema, grade 1 and grade 2+. Therefore, as visual assessment 
progresses, higher sub-epidermal readings were attained. A higher rate of 
32% of all visual erythema was predicted the week before visible signs of 
damage were present. The lack of definitive measurement values has been 
named as a limitation of both studies. The authors do not provide minimum or 
maximum sub-epidermal measurement values (dermal phase units) that 
would indicate tissue damage. It is verified that values increase with 
worsening tissue damage, however specific values are not provided. They 
state that the wide variation of values in the study did not allow for the 
establishment of cut-off points and further assessment is needed in this area. 
 
A further cohort study with 66 nursing home residents evaluated the validity 
of sub-epidermal moisture measurement in identifying early pressure 
damage in darker skin tones (Bates-Jensen et al., 2009). African-Americans 
experience a higher incidence of more severe pressure damage (Grade 2+) 
than Caucasians with a rate of 0.56 per person year compared to 0.35 per 
person year respectively (Lyder et al., 1999). This has been attributed to the 
difficulties in identification of early damage such as erythema due to dark 
pigmentation of the skin. This study showed similar results to the two studies 
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discussed previously. Higher sub-epidermal values predicted a greater 
possibility of grade I or grade II damage within one week. In this study, 88% 
of non-visible erythema was identified using sub-epidermal measurement, 
one week before tissue damage was evident. Favourably, this study provides 
a dermal phase unit (DPU) value of 50 DPU to indicate the risk of pressure 
ulcer development. Those with a DPU of 50 or more were 5 times more likely 
to develop a grade I or grade II ulcer the following week, however the author 
states that this value is only applicable to darker skin tones. 
 
Harrow et al., (2014) conducted a prospective, observational study involving 
sixteen participants in a spinal injury centre. The authors aim was to 
determine the ability of sub-epidermal scanning to differentiate between 
different grades of pressure damage. Participants were visited once by the 
author and their skin was scanned in two areas, at the site of an existing 
pressure sore and at a control site with no evidence of pressure damage. 
Overall sub-epidermal measurement at the pressure ulcer site was greater 
than the control site by 9% and this was statistically significant (p = 0.02). 
Therefore, sub-epidermal measurement appears appropriately differentiate 
between pressure damage and intact skin. The small sample size is a 
limitation of the study. The use of participants from a spinal care unit is also a 
limitation as this reduced the generalisability of the results to the wider 
population. 
 
An inter-rater and inter-device study was conducted to determine the 
reliability of three types of sub-epidermal scanner and their use by different 
individuals. Clendenin et al., (2015) assessed thirty-one volunteers at three 
anatomical sites, sternum, sacrum and heels. Each participant was scanned 
by three individuals to determine inter-rater reliability. Each of the three 
devices was used once by the same raters, on the same participants and the 
same anatomical sites. High reliability was found in both the inter-rater and 
inter-device analysis across all anatomical sites (intraclass correlation 
coefficient (ICC) Sternum – 0.961, 95% confidence interval; 0.955-0.967, ICC 
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Sacrum 0.886, 95% confidence interval; 0.870-0.900, ICC Left Heel 0.848, 
95% confidence interval; 0.827-0.867, ICC Right Heel 0.854, 95% confidence 
interval; 0.834-0.872). One limitation of the study is the use of volunteers 
instead of acute or residential participants. The mean age of the population 
used was 29.8 years and none of the participants were at risk of developing 
pressure damage. Therefore, this population is not representative of the 
intended population of the device. For this reason, results must be 
interpreted with caution.  
 
The final study was conducted in a spinal cord injury centre for war veterans 
(Guihan et al., 2012). The authors recruited 34 veterans with spinal cord 
injury into the study to evaluate the feasibility of using sub-epidermal 
moisture to predict early pressure damage in persons with spinal cord injury. 
Although similar results were found to the studies outlined above, the authors 
could not sufficiently analyse the potential of sub-epidermal measurement as 
they did not encounter enough early stage pressure damage. Despite the fact 
that most participants had one or more pressure ulcers on admission to the 
study, only seven cases of grade I damage were found in 34 people. All other 
damage was grade II or above. This is due to the limited mobility and lack of 
sensation associated with spinal cord injury (Guihan et al., 2012). Sub-
epidermal values were still seen to rise in line with visible tissue damage as 
outlined in the previous studies, sub-epidermal measurement was lowest for 
normal skin (39.3 DPU, standard deviation = 12.6) and higher for 
erythema/stage I pressure ulcers (40.8 DPU, standard deviation = 10.4) 
however no statistical significance could be inferred.  
 
All six studies provided similar, promising results in relation to the use of sub-
epidermal scanning in pressure damage assessment. Sub-epidermal values 
were concurrent with visible tissue damage providing accurate information 
regarding the level of tissue damage. High inter-rater reliability was noted 
meaning the use of the scanner by different clinicians will provide reliable 
results. More significantly, sub-epidermal measurement identified tissue 
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damage before it was visibly evident on the surface of the skin. This element 
of sub-epidermal measurement surpasses current risk assessment as 
clinicians currently have no method of identifying the presence of tissue 
damage until the damage has already occurred. This factor is also promising 
for clinicians struggling to assess patients with darker skin tones as they will 
not be reliant on visual assessment which frequently misses early pressure 
damage due to the dark pigmentation of the skin. 
 
Conversely, there are limitations that apply to each study. The small sample 
size is a limitation in each study as such a small number will not be 
representative of the wider population. Similarly, each study was conducted 
in a specialist area and as such these results may not translate to other 
specialties. Three of these studies were undertaken by the same author and 
this author is a co-contributor in a fourth study. Further research is needed in 
a larger population and by other authors to reinforce the validity of sub-
epidermal moisture measurement. 
 
2.4 Summary 
From a review of the literature it is clear that there are many inconsistencies 
regarding risk assessment in pressure area ulcer prevention. Current risk 
assessment tools have varying degrees of predictive validity depending on 
the environment they are utilised in. The concept of modifying tools shows 
promise, however it would be a difficult process to modify tools to suit every 
speciality. Moreover, the research shows inconsistencies in the predictive 
ability of tools, despite research being conducted in the similar environments. 
Therefore, modification of tools would not guarantee accuracy even if they 
were environmentally specific. The use of clinical judgement in risk 
assessment continues to be useful, however appropriate clinical judgement 
comes with experience and inexperienced clinicians will struggle to risk 
assess using their judgement alone. 
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Sub-epidermal scanning has been shown to be useful in risk assessment of 
pressure damage. Concurrent elevated sub-epidermal moisture and visual 
skin changes suggest that the measurement of sub-epidermal moisture can 
distinguish between damaged and undamaged tissue. Importantly, sub-
epidermal measurement could detect early pressure damage up to a week 
before damage was visible on the skin. This factor alone is invaluable to 
clinicians as it will allow for early implementation of preventative measures. 
This may lead to a decrease in more severe pressure ulcer prevalence.  
 
Nevertheless, minimum and maximum parameters of sub-epidermal moisture 
values need to be highlighted in future research to aid imminent use of sub-
epidermal scanning. Larger studies need to be conducted to assess the 
validity of sub-epidermal scanning on a wider scale. Risk assessment 
through sub-epidermal moisture measurement shows potential; however, 
more research is needed on the topic to reinforce the validity of the current 
research. 
 
2.5 Conclusion 
As stated by Moore and Cowman (2013), risk assessment is the first step in 
pressure ulcer care planning. The outcome of the risk assessment will 
determine the preventative measures, if any, which will be put in place. In this 
regard, the importance of risk assessment cannot be underestimated. A 
literature review has discovered many inconsistencies in the use of risk 
assessment tools. This research does not seem to have consistent or 
succinct views on the validity of risk assessment tools even when the studies 
are conducted in similar environments and with similar populations. As 
shown in the literature review, no tool has been shown to be totally effective. 
In regards to specific risk factors, mobility appears to be the only 
predominant risk factor mentioned throughout the research. Dozens of other 
risk factors have been determined through research but consensus has not 
been reached on which factors contribute to pressure ulcer development. 
39 
 
This may be due to the varying specialities of the studies however, in 
practice, these risk assessment tools will be used in a variety of specialities. 
Therefore, the idea that some tools will be invalid in certain specialities is a 
serious limitation. It is a serious concern for clinicians. 
 
Research regarding sub-epidermal measurement is promising. It has been 
shown that sub-epidermal values change with visible changes in the skin 
meaning this measurement is adequately determining changes in the skin. It 
has been shown to have good inter-rater reliability meaning it is easy to use 
and can be used by any clinician without fear of misinterpreted results. Most 
significantly, it has been shown to identify tissue damage before it is visible 
on the surface of the skin. If sub-epidermal measurement performs as 
suggested in the studies discussed, it could enable clinicians to eliminate 
issues regarding current risk assessment tools and visual assessment. It 
could aid the discovery and diagnosis of deep tissue injury and help provide 
prompt clinical response. Although the research on sub-epidermal 
measurement to date has been positive, more research is needed to verify its 
use. Due to this, the writer has conducted research to determine the 
relationship between current risk assessment tools and sub-epidermal 
measurement. If sub-epidermal measurement can be seen to accurately 
identify those with pressure damage it would be a valuable tool in pressure 
ulcer prevention. 
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Chapter 3 – Research Methodology 
3.1 Introduction 
This chapter will discuss the principles of research methodology. The writer 
briefly describes common research paradigms and following this, research 
methodology is discussed with focus on the chosen methodology of the 
study. Details of the study including sampling, data collection, data analysis, 
reliability, validity and ethical considerations are given. The research 
question, purpose and aim are discussed including the origin and motivation 
for the study. 
 
The purpose of the study was to explore the relationship between three risk 
assessment tools. In order to verify validity, a quantitative method was 
chosen. Quantitative methods are helpful in the assessment of interventions 
as study results are quantifiable. It is particularly useful in identifying trends, 
patterns and for comparative use (Parahoo, 2006). Due to the nature of the 
development of pressure damage, a prospective, observational approach 
was used. This allowed the researcher to follow participants for a period of 
time to determine the effect of the risk assessment tools and therefore, the 
relationship between them (Nieswiadomy, 2012). 
 
3.2 Research Question 
The research question is an important aspect of the study as it guides the 
selection of the most appropriate research method (Polit and Beck, 2012). 
The research question for this study originated from the lack of congruency in 
current risk assessment tools. Many studies, as discussed in the literature 
review, fail to reach agreement on the validity or accuracy of risk assessment 
scales. For example, the study conducted by Hyun et al., (2013) found high 
sensitivity but low specificity in the use of the Braden scale; however, 
Tschannen et al., (2012) reported the Braden scale to be a useful predictor of 
risk. It is important to note that both studies were conducted through 
retrospective analysis of patient records. Also, both studies were conducted 
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in an acute care environment. Many scales have been designed for a specific 
speciality, meaning their validity is often poor when used in other areas (Bell, 
2005). No tool has been validated for use in all specialties. The continuing 
prevalence of pressure ulcers would indicate that further action must be 
implemented to control and reduce pressure ulcer prevalence (Garcia-
Fernandez et al., 2013, Cox, 2012 and Chan et al., 2009). 
 
Advances in technology have brought about the creation of the sub-
epidermal moisture scanner. According to the current research on the use of 
sub-epidermal moisture scanning, pressure damage can be detected up to 
10 days before the skin shows any sign of damage (Bates-Jensen et al, 
2009). This could be highly beneficial to the healthcare sector as clinicians 
would no longer be reliant upon risk assessment tools that use visual skin 
assessments. If damage can be identified at an earlier stage, preventative 
measures can be implemented. This could promote a reduction in more 
severe pressure ulcer prevalence. It is also important to mention its universal 
use; indeed the sub-epidermal moisture scanner can be used in any area, 
irrespective of speciality. 
 
Several studies have been conducted to determine the validity of the sub-
epidermal moisture scanner. Currently, there are no studies to compare the 
relationship between sub-epidermal measurement and risk assessment tools. 
Therefore the research question was formed; 
 
What is the relationship between the Braden scale, Waterlow score and sub-
epidermal measurement? 
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3.3 Research Purpose and Aim 
The purpose of the study was to conduct research to determine the presence 
or absence of a relationship current risk assessment tools and sub-epidermal 
measurement. This was important as no studies have been conducted in this 
capacity. The author believes this research could add to current knowledge in 
the area of pressure ulcer assessment and prevention. 
 
The aim of this study was to compare sub-epidermal moisture scanning with 
the two most commonly used risk assessment tools, the Waterlow score and 
the Braden scale, to determine what relationship, if any, existed. 
 
3.4 Evidence Based Practice and the Role of Research 
Sakett et al., (2000) describe evidence based practice as the collection, 
evaluation and integration of current research and clinical expertise in an 
effort to make informed clinical decisions. The aim of evidence based 
practice is to provide patients with the most advanced care according to 
current research. In relation to tissue viability, pressure damage and wound 
care, local policies are in place in each hospital. National clinical practice 
guidelines such as the National Best Practice and Evidence Based 
Guidelines for Wound Management (HSE, 2009) are in place to support the 
clinician in providing evidence based wound care. Care bundles have been 
introduced, such as the SSKIN bundle (HSE, 2014) to reduce the incidence 
of pressure ulcers. This collaborative is aiming to reduce the incidence of 
avoidable pressure ulcers with the use of an educational initiative. By 
encouraging staff to inspect skin, provide pressure distribution surfaces, 
promote patient movement, effectively manage incontinence and provide 
suitable nutrition, the collaborative hopes to reduce avoidable pressure ulcer 
prevalence to zero. This initiative has been developed based upon research 
which suggests mobility or activity, skin inspection, incontinence and nutrition 
are the highest predictors of risk.  
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Despite the use of clinical practice guidelines and care bundles, pressure 
damage continues to be problematic. The writer believes further research 
regarding new methods of pressure assessment, such as the sub-epidermal 
moisture measurement, may provide valuable insight different methods of 
risk assessment. 
 
3.5 Research Paradigms 
A paradigm is a worldview or perception of the complexities of the issues 
surrounding us (Polit and Beck, 2012). In research, there are two expansive 
paradigms under which research is conducted, the positivist paradigm and 
the constructivist paradigm.  
 
3.5.1 The Positivist Paradigm 
According to Polit and Beck (2012), positivism is a paradigm which endorses 
the rational and scientific. Positivists believe that there is inherent order and 
structure to the universe. This belief guides their research in discovering the 
factors and causes of phenomena (Polit and Beck, 2012). Objectivity is at the 
forefront of the positivist paradigm (Nieswiadomy, 2012). Positivists value a 
scientific approach to research and strive to refrain from allowing personal 
beliefs to affect the nature of their work (Polit and Beck, 2012).  
 
This paradigm focuses on inferential processes to determine the cause and 
effect of actions on the world around them (Polit and Beck, 2012). Research 
that is undertaken is quantifiable to provide measured and specific 
information on the topic of interest (Polit and Beck, 2012). Research samples 
are large in order to deduce generalisations that can be applied to the 
population being studied (Polit and Beck, 2012). 
 
The search for empirical evidence is the most important factor in the positivist 
paradigm. This is a form of evidence which is gathered through the senses, 
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such as the visual observation of skin to determine the presence of tissue 
damage (Polit and Beck, 2012). The use of quantifiable factors allows a non-
bias approach to research as the measurement of data cannot be altered by 
personal belief (Polit and Beck, 2012). Traditionally, this method of research 
has been given more credibility due to its scientific method (Polit and Beck, 
2012) however, it has limitations. Due to the focused nature of positivist 
methods, information around the topic of interest is often omitted meaning a 
full understanding of the topic is lost (Polit and Beck, 2012). 
 
3.5.2 The Constructivist Paradigm 
Constructivism began as an alternative to the positivist movement (Polit and 
Beck, 2012). Unlike positivists, constructionists believe that there is no 
inherent order to the universe. Within constructivism, reality is not fixed, 
rather it is subjective and unique to the individual (Polit and Beck, 2012). 
Constructivists are interested in gaining insight and understanding of 
personal experience. This information is obtained through personal 
interaction with the use of small sample sizes, to gather large amounts of 
data regarding individual experience and belief (Polit and Beck, 2012). 
Information gathered is non-quantifiable and narrative in nature usually 
gathered through interview or focus groups (Polit and Beck, 2012).Research 
focuses on the differences of the lived human experience rather than the 
similarities, as in positivism (Polit and Beck, 2012). Study concepts often 
emerge throughout the study as experience is shared and discovered as 
opposed to positivist research which has a predefined aim and objective 
(Polit and Beck, 2012). 
 
3.6 Study Design 
A prospective, non-experimental design was employed. Prospective data 
collection is employed when a researcher is interested in describing the 
effect of a cause (Parahoo, 2006). A prospective design was used as the 
study was interested in examining the changes in a participants’ skin over 
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time. The prospective nature of the study was imperative as each of the tools 
was measuring a participants’ risk of developing pressure damage. By 
following the participants for a period of four weeks, the author was able to 
determine the relationship between the risk assessment tools and sub-
epidermal measurement by comparison of the participants perceived risk (as 
determined by the risk assessment tools) and actual development of 
pressure damage. 
 
An experimental design has been described as a method of establishing 
causality (Curtis and Drennan, 2013). The causes of pressure damage have 
been widely discussed in previous research. Due to this, the study was not 
concerned with causality. The primary objective of the study was to ascertain 
the presence or absence of a relationship between the tools. Therefore, a 
non-experimental design was employed.  
 
3.7 Research Methodology 
This study used a positivist, quantitative method which can be described as a 
set of systematic, disciplined measurements conducted to retrieve 
information (Polit and Beck, 2012). A quantitative method was used as the 
author wished to retrieve data regarding the use of two risk assessment 
tools, the Braden scale and Waterlow score and compare it with sub-
epidermal. It was important to gather data based upon the different methods 
of risk assessment to verify or deny a relationship. 
 
3.8 Population, Study Setting, Sample and Sampling 
3.8.1 Population and Study Setting 
In research, a population is described as a complete set of persons that 
possess similar characteristics which are of interest to the researcher 
(Nieswiadomy, 2012 and Polit & Beck, 2012). The study was conducted in a 
residential, care of the elderly facility in Dublin therefore the population 
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consisted of elderly people over the age of 65 years with varying medical and 
social backgrounds. The researcher sought permission to access the site 
from the tissue viability nurse specialist and the director of nursing in the 
facility. Also, the researcher met with the clinical nurse managers in the site 
to inform them of the study. A copy of the access letter provided by the 
director of nursing at the study site is provided in Appendix A. 
 
Inclusion and exclusion criteria were minimised to allow for a wide sampling 
of the population. When considering inclusion criteria, it was important to first 
consider predominant risk factors in the development of pressure damage. 
Considerable research has been conducted in this area with many authors 
citing activity and mobility as key indicators of risk (Coleman et al., 2013, 
Cowan et al., 2012, Cox, 2011, Moore et al., 2011 and Verschueren et al., 
2011). Due to this, the writer considered mobility and activity to be the best 
risk factors to use as inclusion criteria as each individual needed to be at risk 
to verify a relationship between tools. Therefore, each individual had their 
mobility and activity assessed by the gatekeeper. The gatekeeper was the 
tissue viability nurse in the study site. Those with poor activity or mobility 
were eligible for the study as these people are at higher risk of developing 
pressure damage.  
 
Study information was provided to potential participants by the tissue viability 
nurse in the study site. If they indicated an interest in partaking in the study, 
the writer was informed and met with the participant to complete consent. 
The World Medical Association (WMA) Declaration of Helsinki (2013) states 
that potential participants must be provided with study aims, methods and 
potential benefits and risks before informed consent can be provided. The 
individual must be deemed competent to make an informed decision to 
partake in the study and therefore provide informed consent (See Appendix B 
– Consent Form). When an individual is unable to provide consent due to 
their medical condition, assent must be obtained from a legally authorised 
authority, in this instance their next of kin (See Appendix C – Assent Form).  
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Only one exclusion criteria was applied. Those not fit to provide consent due 
to their medical condition and without next of kin to provide assent were 
excluded from the study. This was to maintain the ethical integrity of the 
study. 
 
3.8.2 Sample 
A sample is a subset of the target population (Nieswiadomy, 2012 and Polit & 
Beck, 2012). In this instance, a sample was collected from the total number 
of residents in the care of the elderly facility.  
 
3.8.3 Sampling 
Sampling is the process of selecting a portion of the population to act as a 
generalizable representative of the population (Polit and Beck, 2012). Non-
probability, purposive sampling was used to recruit participants in this study. 
This sampling method involves picking participants that the researcher 
believes to be representative of the target population (Nieswiadomy, 2012). 
This research was being conducted to assess the relationship between three 
methods of pressure ulcer risk assessment. Therefore, it was vital that the 
subjects included were likely to be at risk of pressure damage. Non-
probability, purposive sampling was chosen to ensure participants had issues 
with activity and mobility. Those deemed to have limited activity and mobility 
were eligible to be included in the study. A breakdown of the flow of 
participants through the study can be seen in Figure 1. 
 
As this was a preliminary investigation, the writer aimed to recruit 50 
participants to the study. Sample size was calculated using power analysis 
(Cohen, 1988). Power analysis is a statistical method of determining 
appropriate sample sizes for research studies. It will provide an estimate of 
the minimal sample size required for valid results (Gerrish and Lacey, 2010). 
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The use of power analysis is encouraged as it ensures an adequate sample 
size, therefore providing results which will be generalizable to the wider 
population (LoBiondo-Wood and Haber, 2014). In this study, power was set 
at 80%. This provides an 80% probability for obtaining accurate results 
(Gerrish and Lacey, 2010). 
A two sided test was performed as two variables were being assessed, 
current risk assessment methods and sub-epidermal measurement (Duffy, 
2006). A significance level is described as a margin of confidence that 
significant test results were achieved (Gerrish and Lacey, 2010). A 
significance level of 5% was used in this study. This will provide a 95% 
confidence interval for study results, meaning there is a 95% confidence in 
the accuracy of the results (Gerrish and Lacey, 2010). 
 
To determine sample size, a two sided test was performed. Using a 5% 
significance level test, with a power test of 80% power, and a small effect 
size (+/- 0.2) (Sullivan and Feinn 2012) the required sample size was 
approximately forty-seven. Fifty participants were recruited into enhance the 
power of the study. Duffy (2006) states the smaller the sample size, the 
smaller the power therefore there is a greater chance of failure of the study. 
 
Those who met the inclusion criteria were approached by a gatekeeper, 
informed about the study and given an information leaflet (See Appendix D – 
Information Leaflet).. Having been given time to consider whether or not they 
wanted to participate (24-48 hours), those who wished to participate informed 
the gatekeeper. The gatekeeper then recruited respondents into the study. 
Random sampling of all respondents was not used as the writer wished to 
employ as many respondents as possible into the study. All respondents that 
met the inclusion criteria were approach to participate in the study. A 
breakdown of respondents can be seen in Figure 1. 
 
 
49 
 
3.9 Data Collection 
Data collection is considered to be the most important stage in a research 
project (Gerrish and Lacey, 2010). In quantitative research, data collection 
measures can vary. There are two important factors to consider, irrespective 
of collection method. Research must be collected in an objective and 
systematic manner in order to avoid bias and promote consistency 
(LoBiondo-Wood and Haber, 2014). There are three types of data collection 
in quantitative research and the use of each method will depend on the topic 
of the study. These three types are observation, self-report, such as 
interviews or questionnaires, and physiological data (LoBiondo-Wood and 
Haber, 2014). The writer was interested in assessing the relationship 
between three risk assessment methods. In order to achieve this, data 
collection was completed using physiological instruments, namely the 
Waterlow score, the Braden scale and the sub-epidermal moisture scanner. 
Using physiological collection methods provides objectivity and precision to 
the study as the use of these tools reduces the possibility of research bias 
(LoBiondo-Wood and Haber, 2014). The structured scoring of the Braden 
and Waterlow scores provide a clear guide to assist the clinician in evaluating 
risk. The scanner provides a sub-epidermal moisture score for each 
anatomical site. The use of scoring eliminates researcher bias as researcher 
opinion will not affect the score.  
 
Once participants were recruited and consented, the writer began the 
assessment process. Initially, the writer planned to visit each participant three 
times per week, for four weeks. However, after a pilot study, it became 
obvious that participant assessment would take longer than previously 
expected. Visits took place in the morning, before the participants got out of 
bed, to avoid any disturbance in their daily routine. Due to this, the writer had 
limited time each morning to assess participants. The study continued for 
four weeks however visits were reduced to twice per week for each 
participant to allow the writer to complete the study within the required time 
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frame. A staff nurse from the facility accompanied the writer at each visit. On 
each visit the following took place;  
 The shoulders, sacrum, knees and heels of the participant were 
inspected using the EPUAP (2014) visual assessment guidelines. 
Each site was scanned using the sub-epidermal scanner. The 
scanning process took approximately eight seconds per anatomical 
site.  
 Nursing staff were asked to provide information to complete the risk 
assessment tools. This included the individual’s age, mobility/activity 
level, nutritional and continence status. Waterlow and Braden scores 
were recorded weekly for each individual.  
 
Both Waterlow and Braden scores are numerical scales (See Appendix E 
and F respectively), completed by the writer to determine the risk of pressure 
damage development. Each tool is broken down into several subscales 
which are believed to be important factors in the development of pressure 
damage (Morison, 2001). Each subscale has a score, which when added 
together provide a total score which will advise the writer of the individual’s 
level of risk.  
 
Waterlow subscales include body mass index, continence, skin type, mobility, 
sex/age, malnutrition screening risk tool (MUST) and special risk such as 
tissue malnutrition, neurological deficit and recent surgery or trauma 
(Waterlow, 2005). A high Waterlow score indicates a high level of risk. 
Braden subscales include sensory perception, moisture, activity, mobility, 
nutrition, friction and shear (Bergstrom, 1988). A low Braden score indicates 
a high level of risk. 
The sub-epidermal moisture scanner is placed over an anatomical site, such 
as the sacrum. The moisture level of the sub-epidermal tissue is measured 
through the use of electrode structures placed on the surface of the skin. Low 
amplitude signals use surface electrical capacitance to assess the level of 
moisture in the epidermal and sub-epidermal tissues (Bates-Jensen et al., 
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2008). The device (See Image 1) then provides a score to aid the researcher 
in determining the presence or absence of inflammation, as a precursor to 
tissue damage. 
 
Image 1: Sub-epidermal Moisture Scanner 
 
Data collection sheets were used for each participant, at each visit, to 
document Waterlow, Braden and sub-epidermal moisture measurements at 
each of the seven anatomical sites mentioned previously (See Appendix G). 
Visual skin assessment was completed using the European Pressure Ulcer 
Advisory Panel (EPUAP, 2014) classification system which indicates six 
categories or stages of pressure damage.  
 
3.9.1 Pilot Study 
A pilot study is designed to provide preliminary evidence on an intervention. 
They can also be used to assess study viability, enhance the possibility of a 
successful study and help avoid problems or errors (Thabane et al., 2010). 
The writer conducted a small pilot study which involved four participants. 
These participants were assessed for one week using the Braden, Waterlow 
and sub-epidermal scanner. Participants were visited three times per week 
and all seven sites were scanned at each visit. The time taken to perform a 
complete assessment of each participant was calculated and recorded.  
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The participants had to be assessed in the morning, before they got out of 
bed, to avoid any disturbance to their routine. Due to this, the writer had a 
finite amount of time to review participants each morning before their daily 
activities began. The writer calculated the time needed to see each 
participant three times per week for four weeks. Unfortunately, due to time 
constraints, the writer was unable to perform the study as initially designed. 
Instead, participants were visited twice per week for four weeks. Braden and 
Waterlow scores were completed weekly, as in the pilot study. The seven 
anatomical sites remained the same. 
 
3.10 Data Analysis 
The purpose of data analysis is to enable researchers to organise and 
present their data in a quantifiable manner (Polit and Beck, 2012). In 
quantitative research, statistics are used to compile large amounts of data 
into quantifiable information (Polit and Beck, 2012). There are two types of 
statistics in quantitative research, descriptive and inferential (LoBiondo-Wood 
and Haber, 2014). Descriptive statistics, such as averages or percentages, 
are statistics that classify and condense numerical data gathered from study 
samples (Nieswiadomy, 2012). Descriptive statistics can be divided into four 
classes; nominal, ordinal, interval and ratio (Polit and Beck, 2012). Inferential 
statistics are statistics that allow researchers to infer details about an entire 
population by studying a sample of that population (LoBiondo-Wood and 
Haber, 2014). They allow a researcher to find relationships between study 
variables with the aim of finding information which will be generalizable to the 
entire population (Parahoo, 2006). 
 
Descriptive statistics were undertaken in this study as the risk assessment 
scales used are ordinal in nature. They provide scores which enable sorting 
of participants in relation to specific attributes, such as the subscales of 
mobility and continence (Polit and Beck, 2012).  
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Waterlow, Braden and SEM scores were recorded three times per week for a 
period of four weeks. The scoring techniques of the Waterlow score and 
Braden scale are outlined in the table below. 
 
Table 1: Scoring Techniques of Braden and Waterlow Scores 
 
 
 
 
 
 
 
In order to infer information from the data collected, further statistical analysis 
was used to organise, summarise and interpret study results (Polit and Beck, 
2012). This data was entered into a Statistical Package for the Social 
Sciences (SPSS) programme. Population demographics were presented 
using simple descriptive statistics. As the scale of measurement of risk was 
at the ordinal level, the correlation between sub-epidermal moisture 
measurement, Waterlow and Braden scores was determined using Pearson’s 
correlation. This is a correlational test to measure relationships within ordinal 
data (Nieswiadomy, 2012). Pearson correlation coefficients can vary in value 
from -1 to 1. The negative value indicates that as one variable increases, the 
other decreases. The positive value indicates that as one variable increases, 
the other variable increases (Pallant, 2013). Then, p-values were calculated 
to determine the significance of the results. Typically, a small p-value (≤0.05) 
indicates statistical significance. A large p-value (>0.05) indicates a lack of 
statistical significance (Nieswiadomy, 2012). 
 
Waterlow Score Braden Scale 
10+ = At Risk 15-18 = Mild Risk 
15+ = High Risk 13-14 = Moderate Risk 
20+ = Very High Risk 10-12 = High Risk 
 ≤ 9 = Severe Risk 
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Braden and Waterlow scores were assessed by subscale to determine the 
presence or absence of a relationship between individual sub-scores and 
sub-epidermal measurements. Paired T-test analysis was performed to 
evaluate the relationship between variables. This analysis is used when 
comparing the mean scores for the same group of people on different 
occasions (Pallant, 2013), in this instance, on the same participants and 
comparing seven anatomical sites. Once again, p-values were calculated to 
determine the significance of the results. 
 
3.11 Reliability and Validity 
According to Gerrish and Lacey (2010) reliability and validity are key 
concepts of research. Reliability in research is the ability to provide 
consistency in the measurement of an outcome. Equally, validity in research 
is described as the ability to measure what the study aimed to measure 
without bias (Gerrish and Lacey, 2010). Reliability is concerned with 
consistency, accuracy and stability (Lo Biondo-Wood and Haber, 2014). 
Reliability was ensured by the writer through individual participant 
assessment. Only one assessor, the writer, assessed all participants to 
ensure consistency. This eliminated issues regarding inter-rater reliability. 
The same methods, tools and anatomical sites were used for every 
participant to promote accuracy and stability. Reliability and validity are 
imperative in research as results must be representative of the truth. New 
research cannot benefit clinical practice if reliability and validity cannot be 
proven (Polit and Beck, 2012). In order to ensure reliability and validity, 
researchers must be systematic in their approach to conducting research so 
that results can be replicated in future studies (Parahoo, 2006). 
 
When considering validity, internal and external validity must be discussed. 
External validity is a measure to which a studies finding can be generalizable 
to similar populations or settings (Polit and Beck, 2012). Sample selection 
plays a key role in determining external validity. Random sampling would 
provide worthy external validity however this was not possible in the writers 
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study as the presence of specific risk factors was required to ensure 
participants were at risk of pressure damage. Instead, purposive sampling 
was used. To improve external validity, every member of the study site was 
assessed. Those who met the inclusion criteria were invited to join the study. 
As such, the study results would be generalizable to a similar study setting.  
 
Internal validity relates to the instruments ability to measure a variable. There 
are three types of internal validity in research, content validity, criterion-
related validity and construct validity (Polit and Beck, 2012). In this study, two 
validated risk assessment tools were used to assess participants. As 
mentioned in the literature review, the validity of current risk assessment 
tools, such as the Waterlow score and Braden scale, is disputed. Many 
studies have discussed the predictive validity of these scales. Poor predictive 
validity was mentioned in several studies (Hyun et al., 2013, Webster et al., 
2010, Cho et al., 2009) and these studies discouraged the use of these tools. 
Conversely, some studies found these scales to be valid and advocated their 
use (Iranmanesh et al., 2011, Tannen et al., 2010). 
 
The third measurement used in the study was sub-epidermal measurement. 
Current research regarding the validity of sub-epidermal moisture scanning 
suggests positive validity. Bates-Jensen et al., (2009) conducted a 
prospective study in which participants with elevated sub-epidermal moisture 
measurements were found to be 8-10 times more likely to develop pressure 
damage the following week. Similarly, Guihan et al., (2012) noted the validity 
of sub-epidermal moisture readings in their prospective study, with results 
showing correlation between elevated sub-epidermal moisture readings and 
pressure ulcer development.  
 
In this study, reliability and validity were ensured through the consistent use 
of the three tools. Each participant was risk assessed using the Waterlow 
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and Braden scales weekly. The same anatomical areas were scanned twice 
per week on every participant. 
 
3.12 Ethical Considerations 
Ethical guidance for the study was obtained from the World Medical 
Association (WMA) Declaration of Helsinki. Research was undertaken in 
strict accordance with these guidelines. The Declaration of Helsinki (WMA, 
2013) states that it is the researcher’s duty to protect life, safeguard the 
health of their participants, ensure integrity of the study and guarantee 
dignity, self-determination, privacy and confidentiality to their participants. As 
this declaration was specifically designed to guide medical research, further 
guidance was obtained from the Nursing and Midwifery Board of Ireland 
(NMBI) Code of Professional Conduct and Ethics (2014) and the Health 
Service Executive (2006) Guide to Good Research Practice publication. 
The principles of ethical research, as outlined by Beauchamp and Childress 
(2009), specify five key areas for consideration; autonomy, non-maleficence, 
beneficence, justice and professional-patient relationships. 
 
3.12.1 Autonomy 
Autonomy is defined as a method of self-governance. It is the ability to act 
freely in making informed decisions (Beauchamp and Childress, 2009). In 
research, respect for individual autonomy is paramount to ensure the study is 
morally sound (Tingle and Cribb, 2005). 
 
In order to ensure autonomy, a gatekeeper was enlisted to recruit 
participants into the study as to avoid placing undue pressure on people to 
participate. Potential participants were informed of their right to refuse to be 
involved in the study and this would have no effect on their care. Also, 
participants were informed of their right to withdraw consent at any time 
during the study without reason and this would not affect their care. Potential 
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participants and next of kin were given information regarding the details of 
the study and provided with contact details of the researcher, should they 
have any further queries, in order to ensure they were fully informed before 
providing consent. 
 
As the study population was a vulnerable group, extra care was taken in the 
consent process. According to the World Medical Association (WMA) 
Declaration of Helsinki (2013) some societal groups are particularly 
vulnerable in research and may have an increased prospect of being 
mistreated or of incurring additional harm. Therefore, all vulnerable groups 
should receive specifically considered protection. Due to this, strict consent 
procedures were introduced. After recruitment, those appropriate to provide 
consent were consented by the writer. If the participant was unable to provide 
consent due to their medical condition, assent was sought from their next of 
kin. Participants unable to provide consent, and without next of kin, were 
excluded from the study. 
 
 
3.12.2 Non-maleficence 
The principle of non-maleficence refers to healthcare professionals’ 
responsibility to cause no harm (Beauchamp and Childress, 2009). The two 
risk assessment scales, Waterlow and Braden, are numerical scales which 
involve a visual skin assessment. In order to complete the skin assessment, 
each participant had to be positioned on their side. It was recognised in the 
study that there was a possibility of slight discomfort on movement 
depending on the participant’s medical condition. Skin assessment was 
stopped if the researcher felt the participant was in pain or discomfort. The 
sub-epidermal moisture scanner is a hand-held device which is placed on the 
skin for a period of three seconds. The scanning process is painless and the 
device has received the CE mark, confirming it is safe for use. 
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3.12.3 Beneficence 
Beneficence can be described as the act of implementing positive action to 
benefit others (Beauchamp and Childress, 2009). The researcher’s intent for 
the study was to provide clarification regarding the most appropriate risk 
assessment methods in tissue damage. This would be beneficial to future 
risk assessment and pressure damage prevention however the participants’ 
were unlikely to benefit directly from the study and they were informed of this 
before consent was obtained. 
 
 
3.12.4 Justice 
Justice in research is described as the fair and equal treatment of all 
participants (Thompson et al, 2006). The only inclusion criteria used was the 
presence of impaired mobility or activity. All races, religions, genders and 
ages within the population were included if they met the inclusion criteria. All 
participants received identical assessment throughout the research process.  
 
 
3.12.5 Professional-patient Relationships 
This principle is divided into four components; veracity, privacy, 
confidentiality and fidelity (Beauchamp and Childress, 2009). 
 
Veracity: This refers to the comprehensive and objective transmission of 
information to ensure the participant has a complete understanding of the 
study (Beauchamp and Childress, 2009). Information leaflets were provided 
for potential participants before consenting began. Next of kin received 
information leaflets if they were providing assent. Nursing staff in the facility 
were given information leaflets. A brief presentation regarding the details of 
the study was given to the managers of the facility to keep staff informed. 
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Contact details of the researcher and the research supervisor were provided 
to allow for participants, next of kin or staff to enquire further if necessary.  
 
Privacy: Privacy is officially described as a state of limited access. In terms of 
research, the participant has a right to privacy of their person and privacy of 
their information (Beauchamp and Childress, 2009). To ensure informational 
privacy, the writer refrained from reviewing medical records to obtain 
information. Information needed to complete the risk assessment tools such 
as age, body mass index, nutritional and continence status’ were obtained 
from nursing staff to limit the amount of personal and medical information that 
was shared with the writer. 
 
During visual skin assessment privacy was paramount. Skin assessments 
were undertaken in the participants’ bedroom. Only the researcher and one 
staff nurse from the facility were present during the assessment to afford the 
participant as much privacy as possible. 
 
Confidentiality: Confidentiality in research is the concept of protecting the 
information and the identity of the participant (Nieswiadomy, 2012). In order 
to maintain strict confidentiality, all identifying factors were removed from the 
study results. Participants were provided with a study number to ensure 
anonymity. Confidentiality of patient information was paramount. All 
electronic study data was stored in a password protected, applicant unique 
project folder located within the RCSI V: drive. Paper data was scanned and 
stored in the same folder. Paper data was then destroyed. Study data will be 
stored within the V: drive for 5 years. It will then be deleted. 
 
Fidelity: This is the process of building a relationship or trust with participants. 
An important aspect of fidelity is to prioritize participant interest over 
researcher interest (Beauchamp and Childress, 2009). If a participant was 
noted to be uncomfortable during the assessment process, the assessment 
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was stopped. Each participant or next of kin was informed of their right to 
remove themselves or their next of kin from the study at any point, without 
question. 
 
Guided by the ethical principles outlined above, a research study was 
designed to ensure ethical compliance. Ethical approval for the study was 
sought and granted from the Royal College of Surgeons in Ireland Ethics 
Committee (See Appendix H). 
 
 
3.13 Summary 
The purpose of the study was to assess the relationship between the Braden 
scale, Waterlow score and sub-epidermal measurement. This was performed 
using a prospective, non-experimental research design. This design was 
chosen as the writer wished to follow participants over a four week period 
and assess changes in their skin over time as determined by the Braden 
scale, Waterlow score and sub-epidermal measurement. In this way, an 
assessment of the relationship between the tools could be achieved. A 
positivist, quantitative method was used as the writer wished to extract data 
regarding two risk assessment tools and compare it with sub-epidermal 
measurement. This data was then analysed to assess the presence or 
absence of a relationship. 
Non-probability, purposive sampling was used as the writer wished to study a 
group which would be representative of the target population. Thus, 
participants had to be at risk of pressure damage to assess the effect of the 
three tools and therefore determine a relationship. For this reason, the 
presence of limited mobility and activity were the only inclusion criteria for the 
study. Those that were unable to provide consent, or without next of kin to 
provide assent, were excluded from the study. No other exclusion criteria 
were applied. All residents who met the inclusion criteria were invited to 
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participate. A sample size of fifty participants was determined through power 
analysis. 
Data was collected through the weekly use of the Braden scale and Waterlow 
score. Sub-epidermal measurement was conducted twice per week on seven 
anatomical sites. All participants in the study were assessed for four weeks. 
Then, data was analysed using a Statistical Package for Social Sciences 
(SPSS) programme. Correlation between tools was determined using 
Pearson’s Rho. Paired t-test analysis was used to determine the relationship 
between subscales. Significance was determined through the calculation of 
p-values. 
 
Reliability and validity were ensured firstly through the use of validated tools. 
The writer was the only person assessing the participants therefore 
eliminating inter-rater issues. The study was designed and conducted in strict 
accordance with the World Medical Association Declaration of Helsinki 
(2013). The five key principles of research were also considered; autonomy, 
non-maleficence, beneficence, justice and professional-patient relationships. 
Ethical approval was sought and granted by the Royal College of Surgeons 
Research Ethics Committee. 
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Chapter Four – Presentation of Results 
4.1 Introduction 
Pressure ulcer risk assessment is the process in which each person is 
screened for common risk factors for pressure ulcer development in an effort 
to determine those at risk as a precursor to the initiation of preventative 
measures (Moore et al, 2008). According to Kottner et al., (2010) there are 
more than 40 validated risk assessment tools in use today. Two of the most 
commonly used are the Waterlow and Braden scales (O’Tuathail et al, 2011). 
However, despite the use of these validated tools, pressure ulcer 
development and increasing prevalence of pressure ulcers continue to be a 
major healthcare issue with one study citing an 80% increase in pressure 
ulcer prevalence in the last twenty years (Cox, 2012). This has instigated a 
growing interest in other methods of risk assessment. 
 
Sub-epidermal moisture measurement is the process in which the level of 
moisture in the skin is calculated through the use of a hand held scanner. 
This elevated moisture in the sub-epidermal tissue is indicative of an 
inflammatory process, and is therefore an indicator of the presence of tissue 
damage (Guihan et al., 2012, Bates-Jensen et al., 2009, Bates-Jensen et al., 
2008, Bates-Jensen et al., 2007). The purpose of this study was to assess 
the relationship between the Braden scale, Waterlow score and sub-
epidermal measurement.  
 
In order to assess the relationship, study data has been collected from twenty 
nine participants over a four week period. Seven anatomical sites were 
scanned twice weekly for each participant: left and right shoulder, sacrum, 
left and right knee and left and right heel. A sub-epidermal moisture scanner 
was used to scan each anatomical site. Five measurements were acquired 
per site. The initial measurement was taken from the bony prominence of 
each anatomical site. Then, four measurements were taken surrounding the 
bony prominence to evaluate the presence or absence of pressure damage. 
The highest and lowest measurements were taken and the deviation 
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between these two scores identified, if this deviation measured 0.5 or above, 
the score was indicative of elevated sub-epidermal moisture levels.  
 
Braden scale scores and Waterlow scores were evaluated weekly. These 
instruments are the most widely used pressure ulcer risk assessment tools in 
use today (Guy, 2012). In this writer’s study, these risk assessment tools 
were compared to sub-epidermal scores to ascertain the presence or 
absence of a correlation between the two methods of pressure damage 
assessment.  
 
Visual patient skin assessment was carried out using the European Pressure 
Ulcer Advisory Panel (EPUAP, 2014) classification system which outlines six 
categories or stages of pressure damage. The visual assessments were also 
compared with sub-epidermal measurements to evaluate the accuracy of 
visual skin assessment compared to sub-epidermal moisture scanning. 
 
In this results chapter, descriptive statistics for age and gender are described 
using frequency distributions and are presented in tables. Braden and 
Waterlow scores are also presented as frequency distributions and cross 
tabulations. Further analysis was undertaken using the Pearson’s rho to 
determine if there was a relationship between the scores achieved using both 
risk assessment tools. Results are interpreted as follows: High correlation: .5 
to 1.0 or -0.5 to 1.0; Medium correlation: .3 to .5 or -0.3 to .5; Low correlation: 
.1 to .3 or -0.1 to -0.3. P values were calculated to determine the presence or 
absence of statistical significance, with p set at ≤0.05 in keeping with 
statistical rigor. Mean Braden and Waterlow scores for the 4 week study 
period, are presented with their associated standard deviations. 
An exploration of the correlation between total sub-epidermal score, total 
Braden scale and Waterlow scores was also undertaken using Pearson’s 
rho, once again with p set at ≤0.05. Finally, using multiple regression 
individual risk categories of the Braden and Waterlow scores were assessed 
to determine which risk factors, if any, were related to elevated sub-
epidermal measurements therefore indicating which risk factors were most 
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important in terms of pressure ulcer development. Again, p values were 
calculated to assess the statistical significance of the results.  
 
 
4.2 Demographics 
4.2.1 Gender and Age 
The total study population consists of 29 participants. The flow of participants 
from eligibility assessment to through to analysis can be seen in Figure 1. 
 
 
Figure 1: Flow of Participants through the study 
 
 
 
The majority of the participants were female (65.5 %, n=19; see Table 2), 
furthermore the majority were over 81 years of age with those in this age 
Eligible for inclusion (n= 60) 
Not meeting inclusion criteria (n= 98) 
Assessed for eligibility (n= 168) 
Flow of Participants through the Study 
Invited to consent (n= 60) 
Unable to obtain assent (n= 18) 
Declined to participate (n= 2) 
Other (n= 11) 
Provided consent (n= 4) 
Assent obtained (n= 25) 
Analysed (n=29) 
Excluded from analysis (n=0) 
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bracket accounting for 62.1% (n=16) of the participants. The distribution of 
the age of all participants can be seen in Table 3. 
 
Table 2: Gender Distribution of the Participants 
Gender Frequency Percent 
Male 10 34.5 
Female 19 65.5 
Total 29 100.0 
 
 
Table 3: Participant Age Distribution 
Age Frequency Percent 
50-64 2 6.9 
65-74 4 13.8 
75-80 5 17.2 
81+ 18 62.1 
Total 29 100.0 
 
 
4.2.2 Braden and Waterlow Scores 
Weekly Braden scale scores and Waterlow scores are calculated to 
determine the risk of pressure damage according to current risk assessment 
methods. With the Braden scale, the lower the score the higher the risk, and 
as such Braden scores are interpreted as follows; a score of 9 or less 
indicates severe risk of pressure damage, 10-12 indicates high risk, 13-14 
indicates a moderate risk and 15-18 indicates a mild risk. Conversely, with 
the Waterlow risk assessment tool, the higher the score the greater the risk, 
and as such, Waterlow scores are interpreted as follows; 10-14 indicates that 
an individual is at risk of pressure damage, 15-19 indicates a high risk and a 
score of twenty or more indicates a very high risk of pressure damage. 
Braden and Waterlow scores for on admission to the study can be seen in 
Tables 3 and 4 respectively.  
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As can be seen in Table 4, according to the Braden scale 62% of the 
participants were assessed as being at high or severe risk of pressure ulcer 
development. Conversely, according to the Waterlow risk assessment tool, 
79% (n=23) of the participants were assessed as being high risk or very high 
risk of pressure damage (see Table 5).  
 
Table 4: Week One Total Braden Scores 
Braden Score Frequency Percent 
8 1 3.4 
9 2 6.9 
10 1 3.4 
11 6 20.6 
12 8 27.5 
13 3 10.3 
14 2 6.9 
15 4 13.8 
16 1 3.4 
17 1 3.4 
Total 29 100.0 
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Table 5: Week One Total Waterlow Scores. 
Waterlow Score Frequency Percent 
12 1 3.4 
13 2 6.9 
14 3 10.3 
15 5 17.2 
16 4 13.8 
17 4 13.8 
18 2 6.9 
19 3 10.3 
20 2 6.9 
21 1 3.4 
23 1 3.4 
25 1 3.4 
Total 29 100.0 
 
 
Further analysis was undertaken to determine the relationship between 
Braden and Waterlow scores. Firstly, overall scores were recalculated into 3 
values, with 1 indicating at risk/moderate risk, 2 indicating high risk and 3 
indicating very high/severe risk. Table 6 outlines the cross tabulation of the 
scores. As can be seen, according to the Waterlow risk assessment tool, 1 
individual is at severe risk of pressure ulcer development, whereas according 
to the Braden scale that individual is at risk/moderate risk. Similarly, 
according to Waterlow one individual is at risk/moderate risk, whereas 
according to Braden, that individual is at high risk of pressure ulcer 
development. Overall there was agreement between Waterlow and Braden in 
just 48% (n=14) of cases, as highlighted in red within Table 6.  
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Table 6: Week One Waterlow Risk and Week One Braden Risk Cross 
Tabulation 
 
Week 1 Braden Risk 
Total 1 2 3 
 
Week 1 Waterlow 
Risk 
1 4 2 0 6 
2 7 9 2 18 
3 1 3 1 5 
Total 12 14 3 29 
 
 
Further exploration of these data, using Pearsons rho, identified that there 
was just a medium correlation between Waterlow and Braden (r=0.319) 
however, this finding was not statistically significant (p=.092). 
 
4.2.3 Braden and Waterlow Scores over the four week Study Period 
Braden and Waterlow mean scores remained constant throughout the study 
period as can be seen in Table 7. Weekly mean Braden scores varied little 
from 12.34 to 12.18 from week one to week four respectively, indicating that 
the participants were on average at high level risk of developing a pressure 
ulcer. However, the standard deviation indicates variability among the 
participants, with some considered not to be at risk. In keeping with the 
Braden scores, weekly Waterlow means remain constant varying little from 
16.86 in week one to 17.00 in week four. Equally, the Waterlow mean scores 
indicate that on average the participants are at high risk of developing 
pressure damage, however, the standard deviation indicates variability 
among the participants, with some considered not to be at risk. The lack of 
change in either Braden or Waterlow scores over the four week period is 
peculiar. This may indicate a lack of sensitivity of the risk assessment tools. It 
is possible that the tools are not sensitive enough to assess subtle changes 
in the participants’ condition. 
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Table 7: Weekly Mean Braden and Waterlow Scores. 
 N Min Max Mean Std. Deviation 
Week 1 Braden  
29 8 17 12.34 2.143 
Week 2 Braden  28 8 17 12.25 2.171 
Week 3 Braden  
28 8 17 12.14 2.337 
Week 4 Braden  28 7 17 12.18 2.374 
Week 1 Waterlow  
29 12 25 16.86 3.020 
Week 2 Waterlow  28 12 25 16.86 3.076 
Week 3 Waterlow  28 12 25 16.93 3.078 
Week 4 Waterlow  
28 12 25 17.00 3.091 
 
 
4.3 Sub-epidermal Moisture Measurements 
Sub-epidermal moisture measurements were taken on seven anatomical 
sites, twice weekly for a period of four weeks. These sites were; left and right 
shoulder, sacrum, left and right knee, left and right heel. A total of 1,339 sub-
epidermal moisture measurements were recorded. For all participants and for 
all anatomical sites, the minimum sub-epidermal score was 0.0 and 
maximum score was 0.9. All sub-epidermal readings taken throughout the 
study are detailed in Appendix I. 
 
Of all participants, 90% (n=26) had a least one elevated sub-epidermal 
score. Furthermore, 54% (n=16) of participants with elevated sub-epidermal 
measurements had elevated measurements, for three consecutive 
recordings in more than one anatomical site. The marker of three 
consecutive readings was chosen to ensure that the sub-epidermal moisture 
reading was consistently raised, rather than periodic, as a periodic reading 
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may indicate blanchable erythema and not actual pressure ulcer damage. 
Finally, 15% (n=4) of participants with elevated sub-epidermal measurements 
had elevated measurements for three consecutive recordings in more than 
two anatomical sites.  
 
Tables 8 - 12 present the elevated sub-epidermal measurements by 
participant number and anatomical site with the three or more consecutive 
elevated readings highlighted in red. As can be seen 31% (n=9) of 
participants were noted to have sustained elevated readings on their sacrum. 
Furthermore, 31% (n=9) of participants were found to have elevated readings 
on their left and right knee. In addition, 34% (n=11) of participants had 
sustained elevation of the left heel and 31% (n=9) of participants had 
sustained elevation of the right heel. However, no participant had sustained 
elevated readings on either shoulder. 
 
Table 8: Elevated Sacral SEMs by Participant Number 
Participant  
Number 
Sacrum 
Week 
1 
Week 
1 
Week 
2 
Week 
2 
Week 
3 
Week 
3 
Week 
4 
Week 
4 
3 0.1 0.2 0.7 0.1 0.3 0.7 0.5 0.6 
6 0.7 0.4 0.5 0.7 0.4 0.5 0.6 0.5 
11 0.5 0.1 0.4 0.1 0.3 0.6 0.5 0.5 
12 0.5 0.7 0.8 - - - - - 
13 0.1 0.3 0.5 0.6 0.6 0.6 0.4 0.5 
21 0.1 0.4 0.6 0.5 0.5 0.6 0.4 0.3 
22 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.5 
26 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.2 
27 0.5 0.6 0.5 0.5 0.5 0.2 0.5 0.5 
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Table 9: Elevated Left Knee SEMs by Participant Number 
Participant  
Number 
Left Knee 
Week 
1 
Week 
1 
Week 
2 
Week 
2 
Week 
3 
Week 
3 
Week 
4 
Week 
4 
1 0.3 0.3 0.5 0.5 0.3 0.5 0.7 0.7 
2 0.3 0.6 0.3 0.4 0.7 0.6 0.6 0.4 
9 0.4 0.3 0.9 0.7 0.7 0.1 0.4 0.8 
15 0.1 0.0 0.7 0.4 0.6 0.6 0.5 0.6 
18 0.6 0.6 0.5 0.6 0.5 0.6 0.4 0.5 
24 0.2 0.1 0.7 0.5 0.6 0.4 0.1 0.4 
25 0.5 0.4 0.7 0.7 0.5 0.4 0.6 0.6 
27 0.6 0.5 0.5 0.3 0.3 0.5 0.4 0.1 
28 0.6 0.7 0.4 0.5 0.6 0.5 0.4 0.6 
 
 
 
Table 10: Elevated Right Knee SEMs by Participant Number 
Participant  
Number 
Right Knee 
 
Week 1 Week 
1 
Week 
2 
Week 
2 
Week 
3 
Week 
3 
Week 
4 
Week 
4 
6 0.6 0.1 0.6 0.6 0.7 0.6 0.2 0.5 
10 0.5 0.2 0.6 0.6 0.5 0.3 0.2 0.1 
14 0.5 0.5 0.7 0.4 0.4 0.2 0.4 0.1 
15 0.2 0.3 0.2 0.5 0.6 0.8 0.3 0.4 
19 0.1 0.5 0.4 0.4 0.4 0.7 0.5 0.6 
22 0.5 0.6 0.7 0.4 0.9 0.5 0.5 0.5 
24 0.4 0.1 0.5 0.6 0.5 0.5 0.2 0.5 
29 0 0.6 0.2 0.5 0.6 0.5 0.5 0.6 
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Table 11: Elevated Left Heel SEMs by Participant Number 
Participant  
Number 
Left Heel  
 
Week 1 Wee
k 1 
Week 
2 
Wee
k 2 
Wee
k 3 
Wee
k 3 
Wee
k 4 
Wee
k 4 
1 0.1 0.3 0.5 0.4 0.5 0.9 0.6 0.5 
4 0.4 0.2 0.7 0.6 0.5 0.2 0.4 0.6 
7 0.4 0.1 0.7 0.8 0.6 0.3 0.4 0.4 
8 0.0 0.4 0.7 0.7 0.7 0.5 0.4 0.1 
10 0.5 0.2 0.6 0.7 0.6 0.6 0.2 0.4 
16 0.4 0.3 0.3 0.7 0.7 0.6 0.6 0.6 
18 0.2 0.6 0.6 0.8 0.2 0.6 0.3 0.3 
23 0.2 0.3 0.8 0.7 0.5 0.3 0.4 0.3 
24 0.6 0.4 0.8 0.7 0.5 0.4 0.3 0.6 
25 0.4 0.7 0.5 0.9 0.2 0.3 0.3 0.2 
 
 
 
Table 12: Elevated Right Heel SEMs by Participant Number 
Participant  
Number 
Right Heel  
Week 1 Week 
1 
Week 
2 
Week 
2 
Week 
3 
Week 
3 
Week 
4 
Week 
4 
1 0.5 0.7 0.9 0.7 0.3 0.7 0.6 0.5 
3 0.3 0.3 0.5 0.8 0.3 0.5 0.6 0.6 
8 0.4 0.3 0.6 0.7 0.5 0.8 0.4 0.5 
9 0.4 0.1 0.7 0.6 0.5 0.9 0.6 0.2 
15 0.1 0.1 0.4 0.6 0.5 0.5 0.2 0.3 
19 0.1 0.3 0.6 0.5 0.6 0.5 0.6 0.5 
22 0 0.4 0.8 0.6 0.5 0.2 0.4 0.4 
23 0.4 0.4 0.9 0.6 0.5 0.3 0.4 0.2 
24 0.4 0.3 0.6 0.9 0.7 0.3 0.4 0.6 
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4.4 Visual Skin Assessments 
When assessing the skin with the sub-epidermal scanner, a visual 
assessment for each participant and for each anatomical site was also 
undertaken using the EPUAP grading system. Blanchable erythema was also 
noted by the researcher, as it is felt that it is important to distinguish any 
alterations in skin condition. It is possible that blanching erythema may 
indicate early pressure ulcer damage, therefore, correlations between this 
and sub-epidermal scores were also explored.  
 
A total of 1,339 skin assessments were recorded. Table 13 outlines the skin 
assessments in which changes to the skin were noted, all other skin 
assessments were identified as being normal. As can be seen from Table 13, 
2.6% (n=35) of assessments were noted as abnormal, these ranged from 
blanchable erythema to stage II pressure ulcer damage. These abnormal 
assessments were noted among 41% (n=12) of all participants, with 66% 
(n=8) of those displaying skin changes, showing persistent changes (see 
participant numbers highlighted in red in Table 13).  
 
 
 
Table 13: Altered Skin Assessments: Anatomical Site and Day noted 
Week Day Participant Anatomical Site Stage 
2 1 8 Sacrum I 
2 1 13 Sacrum Blanching 
Erythema 
2 1 12 Sacrum II 
2 2 8 Sacrum I 
2 2 13 Sacrum I 
2 2 24 Sacrum I 
3 1 8 Sacrum I 
3 1 13 Sacrum I 
3 1 24 Sacrum I 
4 1 8 Sacrum Blanching 
Erythema 
 
1 1 14 Shoulder Blanching Erythema 
 
1 2 18 L Knee Blanching 
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Erythema 
1 2 28 L Knee Blanching Erythema 
3 2 18 L Knee Blanching 
Erythema 
4 2 1 L Knee Blanching 
Erythema 
4 1 1 L Knee Blanching 
Erythema 
 
1 2 1 R Heel Blanching 
Erythema 
2 1 1 R Heel Blanching 
Erythema 
2 1 16 R Heel Blanching Erythema 
2 1 22 R Heel Blanching 
Erythema 
2 2 1 R Heel Blanching 
Erythema 
2 2 22 R Heel Blanching 
Erythema 
2 2 24 R Heel Blanching 
Erythema 
3 1 24 R Heel Blanching 
Erythema 
 
2 2 24 L Heel Blanching Erythema 
3 1 16 L Heel Blanching 
Erythema 
3 1 19 L Heel Blanching Erythema 
3 2 16 L Heel Blanching 
Erythema 
4 1 16 L Heel Blanching 
Erythema 
4 2 16 L Heel Blanching 
Erythema 
 
4 1 1 R Knee Blanching Erythema 
4 1 2 R Knee Blanching 
Erythema 
4 1 5 R Knee Blanching 
Erythema 
4 2 2 R Knee Blanching 
Erythema 
4 2 5 R Knee Blanching 
Erythema 
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4.4.1. Relationship between Visual Skin Assessment and Sub-Epidermal 
Scores 
4.4.1.1 Sacrum 
Two of the nine participants with three consecutive elevated sub-epidermal 
measurements developed visual signs of pressure damage (see Table 14).  
 
Table 14: Participants with Elevated Sub-Epidermal Scores and 
Abnormal Visual Skin Assessments 
                          Participant Number 
 
3 or more Elevated 
SEMs 
3 6 - 11 12 13 21 22 - 26 27 
Abnormal Visual  
Assessment  
- - 8 - 12 13 - - 24 - - 
 
 
One participant (Participant 13) developed stage I pressure ulcer damage 
and this corresponded with sustained elevated sub-epidermal readings (see 
Table 15).  
 
Table 15: Participant Number 13, Sacral Sub-Epidermal readings and 
Visual Skin Assessment 
Week Day SEM Readings Visual Skin 
Assessment 
1 1 0.1 Normal 
1 2 0.3 Normal 
2 1 0.5 Blanching erythema 
2 2 0.6 I 
3 1 0.6 I 
3 2 0.6 Normal 
4 1 0.4 Normal 
4 2 0.5 Normal 
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Interestingly, participant number twelve, had one elevated sub-epidermal 
reading and then developed a stage 2 pressure ulcer (See Table 16). The 
writer was unable to continue assessing the sacral damage as the area was 
dressed however staff reported the presence of grade II pressure damage 
until the end of the study. 
 
 
Table 16: Participant Number 12, Sacral SEM readings and Visual Skin 
Assessment 
Week Day SEM Readings Visual Skin 
Assessment 
1 1 0.5 Normal 
1 2 0.1 Normal 
2 1 0.4 II 
2 2 Unable to assess Staff report - II 
3 1 Unable to assess Staff report - II 
3 2 Unable to assess Staff report - II 
4 1 Unable to assess Staff report - II 
4 2 Unable to assess Staff report - II 
 
Participant number 8’s sub-epidermal readings are shown in Table 17. As 
can be seen, elevated sub-epidermal readings on week 2, day 2 and week 3, 
day 1 are associated with pressure ulcer damage stage 1.  
 
Table 17: Participant Number 8, Sacral SEM readings and Visual Skin 
Assessment 
 
 
SEM 
Reading  
Week 
1 
Week 
1 
Week 
2 
Week 
2 
Week 
3 
Week 
3 
Week 4 Week 
4 
 
0.3 
 
0.4 
 
0.4 
 
0.9 
 
0.6 
 
0.4 
 
0.6 
 
0.1 
Visual Skin  
Assessment  
Normal Normal Stage 
1 
Stage 
1 
Stage 
1 
Normal Blanching 
Erythema 
Normal 
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4.4.1.2 Left Knee 
Six of the nine participants with three consecutive elevated sub-epidermal 
measurements did not develop any pressure damage. The remaining three 
participants developed blanching erythema after two consecutive elevated 
sub-epidermal readings. No patient developed visual signs of pressure ulcer 
damage. 
 
4.4.1.3 Right Knee 
No visible pressure ulcer damage was noted in any of the nine participants 
with consecutive elevated sub-epidermal measurements of the right knee. 
 
4.4.1.4 Left Heel 
Eight of the ten participants with consecutive elevated measurements of the 
left heel did not develop visible signs of pressure damage. Only one 
participant (number 16) had elevated sub-epidermal readings (highlighted in 
red in Table 18) and evidence of skin changes, however, this was persistent 
blanching erythema and not visible pressure ulcer damage (see Table 18). 
 
Table 18: Participant Number 16, Left Heel Sub-Epidermal readings and 
Visual Skin Assessment 
Week Day SEM Readings Visual Skin 
Assessment 
1 1 0.4 Blanching erythema 
1 2 0.3 Blanching erythema 
2 1 0.3 Blanching erythema 
2 2 0.7 Blanching erythema 
3 1 0.7 Blanching erythema 
3 2 0.6 Blanching erythema 
4 1 0.6 Blanching erythema 
4 2 0.6 Blanching erythema 
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4.4.1.5 Right Heel 
Six of the participants with sustained elevated sub-epidermal measurements 
of the right heel did not develop any visible signs of pressure damage. Three 
participants (Participants 1, 22 and 24) with elevated sub-epidermal 
measurements also presented with blanching erythema. However, no 
participant actually developed evidence of visible pressure ulcer damage.  
 
4.4.1.6 Pressure Ulcer Incidence 
Accordingly, 4 of 29 participants developed pressure ulcer damage, yielding 
a pressure ulcer incidence of 14%. All pressure ulcer damage was noted on 
the sacrum. There was no statistically significant relationship between sub-
epidermal readings and pressure ulcer development (p>0.05).  
 
4.5 Correlation between Braden, Waterlow and Sub-Epidermal Readings 
The aim of this research was to assess the validity of risk assessment using 
a sub-epidermal moisture (SEM) measurement and compare it to traditional 
pressure ulcer risk assessment methods such as the Waterlow score and 
Braden scale. In this study, Braden scale scores, Waterlow scores and SEM 
readings were compared to explore the correlation between the three risk 
assessment tools. Correlations were calculated between total sub-epidermal 
readings and week 1 Braden and Waterlow scores. Weeks 2, 3 and 4 Braden 
and Waterlow scores were not correlated as these remained constant for the 
duration of the study. 
 
As shown in Table 19, there is a low negative correlation between sub-
epidermal measurement and Braden scores (r=-.234), however this is not 
statistically significant (p=.222). There is no correlation between sub-
epidermal measurement and Waterlow scores (r=.095), this finding was not 
statistically significant (p=.624). 
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Table 19: Correlations between SEM, Braden and Waterlow scores 
 
 
Week 1 
Braden Scale 
Week 1  
Waterlow Scale 
 
Total 
SEM 
Pearson 
Correlation 
-.234 .095 
Sig. (2-tailed) .222 .624 
N 29 29 
 
 
4.6 Risk factors Associated with Sub-Epidermal Changes 
4.6.1 Braden Scale 
In order to analyse which risk factor from the Braden Scale most closely 
predicts changes in sub-epidermal readings, standard multiple regression 
analysis was conducted. Using the enter method, the model summary is as 
follows (f=.784, p=0.592, Adjusted R Square -.049). The results of the 
analysis (see Table 20) show that sensory perception and mobility were the 
highest predictors, however these were not statistically significant (Beta = 
.446, 95% C.I. = -.035 to .177; p=.176); (Beta = -.423, 95% C.I. = -.284 to 
.067; p=.212 respectively). The standardised Beta coefficient indicates the 
contribution of each variable to the model. A large value indicates that a unit 
change in the variable will have a large effect on the criterion variable. In this 
instance, a decrease of one standard deviation of sensory perception will 
result in an increase of .446 standard deviations of sub-epidermal readings. 
Similarly, as mobility decreases by one standard deviation, there will be a 
corresponding increase of .423 standard deviations of sub-epidermal 
readings. However, as stated, these findings are not statistically significant. 
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Table 20: Multiple Regression Analysis: Braden Risk Factors for 
Elevation in SEM 
 Unstandardized  
Coefficients 
Standardised 
Coefficients 
  95% CI for B 
 B Std Error Beta t sig Lower 
Bound 
Upper 
Bound 
Braden 
Scale  
Sensory  
Perception 
.071 .051 .446 1.396 .176 -.035 .177 
Braden 
Scale  
Mobility 
-.108 .084 -.423 -
1.284 
.212 -.284 .067 
 
4.6.2 Waterlow Scale 
In order to analyse which risk factor from the Waterlow Scale most closely 
predicts changes in sub-epidermal readings, standard multiple regression 
analysis was conducted. Using the enter method, the model summary is as 
follows (f=1.768, p=0.141, Adjusted R Square .198). The results of the 
analysis (see Table 21) show that mobility and neurological deficit were the 
highest predictors, and these findings were statistically significant (Beta =-
.474, 95% C.I. = -.126 to -.009; p=.027); (Beta = -.612, 95% C.I. = -.071 to-
.009; p=.013 respectively). In this instance, a decrease of one standard 
deviation of mobility will result in an increase of .474 standard deviations of 
sub-epidermal readings. Similarly, as mobility decreases by one standard 
deviation, there will be a corresponding increase of .612 standard deviations 
of sub-epidermal readings.  
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Table 21: Multiple Regression Analysis: Waterlow Risk Factors for 
Elevation in SEM 
 Unstandardized  
Coefficients 
Standardised 
Coefficients 
  95% CI for B 
 B Std Error Beta t sig Lower 
Bound 
Upper 
Bound 
Waterlow 
Scale  
Mobility 
-.067 .028 -.474 -
2.397 
.027 -.126 -.009 
Waterlow 
Neurological 
Deficit 
-.040 .015 -.612 -
2.725 
.013 -.071 -.009 
 
 
4.7 Summary 
A total of 29 participants were included in this study, SEM readings and 
visual skin assessments were undertaken twice weekly for four weeks over 7 
anatomical areas, yielding 1,339 visual skin and 1,339 SEM assessments. 
Waterlow and Braden scores were calculated once weekly for the 4 weeks.  
 
When the study participants were assessed using the Braden scale, 62% 
were found to be at high or severe risk of pressure damage. However, when 
assessed using the Waterlow score, 79% of participants were deemed to be 
at high or very high risk of pressure damage. Agreement between the Braden 
and Waterlow tools were only noted in 48% of cases. However, only medium 
correlation was found in these results and this was not statistically significant. 
It is important to note the lack of variation in both Braden and Waterlow 
scores. Indeed, very little change in score was noted over the four week 
study period. This may indicate a lack of sensitivity of the risk assessment 
tools. It is possible that the tools are not sensitive enough to assess subtle 
changes in the participants’ condition. 
 
Sub-epidermal moisture assessment of participants indicated that 90% had 
at least one elevated sub-epidermal reading. Of these, 54% had three 
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consecutive elevated readings in more than one anatomical site. 
Furthermore, 15% had three consecutive elevated readings in more than two 
anatomical sites. It is important to note that an exploration of the sub-
epidermal measurements show variable values. Some participants were 
noted to have brief periods of elevated readings, however these readings 
then return to normal. The writer believes that this variance may be 
attributable to preventative interventions. The initial elevated sub-epidermal 
reading indicates the presence of pressure damage then, preventative 
measures such as repositioning occur. The preventative measures reduced 
the risk and therefore the sub-epidermal measurement returns to normal. 
 
When correlation was performed between the Braden scale scores and sub-
epidermal measurements, no statistically significant relationship was found. 
Similarly, correlation between the Waterlow scores and sub-epidermal 
measurements showed no statistically significant relationships.  
 
Multiple regression analysis showed that the Braden subscales of sensory 
perception and mobility were the highest predictors of sub-epidermal 
changes however this finding was not statistically significant. Waterlow 
subscales of mobility and neurological deficit were seen to be the highest 
predictors of sub-epidermal changes, conversely this was statistically 
significant. Sensory perception and neurological deficit are very similar 
subscales. They are both used to identify participants with motor or sensory 
loss due to a range of conditions such as multiple sclerosis and paraplegia. It 
is interesting to note that both scales showed the same predictors when 
multiple regression was used.  
 
4.8 Conclusion 
The purpose of this study was to determine the relationship between the 
Braden scale, Waterlow score and sub-epidermal moisture measurement. 
When the Braden, Waterlow and sub-epidermal measurements where 
compared, no statistically significant relationship was found. However, when 
multiple regression was undertaken to determine the highest predictors of 
sub-epidermal moisture changes, both Braden and Waterlow showed similar 
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results. Braden predictors were noted to be mobility and sensory perception. 
Waterlow predictors were noted as mobility and neurological deficit. Braden 
predictors were not found to be statistically significant however, Waterlow 
predictors of mobility and neurological deficit were found to be statistically 
significant.  
 
The inconsistency between the Braden and Waterlow scores is notable. The 
Braden scale described 62% of participants to be at high or severe risk of 
pressure damage. Yet, when assessed using the Waterlow score, 79% of 
participants were deemed to be at high or very high risk of pressure damage. 
However, this was not noted to be statistically significant. The lack of 
variance in the weekly Braden and Waterlow scores is also noteworthy. This 
may indicate a lack of sensitivity of the risk assessment tools. It is possible 
that the tools are not sensitive enough to assess subtle changes in the 
participants’ condition. 
 
Interestingly, the sub-epidermal measurements identified 90% of participants 
as having consistent elevated measurements, indicating the presence of 
tissue damage. Sub-epidermal scores were seen to be elevated before and 
with the presence of blanching erythema. Therefore, sub-epidermal 
measurement could be detecting damage before it is visibly evident.  
 
Overall, Braden and Waterlow scores determined the participants to be at 
high risk of pressure damage. Over the four week study period, neither 
Braden nor Waterlow showed any variance. However, a significant proportion 
of participants went on to develop pressure damage (14%). This shows that 
changes in the participant condition are not being recognised by the tool 
therefore it may not be adequately sensitive to determine risk. 
 
Sub-epidermal measurements continued to vary over the course of the study 
and this appeared to be in line with prevention strategies employed. Elevated 
sub-epidermal scores were also seen to coincide with visual skin 
assessment. Therefore, sub-epidermal measurement may be providing a 
more accurate and participant specific analysis of the skin and underlying 
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pressure ulcer development when compared to the generic analysis provided 
by risk assessment tools. 
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Chapter Five – Discussion 
5.1 Introduction 
This chapter presents a discussion regarding the findings of this study and 
the manner in which they relate to current research and the existing 
literature. Firstly, a summary of the study findings is presented. This is 
followed by a discussion of the study demographics and the concept of risk. 
Current issues in risk assessment are then discussed along with the findings 
regarding the use of sub-epidermal moisture measurement. Finally, a 
summary and conclusion are provided. 
 
The writer has found several points of interest in relation to the use of risk 
assessment that would bring their continued use into question. Firstly, in 
comparing Braden and Waterlow scores, the writer noted that these scales 
only agreed on the risk status of participants in 48% of cases. Therefore, they 
did not agree in 52% of cases, meaning differing risk statuses were assigned 
to the same participant. This will inevitably effect the clinicians’ decision to 
implement preventative measures and may lead to insufficient or inaccurate 
action. 
 
When risk assessment tools were broken down and assessed by subscale, 
none of the Braden subscales were found to be significant predictors of risk. 
The small sample size in the writer’s study must be kept in mind however, 
this finding is still of interest to clinicians considering the wide spread use of 
the Braden scale. Two subscales of the Waterlow score were noted to be 
predictively valid in the determination of pressure ulcer development, mobility 
and neurological deficit. The eight subscales were not found to be 
predictively valid and this is of concern to the writer as the large proportion of 
potentially invalid subscales will undoubtedly affect the final risk score. 
 
A concerning point noted in the writer’s study was the persistence in pressure 
ulcer incidence despite the use of a validated tool. The study site was using 
the Braden scale before the study was undertaken yet a significant number of 
participants developed pressure damage. If the tool is determined to be 
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predictively valid and preventative measures are undertaken, there should be 
no incidence of pressure damage. This would lead the writer to believe that 
either prevention is not being implemented appropriately or the risk 
assessment tool is not adequately predicting risk. Interestingly, sub-
epidermal moisture measurement showed elevated sub-epidermal moisture 
for at least one reading prior to visual signs of injury in each of the four 
participants who developed pressure damage. 
 
Most significantly, the writer noted a lack of sensitivity in the risk assessment 
tools. None of the participants risk status changed throughout the course of 
the study. It is difficult to believe that none of the participants’ condition 
changed at all over the four week study period, given the study population 
included in this study. It is possible that these risk assessment tools simply 
are not sensitive enough to identify minute, yet significant, changes in the 
individuals’ responses to pressure and shear and as such this is a serious 
limitation. These actual changes in the individuals’ responses can be seen by 
the varying sub-epidermal moisture measurements noted throughout the 
study period. Many participants sub-epidermal moisture measurement scores 
fluctuated from reading to reading indicating the presence of slight changes 
in the condition of the skin.  
 
Each of these findings will be now be discussed in detail in relation to current 
knowledge regarding risk assessment in the prevention of pressure ulcers. 
Finally a summary and conclusion will be provided, bringing the salient points 
of the discussion together.  
 
5.2 Sample Size 
The sample size for the study was determined using a power analysis. The 
required sample size was forty-seven participants. Previous research 
regarding sub-epidermal measurement was noted to have similar sample 
sizes such as Clendenin et al., (2015) and Guihan et al., (2012) with thirty-
one and thirty-four participants participating in these studies, respectively. 
However, in previous sub-epidermal moisture measurement research, small 
sample size has been noted as a study limitation (Harrow et al., 2014, 
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Guihan et al., 2012, Bates-Jensen et al., 2009, Bates-Jensen et al, 2008 and 
Bates-Jensen et al., 2007). The only study that discusses the reasoning for 
this small sample size is Guihan et al., (2012). They have attributed the small 
sample size to difficulties in recruitment and retention of participants. The 
writer had similar difficulties in attaining appropriate sample size.  
 
Initially, the writer aimed to recruit fifty participants to ensure an adequate 
sample size in case of the withdrawal of participants. The tissue viability 
nurse in the study site approached fifty participants who she deemed to be at 
risk of pressure damage due to poor mobility and activity scores, according to 
the Braden Scale (Bergstrom et al., 1987). Of these fifty participants, only 
four participants were capable of providing informed consent. The other forty-
six participants were unable to provide informed consent due to their medical 
condition. Several authors have previously discussed the ethical dilemmas in 
conducting research within a vulnerable population (Beck et al., 2003 and 
Moore et al., 2003). As the participants for this study were unable to provide 
informed consent, assent was sought from their next of kin. This process of 
obtaining assent created several issues. Eight of the forty-six potential 
participants had no next of kin and were therefore excluded from the study to 
maintain ethical integrity. Two potential participants’ next of kin declined to 
have their relative partake in the study. Sadly, three potential participants 
passed away during the assent process. The remaining thirty-three potential 
participants’, who were unable to give informed consent, had information 
leaflets provided by the gate keeper, to their next of kin. Assent was obtained 
from twenty-five families over the period of eight weeks. The remaining eight 
participants’ next of kin did not attend the study site during the recruitment 
stage therefore; these participants could not be included in the study. Similar 
recruitment issues were noted by Whelan et al., (2013) in their study 
involving care home residents. The authors noted that several relatives 
declined to assent. More notably, Whelan et al., (2013) found that a large 
proportion of relatives could not be contacted therefore; assent could not be 
obtained. 
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There is much debate in the literature pertaining to individuals with cognitive 
impairment choosing whether or not they wish to participate in research 
(Slaughter et al., 2007, Black et al., 2008, Black et al., 2010, and Overton et 
al., 2013). Some of this debate pertains to those with dementia, a condition 
faced by many in this writer’s research. It is argued than simply excluding 
individuals based upon their lack of ability to freely consent is an ethical 
dilemma in itself, because this limits the ability to address important research 
questions (Black et al., 2010). However, despite this, it is clear that enrolling 
people who cannot freely decide whether they wish to participate or not 
raises ethical, legal, and practical challenges within the research process 
(Black et al., 2010). The Health Service Executive in Ireland has a policy of 
consent (HSE 2014). Within this document, there is no specific guidance for 
the inclusion of older persons with reduced capacity in the research process. 
It is evident, that greater clarity is required to safe guard the individuals and 
researchers within the process of research involving older persons. The 
Nursing and Midwifery Board of Ireland (NMBI, 2007) stress the importance 
of providing additional protection regarding participation in research studies 
for those with diminished levels of autonomy. Further, the NMBI (2007) 
advise nurses and midwives to seek the direction of the appropriate or 
relevant Research Ethics Committee and as such it was on this premise that 
the writer concentrated the approach to acquiring consent or assent.  
 
The writer was aiming to recruit fifty participants however, due to time 
constraint and limited next of kin visits, it was not possible to gain assent 
from the remaining potential participants’ next of kin. In total, consent and 
assent was obtained from twenty-nine participants. Although the required 
sample size was not met, this study sample size is similar to other sub-
epidermal measurement studies with sample sizes ranging from sixteen 
participants (Harrow et al., 2014) to sixty-six participants (Bates-Jensen et 
al., 2009). 
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5.3 Follow-Up 
When evaluating previous sub-epidermal moisture measurement research it 
was noted that many studies assessed participants weekly (Bates-Jensen et 
al., 2009, Bates-Jensen et al., 2008 and Bates-Jensen et al., 2007) however 
these studies were conducted over longer time periods (twenty weeks, 
twenty weeks and fifty weeks respectively). One study, which was conducted 
over a six week period, attempted to measure daily and weekly sub-
epidermal moisture measurement variances to determine the most 
appropriate time frame to identify sub-epidermal changes (Guihan et al., 
2012) however this could not be determined due to small sample size. The 
remaining two studies were single point in time sub-epidermal moisture 
measurements (Clendenin et al., 2015 and Harrow et al., 2014).  
 
Single point in time measurement was not appropriate for this study as the 
writer wished to assess the change in skin condition over time. Although 
other studies had longer follow up periods, the writer was unable to follow up 
the study participants for such lengths of time as the research was being 
completed as a  Master by Research degree therefore; time was limited. 
Furthermore, the studies of Defloor (2005), Vanderwee (2007) and Moore 
(2011) all followed patients up for a 4 week period and in the study of Moore 
(2011) the mean time to pressure ulcer development was 24 days in the 
experimental group and 17 days in the control group. Therefore, a 4 week 
follow up was considered a sufficient robust follow up period. 
 
The writer initially aimed to visit each participant three times per week for four 
weeks to perform sub-epidermal moisture measurements. However, due to 
time constraints, three visits per week would not have allowed for completion 
of the study within the required period. Therefore, participants were seen 
twice per week for a period of four weeks. At each visit, the seven anatomical 
sites were scanned using a sub-epidermal moisture scanner and a visual 
assessment (according to EPUAP, 2014) was completed. This number of 
anatomical sites assessed in the writer’s study is higher than most sub-
epidermal moisture measurement studies. The only study that assessed 
more sites was Guihan et al., (2012) with nine anatomical sites included. 
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These sites used in the writers study were assessed due to the frequency of 
pressure ulcer incidence in these anatomical sites, in this population. Weekly 
Braden and Waterlow scores were calculated for each participant as risk 
assessment practice dictates that risk assessment should be completed 
weekly. In this manner, the writer attained a sizable number of sub-epidermal 
moisture measurements (n= 1,339), which is comparable to other studies of 
this nature. 
 
5.4 Demographics 
The study consisted of twenty nine participants. The majority of participants 
were female (65.5%). Drennan et al., (2012) outline that owing to life 
expectancy differing among males (77.3 years) and females (80.8 years), 
that there is a greater proportion of women in residential care. Furthermore, 
as age increases, so too does the number of women in residential care with 
76% of female residents in the nursing home sector aged 80 years and over 
compared to 56% of men. 
 
The majority of study participants were over eighty-one years of age (62.1%). 
As it was a care of the elderly setting, there were no participants under the 
age of fifty years in the study. Drennan et al., (2012) outline that almost 6% of 
the population of people aged 65 years and older in Ireland, are receiving 
residential care. Although pressure ulcers are not confined to the elderly 
population, studies have shown that advancing age is an important risk factor 
in the development of pressure damage (Moore et al., 2013, Shanin et al., 
2008 and Nixon et al., 2006).  
 
Reflecting on the aging demographic of our society it is interesting to note 
that Chan et al., (2009) estimate that older persons will represent 17% of the 
global population by 2050, compared with only 7% in 2002. Indeed, 
according to the Central Statistics Office Census (2011) 11.6% of Irelands 
population are 65 years or above. Furthermore, population and Labour Force 
Projections for 2016-2046 (Central Statistics Office, 2013), estimate that 
those of 65 years and above will steadily increase in the coming years. As a 
result, by 2021, 14.9% of the population will be 65 years or above. This figure 
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is estimated to increase to 18.7% in 2031 and increase further to 22.4% in 
2041. Subsequently, as our population ages, the risk of pressure ulcer 
prevalence increasing exists unless good prevention strategies are 
employed. Furthermore, as a result of increased numbers of pressure ulcers 
there will be a corresponding increase in healthcare costs with the presence 
of pressure ulcers also negatively affecting individual quality of life.  
 
Although this study sample is not necessarily representative of all those at 
risk of pressure damage, it does represent older individuals who are a 
significant proportion of those affected. It is important to remember that 
pressure ulcers are a preventable healthcare complication. Indeed, pressure 
damage is believed to be preventable in 95% of cases (Garcia-Fernandez et 
al., 2013 and Chan et al., 2009). The aging demographic of our society will 
be a cause for concern in the healthcare sector due to increasing healthcare 
costs. Any method of cost containment, such as a reduction in pressure ulcer 
incidence, will be vastly beneficial to the healthcare sector. 
 
Of the six sub-epidermal moisture measurement studies discussed in the 
literature review, three of these studies were conducted in a residential care 
of the elderly environment (Bates-Jensen et al., 2009, Bates-Jensen et al., 
2008 and Bates-Jensen et al., 2007). Unfortunately, none of these studies 
provide a description regarding the age profile of their study population 
however, as each study was conducted in a care of the elderly facility, the 
author has assumed that the age profiles of these studies is similar to the 
writers study. 
 
5.4.1 Risk Factors for Inclusion in the Study 
The ability to recognise those people at risk of developing pressure damage 
is an essential part of nursing care (Guy, 2012). Various risk factors have 
been cited in the development of pressure damage such as older age (Moore 
et al., 2013, Shahin et al., 2008 and Nixon et al., 2006), incontinence (Sayer 
et al., 2008), friction or shear (Lahmann et al., 2011), high body mass index 
(Alderden et al., 2011), non-blanching erythema (Shahin et al., 2008 and 
Nixon et al., 2006), malnutrition (Sayer et al., 2008) and poor tissue perfusion 
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(Coleman et al., 2013). From a review of the existing research, mobility 
appears to be the predominant risk factor in pressure ulcer development 
(Coleman et al., 2013, Moore et al., 2013, Lahmann et al., 2011 and Bouten 
et al., 2003). However, with existing research citing so many varying risk 
factors, it is difficult to determine the most influential risk factors to assist risk 
assessment in each clinical speciality. It is evident, therefore, that a greater 
understanding of the relationship between the commonly cited risk factors 
and the pathology of pressure ulcer development is needed. Indeed, such an 
understanding will provide greater clarity for clinicians in differentiating which 
are the risk factors most important to consider. 
 
When sampling from the study population for this study, it was important to 
ensure those sampled were actually at risk of pressure damage. If they were 
not deemed to be a risk, the relationship between risk assessment tools and 
sub-epidermal measurement could not have been studied. Due to the fact 
that the study was being conducted in a care of the elderly setting, special 
care had to be taken to include risk factors for this population. As seen in risk 
factor research, mobility and older age are frequently cited as predictors of 
risk (Coleman et al., 2013, Moore et al., 2013, Shanin et al., 2008, Nixon et 
al., 2006 and Bouten et al., 2003). 
 
The study population were all over the age of sixty-five years due to the study 
setting being a residential care of the elderly facility. Drennan et al., (2012), 
suggest that the probability of requiring nursing home care rises with age, 
with 70% of those requiring long-stay beds, approximately being aged 80 
years and older. Furthermore, 12% of all people in Ireland aged 80- 84 years 
are receiving long-term care compared with 2.3% of people aged 65 years of 
age and older (Drennan et al., 2012). Therefore, because the risk factor of 
age was synonymous with the population, mobility was considered to be the 
primary risk factor in assessment of possible participants for inclusion in the 
study. Several previous studies regarding the assessment of sub-epidermal 
measurement have employed participants with impaired mobility. Both 
Harrow et al., (2014) and Guihan et al., (2012) conducted their studies in 
spinal cord injury centres. These participants had varying levels of spinal 
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cord injury rendering them either paraplegic or quadriplegic. Furthermore, 
three other studies (Bates-Jensen et al., 2009, Bates-Jensen et al., 2008, 
Bates-Jensen et al., 2007) conducted their research in care of the elderly 
environments. Although these studies have not specified their risk factor 
inclusion criteria, the author has assumed the risk factors are similar due to 
the similar study setting.  
 
The risk assessment tool in use in the study site was the Braden scale 
(Bergstrom al, 1987). This scale includes the subscales of mobility and 
activity. Both of these subscales are intertwined as the vast majority of 
residents were immobile with limited activity which confines them to bed or to 
a chair. For this reason, any resident noted to have poor mobility and activity 
was appropriate for inclusion in the study. 
 
5.5 Risk Assessment 
Pressure ulcer risk assessment is the practice of screening an individual for 
common risk factors in the development of pressure ulcers in an effort to 
determine those at risk as a precursor to the initiation of preventative 
measures (Moore et al, 2008). International guidelines recommend the use of 
a validated risk assessment tool (EPUAP, 2014). A multitude of differing tools 
have been developed to analyse the risk to each individual, two of the most 
commonly used are the Waterlow and Braden scales (Guy, 2012 and 
O’Tuathail et al, 2011). Each scale provides a list of common risk factors or 
subscales to help assess the patient and identify those at risk of pressure 
ulcer development. These risk factors include but are not limited to age, 
weight, mobility, nutrition and continence status. The tool provides the 
practitioner with a score which indicates a low, medium or high risk of 
pressure ulcer development. Preventative measures should then be initiated 
in the form of a care plan, as appropriate to the perceived level of risk.  
The validity of these tools are essential as the perceived risk as determined 
by the output of the assessment, will determine the need for preventative 
intervention. As seen in the literature review, the results of studies regarding 
the use of risk assessment tools show varying degrees of validity and 
reliability (Hyun et al., 2013, Tschannen et al., 2012, Iranmanesh et al., 2011, 
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Jackson et al., 2011, Tannen et al., 2010, Webster et al., 2010, Cho et al., 
2009 and Kim et al., 2009). Throughout the literature reviewed there were 
three reoccurring themes; predictive validity of risk assessment tools, 
modification of existing risk assessment tools and the use of clinical 
judgement in risk assessment.  
 
The only theme which was relevant to the writers study was predictive validity 
of risk assessment tools. Predictive validity is a determination of how well a 
risk assessment tool is measuring what it is intended to measure and 
furthermore, how well results achieved from the risk assessment can be used 
to predict pressure ulcer development among patients (Anthony, 1999). Both 
previous research (Hyun et al., 2013, Jackson et al., 2011, Cho et al., 2010, 
Tannen et al., 2010, Webster et al., 2010 and Kin et al., 2009) and the writers 
study found inconsistencies in the predictive validity of risk assessment tools. 
In the writers study, neither Braden nor Waterlow scores changed for any 
participant over the four week study period. This would cause the writer to 
question the sensitivity of these tools as it is unlikely that none of the 
participants’ conditions changed at all over the study period. Several other 
authors noted issues in low sensitivity of risk assessment tools. Both Tannen 
et al., (2010) and Webster et al., (2010) note the low sensitivity of the 
Waterlow score with sensitivity of 72% and 0.67 (95% confidence interval; 
0.35-0.88) respectively. Similarly, Cho et al., (2010) note the sensitivity of the 
Braden scale to be 75%. This is of serious concern to clinicians as these 
tools are the only guidance available in the determination of risk in pressure 
ulcer development. If they are not predicting risk appropriately, prevention will 
be applied when it is not needed creating unnecessary healthcare expenses. 
Conversely, if risk is underestimated, prevention will not be provided to those 
who need it which will add to the growing incidence of pressure ulcer 
development.  
 
Other similarities have been noted between previous risk assessment 
research and the writers study. In studies comparing several risk assessment 
tools, there appears to be varying agreement of risk despite the use of the 
same sample (Tannen et al., 2010 and Kim et al., 2009). For instance, the 
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writers study only showed agreement between the Braden and Waterlow 
scores in 48% of cases. Thus, these tools did not agree on the risk level in 
52% of cases therefore, different interventions would be advised depending 
on the risk score. Furthermore, incidences of pressure ulcers have been 
noted in the literature despite studies having used a particular risk 
assessment tool, identifying the patient to be at risk (Pancorbo-Hidalgo et al., 
2006, Saleh et al., 2009, Webster et al., 2011 and Moore & Cowman, 2014). 
It is reasonable to assume that when the patient is deemed to be at risk, then 
appropriate prevention strategies are employed, thereby combating the risk 
(Moore & Cowman, 2014). It is evident within the literature that this is not the 
case, suggesting one of two problems. Either the risk assessment tool is not 
specific enough, or the interventions are not appropriate (Moore et al., 2013 
and Johansen et al., 2014).  
 
The Cochrane systematic review of Moore and Cowman (2014) noted risk 
assessment alone will not change risk status unless appropriate interventions 
are applied. Furthermore, a European prevalence study conducted by 
EPUAP (2002) found that only 9.7% of patients were receiving adequate 
preventative measures. A qualitative study by Johansen et al., (2014) 
discovered that the process of risk assessment did not necessarily lead to 
the implementation of preventative measures. The inconsistency in the 
creation and follow up of individual care plans was also noted. The study 
participants noted a lack of time, equipment and staff competence as 
contributory factors in inconsistent pressure area care (Johansen et al., 
2014). However, as stated by the Code of Professional Conduct (ABA, 2000), 
care planning is essential in providing quality patient care, therefore is a legal 
requirement of nursing care. Consequently, it is difficult to understand the 
shortcomings described in the provision of prevention.  
 
Interestingly, it is important to note that the writer witnessed many types of 
preventative intervention in actual use in the study site. Pressure relieving 
mattresses and cushions were in use for bed or chair bound patients. 
Positioning supports were provided to those with contractures to prevent 
pressure damage. Occupational therapists were involved in the seating and 
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sleeping positions of those at highest risk of pressure damage. Nutritional 
supplementation and dietary advice was provided by the site dietician indeed, 
several participants were being fed percutaneously at night to supplement 
their nutritional intake. The writer was unable to determine the specific cause 
of pressure ulcer incidence in the study as specific preventative measures 
were not recorded for each participant due to time constraints. However, with 
so many preventative measures witnessed, it is difficult to believe that 
insufficient prevention was the cause. Irrespective of cause, this is a worrying 
finding for clinicians. In order to reduce incidence, clinicians are reliant on 
predictively valid tools and the implication of prevention is a necessity. It is 
possible that the use of sub-epidermal scanning may give the clinician a 
definitive marker of the presence or absence of pressure damage therefore, 
disregarding risk status. The writer believes that a more definitive tool may 
encourage the use of preventative measures as it would leave far less no 
room for ambiguity. 
 
Furthermore, the most important factor to note in the writers study is the lack 
of variation in risk status over the four week study period. Very little change 
was noted in any participants risk assessment score throughout the study. 
The sensitivity of these tools is questionable if no change is noted in any 
participant over a four week period. Yet, changes in sub-epidermal moisture 
measurement scores were noted, suggesting that the risk assessment tool is 
unable to detect subtle changes in patients’ responses to pressure and shear 
forces. This is of concern to the clinician as risk assessment tools are widely 
used in practice, yet seem inherently flawed. 
 
5.5.1 Predictive Validity of Risk Assessment Tools 
Eight studies regarding the predictive validity of risk assessment tools have 
been reviewed (Hyun et al., 2013, Tschannen et al., 2012, Iranmanesh et al., 
2011, Jackson et al., 2011, Cho et al., 2010, Tannen et al., 2010, Webster et 
al., 2010 and Kim et al., 2009). These studies assessed several tools, each 
of which had been validated in previous studies. These tools included the 
Braden Scale, the Waterlow Score, Song and Choi, Cubbin and Jackson and 
the Care Dependency Scale. Although it is important to discover information 
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about several risk assessment tools, the writers’ primary concern was in 
ascertaining the validity of the Braden scale and Waterlow score. Therefore, 
any studies found regarding the assessment of these tools were included. 
Seven of the eight studies reviewed reported on the validity of the Braden 
scale. Only two of these studies cited good predictive validity and advocated 
the use of the scale (Tschannen et al., 2013 and Iranmanesh et al., 2011). 
The other five studies noted insufficient predictive validity (Hyun et al., 2013 
and Cho et al., 2010) or recommended the use of a different, more predictive 
tool (Jackson et al., 2011, Tannen et al., 2010 and Kim et al., 2009).  
 
In the writer’s study, when the risk assessment subscales of the Braden 
scale were analysed using multiple regression, none of the subscales 
appeared to be significant predictors of the development of pressure 
damage. Given the small sample size, the findings here should be interpreted 
with caution. However, in a study within a similar population in Ireland, also 
using multiple regression Moore et al., (2011) found that only the sub scales 
of activity and mobility of the Braden Scale were predictive of pressure ulcer 
development. These findings are supported by others who question the 
primary relationship between age, incontinence and malnutrition and 
pressure ulcer development, given that none of these factors expose the 
individual to pressure and shear (Oomens et al., 2010). Rather, these factors 
contribute to the individuals’ response to pressure and shear, but if pressure 
and shear are not present in the first place, the individual will not develop a 
pressure ulcer (Moore et al., 2011). Therefore, use of all the subscales of 
Braden may not sufficiently determine risk and thereby prompt the use of 
appropriate preventative measures. If none of these subscales are valid 
predictors of pressure damage, then the tool as a whole is inherently flawed 
(Anthony, 1999). The lack of evidence to support any of the Braden 
subscales is concerning and therefore prompts the writer to question its 
widespread use. 
 
Two studies researched the validity of the Waterlow score. Tannen et al., 
(2010) and Webster et al., (2010) both cited a low positive predictive value 
and advised against using the Waterlow score. However, in the writer’s 
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study, when the risk assessment subscales of the Waterlow were analysed 
using multiple regression, the Waterlow subscales of mobility and 
neurological deficit were found to be important predictors and these results 
were statistically significant. This concurs with current risk factor research 
(Moore et al., 2011). Although two of the Waterlow subscales were found to 
be accurate predictors of pressure damage, there were eight subscales that 
showed no predictive value in the determination of pressure damage 
development. While having due cognisance of the small sample size in the 
writers study, the outcomes, none the less are supported by others (Oomens 
et al 2010). Therefore, the large proportion of predictively invalid subscales 
will alter the ability of the tool as a whole, and diminish its predictive validity 
(Anthony, 1999). 
 
As seen in the literature review, all risk assessment tools are appraised 
based upon their predictive validity (Pancorbo-Hidalgo et al., 2006). 
However, in most studies, the authors do not note the preventative measures 
in use, and as such do not consider the confounding variables exerted by 
these measures on the incidence of pressure damage within the given 
studies (Defloor, 2005). Calculating predictive validity does not give clinicians 
an accurate picture of the validity of a risk assessment tool as prevention will 
alter the outcome. If healthcare professionals are to continue to conduct 
research regarding the validity of risk assessment tools, another method of 
determining validity should be considered as the current method may not be 
the most appropriate (Defloor, 2005). 
 
 
 
5.5.2 Agreement between Risk Assessment Scales 
In the writer’s study of risk assessment tools, Braden and Waterlow scores 
were calculated for each participant weekly. In week one, the Braden scale 
determined that 62% of the participants were at high or severe risk of 
pressure damage. Conversely, the Waterlow score determined that 79% of 
the participants were a high or very high risk. There was agreement between 
the Braden and Waterlow scores in just 48% of cases. This is of concern to 
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clinicians as both tools are validated for use, yet are providing significantly 
different results.  
 
Of the research reviewed in the literature review, only one study performed a 
comparative review of the predictive validity of the Braden and Waterlow 
scores. Tannen et al., (2010) found that the Braden scale was an accurate 
predictor of pressure damage with sensitivity and specificity of 84% and 74% 
respectively. Conversely, the Waterlow score only showed sensitivity and 
specificity of 72% and 4% respectively. This low level of specificity will mean 
many people will be determined to be at risk when in fact they are not. This is 
evident in the writers study when the Waterlow score determined 79% of 
participants to be at high or severe risk of pressure damage yet the Braden 
scale determined 62% of this population to be at high or severe risk. Tannen 
et al., (2010) have not specified the agreement rate between the scales in 
their study however, it is disconcerting that specificity is so vastly different 
considering the fact the risk assessments were completed using the same 
sample.  
 
In this care of the older person environment, the Waterlow scale would not be 
an ideal predictor of risk. However; it is difficult to determine how these 
results would apply to another clinical environment or speciality. This is an 
inherent problem given the use of this risk assessment tool across a wide 
variety of clinical settings (Moore & Cowman, 2014). As such, clinicians may 
not know the predictive validity of the instrument for their clinical area, unless 
they conducted their own research to determine this. This is of concern to 
clinicians as the choice of risk assessment tool for their clinical setting will 
determine its accuracy, depending on the appropriateness of use of the 
instrument within the given site (Webster et al., 2011). If two validated tools 
provide differing risk status measures, preventative measures will also differ. 
Picking the most predictively valid tool for the clinical site will help contain the 
costs of preventative intervention but it will also help to reduce 
prevalence/incidence (Anthony, 1999).  
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However, many clinical areas will not be capable of conducting research to 
determine the most valid tool for their site. Therefore, clinicians must make 
an informed decision regarding which tool is appropriate for their clinical site, 
while taking the limitations of the existing tools into consideration (Defloor, 
2005). If different tools are providing widely varying results, caution must be 
taken in deciding which risk assessment tool is appropriate for each clinical 
setting in order to attain predictively valid results. A review of the research 
has shown dissimilarity in the predictive validity of risk assessment tools. 
Unfortunately, even when studies are conducted in similar environments with 
similar specialities it can be difficult to determine whether their results can be 
applied to other environments. For instance, both Iranmanesh et al., (2011) 
and Kim et al., (2009) performed prospective studies regarding the validity of 
the Braden scale. Both studies were conducted in an intensive care 
environment however, despite the similarities in the studies, opposing results 
are shown. Iranmanesh et al., (2011) advocates the use of the Braden scale 
due to the good predictive ability found in the study. Conversely, Kim et al., 
(2009) noted the Braden scale to have poor predictive validity and 
recommended the use of different, more predictive tool.  
 
This is a major limitation of risk assessment tools and this would help to 
explain the wide variation of results in research regarding the use of these 
tools. It seems to be very difficult to replicate a study due to varying clinical 
specialities and environments. Indeed, even when research is conducted in 
the same speciality such as those of Kim et al., (2009) and Iranmanesh et al., 
(2011), agreement cannot be reached on the predictive validity of the Braden 
scale therefore; one can question how clinicians might determine their 
usefulness in clinical practice. Similarly, when two scales are used in the 
same environment, as in the writers study, risk assessment tools still cannot 
agree on the level of risk. This poses serious difficulties in the use of risk 
assessment tools due to the difficulty in determining the best tool for each 
clinical site. If the writers study setting were using the Waterlow score instead 
of the Braden scale, preventative measures would have been provided to a 
further 17% of the participants. This would significantly increase the cost of 
prevention yet there may be no clinical need for such interventions.5.5.3  
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Incidence of Pressure Ulcers 
Another interesting finding noted by the writer in the review of predictive 
validity of risk assessment tools is the incidence of pressure ulcers. Two of 
the studies compared their current risk assessment tool with another tool to 
determine the best predictor of risk (Jackson et al., 2011 and Tannen et al., 
2010). Tannen et al., (2010) compared the validity of the Braden scale, the 
Waterlow score and their current risk assessment tool, the Care Dependency 
scale. They noted good predictive validity in both the Braden and Care 
Dependency scales but advised the use of the Care Dependency scale as it 
was already the risk assessment tool at use in the hospital. However, if the 
Care Dependency scale is already in use at the study site, and it has been 
determined as an adequate predictor of risk, then one can question why 
pressure ulcer incidence persists. The exact incidence rate has not been 
declared by the author however, there must have been incidence to 
determine the validity. Similarly, Jackson et al., (2011) compared their current 
risk assessment tool to the Braden scale and found no statistically significant 
difference in the validity of the tools. Therefore, the author advised to 
continue using their current risk assessment tool. If these tools were in use 
before the study intervention and during the study, and they are deemed to 
have good predictive validity, appropriate preventative measures should be 
initiated according to the risk status. Therefore, there should be no incidence 
of pressure damage. The presence of incidence is concerning and it would 
suggest to the writer that either preventative measures are not being 
provided or the risk assessment tools are not adequately predictive despite 
the results of the study.  
 
Similar findings were noted in the authors study. Both the Braden and 
Waterlow scores determined that a large proportion of the participants were 
at high or severe risk of pressure damage. The Braden scale was the tool in 
use by the staff in the study site therefore, the writer would assume similar 
Braden scores were attained. If the Braden scores are determining that 
residents are at risk, preventative intervention should be put in place (Moore 
& Cowman 2014). Many preventative interventions were noted by the writer 
such as pressure relieving mattresses, pressure relieving cushions for chair-
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bound individuals, and positioning supports to relieve areas at risk of 
breakdown (such as the heels). A dietician and occupational therapist were 
also involved in the care of the participants. Despite this, 14% of participants 
went on to develop pressure damage. This is a similar result to both Jackson 
et al (2011) and Tannen et al., (2010) studies. When the risk assessment tool 
provided the clinician with a high risk score, preventative intervention would 
have occurred. This should have prevented the occurrence of pressure 
damage but it did not. Indeed, a sizeable portion of the participant population 
developed pressure damage. This would indicate, that the risk assessment 
tools are not sensitive enough to alert staff to small, yet significant changes in 
an individuals’ condition and challenges the current method of risk 
assessment in the clinical setting. 
 
5.5.4 Lack of Variation in Risk Assessment Tool Results over Time 
The final and most significant factor in the writer’s study is the consistency of 
the Braden and Waterlow scores over time. Very little change in either score 
was noted for any participant over the four week study period. This presents 
another concern for clinicians. It is unlikely that all participants’ risk of 
pressure damage remained the same for the entire study period. As stated 
previously, this could indicate a lack of sensitivity of both the risk assessment 
tools. As seen in the writers study, 14% of participants developed pressure 
damage. If the risk assessment tools were accurately predicting risk, 
prevention would have been provided. Several preventative interventions 
were noted by the writer while conducting the study. Therefore, there should 
have been no incidence of pressure damage. Unfortunately, the studies in 
the literature review do not outline their risk assessment results throughout 
their study period so the writer was unable to determine if previous research 
has noted a similar finding. Nevertheless, it is an important finding as it 
reiterates the limitations of risk assessment tools. 
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5.5.5 Summary  
The practice of pressure ulcer risk assessment is the only method available 
to clinicians to determine the likelihood of developing pressure damage. 
However, as seen throughout the research, there are many limitations to 
these tools. Predictive validity of the tools is questionable and opinion 
appears to be divided on the use of these tools. Although predictive validity 
was not used to determine the usefulness of risk assessment tools in the 
writers study, it is important to note that all other risk assessment tool 
research has determined the validity of these tools by calculating predictive 
validity. None of the authors have mentioned the effect of preventative 
intervention on predictive validity. The writer would question whether true 
predictive validity can be assessed in this manner as the effect of 
preventative measures on the outcome will never be known.  
 
The lack of agreement between risk assessment scales is of concern as the 
perceived level of risk will determine the preventative measures used. 
Special care must be taken by the clinician to use the most appropriate tool 
for their clinical environment to ensure the most accurate assessment of their 
population.  
 
Disconcertingly, in studies where the current tool in use was determined to 
be a good predictor of risk, incidence of pressure ulcers were still noted. 
Therefore, even though the research has determined this tool is a good 
predictor and preventive interventions were in use, it did not prevent the 
incidence of pressure damage. This would indicate that the tool is not 
predictively valid despite the findings of the research. 
 
Most significantly, the writer noted a lack of variation in risk assessment 
score over the four week study period. None of the participants risk status 
changed throughout the duration of the study. This was concerning to the 
writer as it is unlikely that none of the participants conditions changed over 
the study period. This lack of variation would appear to suggest poor 
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sensitivity of both the Braden and Waterlow tools and this is a seriously 
limitation. 
 
As seen from the studies mentioned above, there is no tool or method 
available that gives the clinician 100% validity. Each tool or method appears 
to show limitations therefore, risk assessment in its current form should be 
used with caution and with these limitations in mind. Unfortunately, despite 
the limitations in the use of risk assessment tools, there is no superior 
method of risk assessment yet available therefore, clinicians have no option 
but to use current risk assessment tools.  
 
5.6 Sub-epidermal Moisture Measurement 
Pressure ulcers impose a substantial problem in relation to quality of life and 
inflict a large burden on the healthcare sector (Shoham and Gefin, 2012). As 
can be seen from the research above, there are many inconsistencies and 
concerns regarding the use of risk assessment tools. However, presently, 
clinicians have no other method of determining risk. However, if sub-
epidermal moisture measurement can perform in practice as it has in 
research this could be a reliable and valuable method of detecting early 
tissue damage. 
 
5.6.1 Sub-epidermal Moisture Measurement 
Sub-epidermal moisture measurement is the process in which the level of 
moisture in the sub-epidermal layers of the skin is calculated through the use 
of a hand held scanning device. Elevated sub-epidermal moisture content 
has been shown to be a reliable indicator of tissue damage due to the natural 
inflammatory response of the body (Guihan et al., 2012, Bates-Jensen et al., 
2007). When tissue damage occurs, a healing response is triggered, 
beginning with an initial inflammatory reaction. This inflammatory phase 
causes oedema and therefore an increase in tissue moisture (Sussman and 
Bates-Jensen, 2012). This is relevant to pressure ulcer risk assessment as 
the presence of increased sub-epidermal moisture is a marker of 
inflammation and therefore, an indicator of tissue damage (Sussman and 
Bates-Jensen, 2012). If sub-epidermal moisture can be measured, the 
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presence or absence of tissue damage can be established and appropriate 
preventative measures introduced.  
 
Previous studies regarding the use of sub-epidermal moisture measurement 
have noted several interesting factors. Firstly, sub-epidermal moisture 
measurement appears to be concurrent with tissue damage (Harrow et al., 
2014, Guihan et al., 2012, Bates-Jensen et al., 2008, Bates-Jensen et al., 
2007). Each of these studies noted a relationship between increasing sub-
epidermal moisture measurement scores and worsening tissue damage. The 
pilot study of Bates-Jensen et al., (2007) noted a statistically significant 
relationship between elevated sub-epidermal moisture measurement scores 
and higher grades of tissue damage. In the Harrow et al., (2014) study of 
patients with spinal cord injury, overall sub-epidermal moisture measurement 
scores were 9% greater at existing pressure ulcer sites than at healthy 
control sites and this result was found to be statistically significant. Guihan et 
al., (2011) noted elevated sub-epidermal moisture measurement scores in 
higher grade pressure damage however statistical significance could not be 
inferred. A follow up to Bates-Jensen et al., (2007) pilot study (Bates-Jensen 
et al., 2008) provided a more comprehensive analysis of this relationship. 
This study showed a statistically significant relationship between four 
different levels of tissue damage; no damage, blanching erythema, grade I 
and grade II. Therefore, the sub-epidermal moisture measurement value 
increases as tissue damage increases, accurately determining the level of 
tissue damage.  
 
This is a very important point in relation to suspected deep tissue injury as it 
is not visible on the surface of the skin. If measuring the sub-epidermal 
moisture content provides the clinician with a high measurement, and 
damage is not visible then deep tissue injury should be considered. The 
ability to determine the presence of deep tissue injury would allow clinicians 
to put preventative measures in place before damage becomes evident on 
the surface of the skin, therefore preventing further and more serious tissue 
damage. 
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Unlike previous research, the sub-epidermal moisture measurements in the 
writers study were not consistently concurrent with visible tissue damage. 
The writer believes this is due to preventative interventions which were being 
provided in the study site. If visual indicators of damage are present, such as 
erythema, staff in the study site would instigate preventative measures such 
as more frequent repositioning. Due to this, it is possible that participants 
could have fluctuating sub-epidermal moisture measurements as 
interventions are provided and their skin condition improves. The second 
finding noted in sub-epidermal research confirms this. Several studies noted 
that sub-epidermal moisture measurement was capable of detecting tissue 
damage before it was visible on the surface of the skin (Bates-Jensen et al., 
2009, Bates-Jensen et al., 2008, Bates-Jensen et al., 2007). In Bates-Jensen 
et al., (2007), 26% of all grade I damage was predicated by elevated sub-
epidermal moisture measurements one week before any visual signs of 
damage were present. Interestingly, in the follow up study (Bates-Jensen et 
al., 2008) further confirmation was provided when it was noted that 32% of 
grade I damage was predicted one week before visible signs through 
elevated sub-epidermal moisture measurements. Most telling is the Bates-
Jensen et al., (2009) study of sub-epidermal moisture measurement in 
persons with darker skin tones. The darker pigment in these participants skin 
prevents clinicians from recognising the initial signs of pressure damage such 
as erythema. In this study, 88% of non-visible damage was predicted one 
week before damage was evident on the skins surface.  
 
In the writers study, four of the twenty-nine participants developed pressure 
damage. There were three grade I pressure ulcers and one grade II noted. 
All four instances of damage were found on the sacrum. Participant thirteen 
developed grade I damage after two consecutive elevated sub-epidermal 
moisture measurements. The presence of blanching erythema was noted 
after one elevated sub-epidermal moisture measurement reading. Participant 
eleven developed a grade II pressure ulcer after one elevated sub-epidermal 
moisture measurement reading. Interestingly, this participant showed no 
visual signs of pressure damage and subsequently, rapidly developed grade 
II damage. Participant eight developed grade I damage after two elevated 
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measurements however, blanching erythema was noted with the first 
elevated reading. Participant twenty-four developed grade I damage after 
one elevated measurement. Despite the elevated sub-epidermal moisture 
measurement reading there were no visual signs of skin damage. The 
incidence of pressure damage in the study was too small to verify statistical 
significance but these findings are in line with previous research which shows 
that elevated sub-epidermal readings indicate the presence of pressure 
damage before it is visibly evident on the skin.  
 
This finding is of great importance to clinicians in their assessment of the skin 
in two ways. As seen in the writers study, some people will rapidly develop 
pressure damage without any visual warning signs on the skin. The current 
method of risk assessment depends on this visual skin assessment and will 
therefore be unable to identify this category of people who do not display 
visual skin changes. Secondly, a similar principle can be applied in relation to 
suspected deep tissue injury. This type of damage occurs in the muscle 
layers of the tissue, below the surface of the skin. This damage only 
becomes visible when the damage reaches the surface of the skin (Oomens 
et al., 2010). Therefore, damage will be present before clinicians are aware it 
exists. By using sub-epidermal moisture scanning, invisible deep tissue 
injuries can be discovered and preventative measures put in place to prevent 
further tissue breakdown. 
 
Although the writer was unable to determine the predictive capacity of sub-
epidermal moisture measurement as shown in previous studies, several 
important findings can be noted. Many participants were seen to have 
blanchable erythema. Some participants, such as participant eight and 
participant thirteen, went on to develop grade I damage yet, the other 
participants with blanchable erythema did not develop further pressure 
damage. Currently, some research advises clinicians to wait for grade 1 
damage before preventative intervention is put in place. This approach is 
deemed to reduce the unnecessary use of preventative measures for those 
who do not go on to develop further tissue damage (Vanderwee, 2007). If 
sub-epidermal moisture measurement were used, those with blanchable 
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erythema could be assessed. Elevated measurements could indicate those 
that need prevention and those that do not. In this manner, we would not 
have to wait for the presence of pressure damage before initiating 
intervention. More importantly, prevention would be provided to those that 
need it. 
 
Equally, two participants developed pressure damage without any warning 
signs of visual damage. Currently, a combination of a risk assessment tool 
and visual skin assessment are used by the clinician to determine the need 
for intervention (EPUAP, 2014). As seen in participant eleven and participant 
twenty-four, neither of these methods have prevented the development of 
pressure damage. This is due, in part, to the lack of visual damage on the 
skin. When these participants were assessed, their skin appeared to be 
healthy; therefore staff did not initiate intervention. This is especially worrying 
in the case of participant twelve who went on to develop grade II damage. 
Sadly, the presence of grade II damage remained for the duration of the 
study. In this case, the participant’s skin condition rapidly deteriorated. Visual 
assessment appeared normal in week one yet, by week two, grade II 
pressure damage had developed with no evidence of grade I damage.  
 
As stated by EPUAP (2014) the progression of pressure damage is not 
always linear. The practice of waiting for the presence of grade I damage is 
practical in regard to the current method of risk assessment as the clinician is 
not provided with clear evidence as to which patient will develop further 
damage (Vanderwee, 2007). Applying prevention to every person with 
blanchable erythema would not be cost effective. However, as seen in the 
writers study, there are some patients who need prevention once the 
presence of blanching erythema is noted. In each of the four participants who 
developed pressure damage, sub-epidermal measurement was elevated for 
at least one reading before damage was evident. It also determined the 
presence of damage in the two participants who showed no visible signs of 
tissue damage. In this manner, sub-epidermal moisture measurement is 
more sensitive to minute changes in the condition of the skin (Bates-Jensen 
et al., 2009). As seen in the writers study, these minute changes may not be 
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evident through the use of risk assessment tools and some are not evident 
through visual assessment. This point is further verified by the fact that four 
participants developed pressure damage. If the use of a risk assessment tool 
and visual skin inspection are reliable methods of risk assessment, then 
those at risk would be accurately identified and preventative measures put in 
place. This should prevent the incidence of pressure damage yet it did not. 
Sub-epidermal moisture measurement could be a reliable alternative to 
differentiate between those who require intervention and those that do not. 
 
5.6.2 Pathology and Cell Deformation 
Historically, pressure ulcer development has been attributed to a lack of 
oxygenation of tissue otherwise referred to as ischemia (Stekelenburg et al., 
2008). Recently, there has been growing interest in other contributing factors 
in cell pathology and deformation. This research has shown that there 
appears to be four contributing factors in the deformation of cells and 
development of pressure damage; 
1. Localised ischemia 
2. Ischemia-reperfusion injury 
3. Impaired interstitial fluid flow 
4. Sustained deformation of cells due to mechanical loading 
Localised ischemia in tissue damage is caused by compression of the tissue 
and surrounding structures including the capillaries. This closure of 
capillaries prevents adequate blood flow and therefore causes ischemia 
(Michel and Gilott, 1990). The first research into pressure ulcer aetiology 
determined ischemia to be the predominant factor in development of 
pressure damage (Daniel et al., 1982). More recent studies confirmed this 
theory (Hermann et al., 1999). However, more recent studies have defined 
ischemic damage as a slow process in which damage is reversible (Oomens 
et al., 2014 and Stekelenburg et al., 2008). Therefore, ischemia alone could 
not account for rapidly occurring pressure damage. Other factors must be 
considered. 
 
Ischemia-reperfusion injury is described as an injury to the tissue or cells 
resulting from a reperfusion of blood to a previously ischemic area (Pretto, 
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1991). Several hypotheses exist regarding the exact mechanism of ischemia-
reperfusion injury yet the exact cause is unknown however, each mechanism 
results in tissue damage and inflammation (Houwing et al., 2000 and Peirce 
et al., 2000). 
 
Impaired interstitial fluid flow is caused by a disruption to lymph circulation 
and the transport of interstitial fluid (Reddy, 1990). Normal cell function 
depends on appropriate blood flow not only to deliver nutrients to the cells 
but also to remove waste products through interstitial fluid and lymph 
circulation (Tweed, 2003). Any prolonged disturbance to tissue cells will lead 
to cell damage and eventually cell death (Shayn et al., 2000). 
 
Sustained deformation of cells due to mechanical loading is thought to be a 
majorly significant contributor to tissue damage, not solely due to ischemia as 
previously thought but in fact due to deformation of cells in the tissue. 
Stekelenburg et al., (2008) study compared the effects of ischemia on tissue 
damage and compared it to the effect of sustained mechanical loading. The 
animal study showed that continuous mechanical loading for a period of two 
hours led to irreversible tissue damage. However, tissue damage caused by 
ischemia alone resulted in reversible tissue damage. The study also noted 
the development time of tissue damage in reference to ischemia and 
sustained mechanical loading. Cell viability in the hypoxic tissue was 70% 
after twenty-two hours. Conversely, in the tissue with sustained mechanical 
loading, tissue damage could be seen within one hour and after twenty-two 
hours cell death had occurred in 60% of cells. It would appear sustained 
mechanical loading causes rapid tissue damage and this is of concern for 
clinicians. The same finding was noted in an earlier study by Breuls et al., 
(2003). This mechanical loading is a result of sustained periods on hard 
surfaces such as emergency trolleys or operating theatre beds (Stekelenburg 
et al., 2008). This would appear to correspond with risk factor research which 
states that mobility is a key factor in pressure ulcer development. A study by 
Zimlichman et al., (2011) reiterates this finding. A motion study was 
conducted to record and analyse the relationship between movement and 
pressure ulcer risk status. Motion detectors were used to record each 
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participant’s movement then, a motion score was assigned. The study found 
that sensitivity and specificity of the motion score were 85% and 93% 
respectively. These results show more promising sensitivity and specificity 
than any of the studies regarding risk assessment tools. Further studies by 
Kallman et al., (2015) and Siddiqui et al., (2013) confirm the usefulness of 
monitoring movement in the prevention of pressure damage. 
 
Current methods of risk assessment do not give the clinician the opportunity 
to determine cellular or deep tissue damage as it is not always visible on the 
surface of the skin (Gefen et al., 2013). Recent research shows that 
sustained mechanical loading can lead to rapid tissue damage (Linder-Ganz 
et al., 2006). This damage is not always visible on the skin’s surface as seen 
in the writers study. More importantly, in relation to deep tissue injury, 
damage occurs deep within the muscular layers of the tissue and progresses 
outwardly towards the surface of the skin (Stekelenburg et al., 2008). If 
healthcare professionals wait for visible signs of pressure damage, serious 
pressure damage could occur (Gefen et al., 2013). The promising use of sub-
epidermal moisture measurement could alleviate this problem as deep tissue 
injury could be identified early and further deterioration prevented. 
Although the writers study has not shown statistical significance in relation to 
the predictive capacity of sub-epidermal measurement, many positive factors 
were discovered. Risk assessment tools have been shown to be unreliable in 
the detection of risk and their efficacy is debatable. It is clearly shown in the 
research that mobility is the key factor in the development of pressure 
damage. The writer believes that clinicians could benefit from combining sub-
epidermal assessment with a motion score as seen in Zimlichman et al., 
(2011). In this manner, those determined to be at risk due to reduced mobility 
could be assessed using sub-epidermal moisture scanning. Those with 
elevated readings could have preventative measures applied in an effort to 
prevent pressure ulcer incidence. This method would also cater to those who 
do not show visible signs of pressure development. More significantly, it will 
detect the initial development of deep tissue injury and clinicians can 
intervene before further damage occurs. 
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5.7 Contribution to Current Knowledge 
From the review of the literature it is clear there are several issues in the use 
of risk assessment tools. The questionable validity of these tools is the first 
and most pressing issue. The validity of each risk assessment tool is 
determined through the calculation of sensitivity, specificity and predictive 
values. None of the authors in the review of literature mentioned the effect of 
preventative measures on these values. If an individual is deemed to be at 
risk, a care plan will be put in place by the clinician. This may involve a range 
of preventative measures in order to reduce risk and avoid pressure ulcer 
development. However, no author has noted what effect this will have on the 
outcome of pressure ulcer development. Even if a tool adequately predicts 
risk, preventative intervention will alter the outcome and therefore sensitivity, 
specificity and predictive values are not a true representation of the validity or 
reliability of risk assessment tools. Therefore, the clinician must use these 
tools with caution. 
 
Another issue seen in the research of risk assessment tools is the lack of 
agreement between risk assessment tools. Different tools provide different 
risk status to each person. This element of risk assessment practice adds 
further confusion to the debate surrounding their efficacy. How are clinicians 
supposed to determine the best and most valid risk assessment tool for their 
clinical environment when research has shown that tools and results are site 
specific? 
 
Most significantly, two studies assessing the validity of their current risk 
assessment tool noted their predictive validity and advocated their use. Yet, 
in order to determine predictive validity there had to be incidence of pressure 
damage. If these tools were in use before the study, and they are deemed to 
be predictively valid, then pressure damage should not occur as the tool 
would provide adequate warning of risk to the clinician. However, it can be 
seen that they are not preventing pressure ulcer development and therefore, 
cannot be as predictive as the study has determined. 
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The uncertainty regarding risk assessment tools is disconcerting. Uncertainty 
in the use of risk assessment tools were also noted in the writer’s study 
which assessed the use of the Braden and Waterlow scales. Interestingly, 
when both risk assessments were compared, agreement of the level of risk 
was only reached in 48% of cases. Therefore, depending on the tool of 
choice, different levels of risk would be shown. This would affect the 
clinicians’ decision to initiate preventative measures and could therefore have 
an effect on the development of pressure damage. The writer believes this 
inconsistency stems from the tool design. The Waterlow score was initially 
designed for use in an acute or surgical setting. Therefore, it is not surprising 
that its use in a residential setting has shown unusual results. This furthers 
the argument that certain tools are more applicable to specific specialties and 
clinicians must take care when choosing the most appropriate tool for their 
clinical setting. Furthermore, very little change in either the Braden or 
Waterlow scores was seen over the four week study period. This was not 
noted in any of the studies in the literature review. This would appear to 
suggest that none of the participants risk status changed over the four week 
study period. Yet, four participants went on to develop pressure damage. If 
their risk was adequately determined, there should have been no incidence 
of pressure damage. 
 
When both scales were analysed by subscale, none of the Braden subscales 
were seen to be significant predictors of risk. Only two of the Waterlow 
subscales, mobility and neurological deficit, were statistically significant 
predictors of risk and this correlates with previous research.  
 
The prevailing point to note throughout the literature and the writers study is 
the presence of incidence. If these tools are performing appropriately, risk 
should be determined and the incidence of pressure damage prevented. 
However, in all the studies, including the writer’s, there were instances of 
pressure damage. In the writer’s study, 14% of participants developed 
pressure damage. If we are to believe that 95% of pressure damage is 
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preventable, then a large portion of these participants should not have 
developed pressure ulcers at all.  
 
This research contributes to our knowledge of risk assessment as it further 
verifies the inconsistencies in risk assessment tools. The validity of these 
tools can be seen to vary from study to study. The methods of calculating 
validity are flawed as preventative measures are not taken into account. Most 
importantly, incidence of pressure damage still occurred irrespective of which 
tool was in use. A more appropriate method of determining risk must be 
found if clinicians are to prevent the incidence of pressure damage.  
 
Previous studies regarding the use of sub-epidermal moisture measurement 
have shown two promising results. Sub-epidermal moisture measurements 
appear to increase as tissue damage increases (Harrow et al., 2014, Guihan 
et al., 2012, Bates-Jensen et al., 2008 and Bates-Jensen et al., 2007). 
Therefore, sub-epidermal moisture measurements offer an alternate for 
accurately identifying the level of damage in the tissue. More importantly, it 
has been shown to be capable of determining the presence of damage 
before it is visible on the surface of the skin (Bates-Jensen et al., 2009, 
Bates-Jensen et al., 2008, Bates-Jensen et al., 2007). If this could be 
verified, it would be highly beneficial to clinicians in the detection of deep 
tissue injury but it would also be of great assistance in identifying those that 
do not display visual warnings of damage such as those with darker skin 
tone. 
 
Unfortunately, neither of these results could be seen in the writers study due 
to a variety of factors. Firstly, the writer was unable to verify the trend in 
increasing sub-epidermal moisture measurement and tissue damage as this 
populations sub-epidermal moisture measurement results were seen to 
fluctuate. For instance, an elevated sub-epidermal moisture measurement 
could be followed by a normal measurement which could become elevated 
again on the next measure. The writer believes this is due to the effect of 
preventative intervention. The initial elevated reading indicated the presence 
of damage, prevention altered the risk therefore reducing the tissue damage 
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by the next measure and returning the sub-epidermal moisture value to 
normal. 
 
The writers study could not assess the ability of the sub-epidermal moisture 
scanner to detect damage before it was visible on the surface of the skin 
because there was limited development of pressure damage. Four 
participants of twenty-nine developed pressure damage. Of these four, two 
showed visual signs of tissue damage soon after the presence of an elevated 
sub-epidermal reading. However, two participants showed no signs of visual 
tissue damage before developing either grade I or grade II damage. Both 
participants had elevated sub-epidermal readings before the development of 
pressure damage. Unfortunately, this number was too small to provide 
statistical significance however it is important to note that this element 
warrants further investigation. 
 
Although statistical significance could not be inferred there were several 
interesting points to note. Many participants developed blanching erythema. 
This is not considered to be pressure damage and current research advises 
clinicians to wait for stage I damage before initiating intervention 
(Vanderwee, 2007). Three participants developed grade I damage that did 
not deteriorate any further during the course of the study and the writer 
believes this was due to appropriate intervention. However, one participant 
never showed visual signs of grade I damage and rapidly developed grade II 
damage. As stated by EPUAP (2014) pressure damage is not always linear. 
In this way, the practice of waiting for grade I damage is flawed. Some 
individuals will develop a pressure ulcer more rapidly than others. The study 
site was using the Braden scale to evaluate participant risk. It is interesting to 
note that this participant’s score did not change from the time of intact skin, to 
the development of grade II damage however elevated sub-epidermal 
moisture measurement indicated the presence of damage. It is possible that, 
had sub-epidermal moisture measurement been used, the presence of an 
elevated measurement would have been an indicator to intervene and this 
participant may not have developed grade II damage. In this manner, sub-
epidermal moisture measurement appears to be more sensitive to minute 
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changes in the tissue therefore, it could be a more appropriate method of 
determining the presence of damage. 
 
The research question was; 
What is the relationship between the Braden scale, Waterlow score and sub-
epidermal measurement? 
 
The study showed that there was low negative correlation between sub-
epidermal measurement and the Braden scale however, this was not 
statistically significant. There was no correlation seen between sub-epidermal 
measurement and the Waterlow score however, this was not statistically 
significant. This is surprising considering the fact that both Braden and 
Waterlow identified a large proportion (62% and 79% respectively) of the 
participants to be at high or severe risk of pressure damage and sub-
epidermal measurements found 90% of participants to have elevated 
readings. The writer believes there was no correlation between the three 
tools as the Braden and Waterlow scales remained static throughout the 
study yet the sub-epidermal measurements varied. Very little change was 
noted for any participant in either the Braden or Waterlow score over the four 
week study period. However, sub-epidermal scores appeared to vary from 
abnormal to normal as the condition of the tissue changed. This would 
appear to highlight the lack of sensitivity of risk assessment tools in detecting 
minute changes in the condition of the tissues and indicate that sub-
epidermal measurement can identify these minute changes. 
 
Although the writer’s study did not show statistical significance in regards to 
sub-epidermal moisture measurement, the writer believes this is due to the 
small sample size and not the efficacy of sub-epidermal moisture scanning. 
Previous research regarding this method of assessing tissue damage has 
been promising. Further research is needed in this area to further verify the 
benefits of its use in the clinical area. 
 
 
 
117 
 
 
 
5.8 Summary 
Assessment of risk in the development of pressure ulcers is an essential tool 
to prevent and therefore, reduce the incidence of pressure damage. As seen 
in previous literature, pressure damage is preventable in 95% of cases (Chan 
et al., 2009). The economic and social ramifications of pressure damage are 
vast. They can drastically impair quality of life and cause considerable 
suffering for the individual. The cost of treating pressure damage is 
considerable and this is a large burden on the healthcare sector not just in 
terms of finance but also in regards to increased workload. Global prevalence 
has almost doubled between 2001 and 2009 (Garcia-Fernandez et al., 2013). 
Bennett et al., (2008) estimate that 2-4% of global healthcare expenditure is 
used to treat pressure damage each year. It is clear from this figure that 
many preventable pressure ulcers are occurring despite the use of risk 
assessment. Clinicians are advised to employ the use of a validated risk 
assessment tool in their practice to aid the prevention of pressure damage 
(EPUAP, 2014). There are over forty validated risk assessment tools being 
used across the world at present (Kottner et al., 2010). The inconsistencies in 
the use of risk assessment tools have been outlined in the research and in 
this study. The questionable validity is a worry for clinicians and creates 
problems in the assessment of risk and the provision of preventative 
measures. A more proficient and reliable method of determining risk is 
urgently needed. The use of sub-epidermal moisture scanning in the 
identification of tissue damage appears to be a promising avenue. Although 
this study could not prove statistical significance, previous studies detailed 
the benefits in using sub-epidermal moisture measurement. 
 
Pressure ulcers are a growing problem in the healthcare sector and clinicians 
must make every effort to tackle this problem. A more effective method of risk 
assessment will aid the clinician to reduce prevalence and control the 
negative consequences that pressure ulcers create. The writer believes that 
clinicians could benefit from combining sub-epidermal moisture measurement 
with a motion score similar to that of Zimlichman et al., (2011). Therefore, 
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those determined to be at risk due to reduced mobility could be assessed 
using sub-epidermal moisture measurement. If elevated sub-epidermal 
moisture readings were found, clinicians could initiate preventative measures 
in an effort to prevent pressure ulcer occurrence. This method would also 
cater to those who do not show visible signs of pressure damage. More 
significantly, it will detect the initial development of deep tissue injury and 
clinicians can intervene before further damage occurs. 
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Chapter Six – Conclusions and Recommendations 
6.1 Introduction 
The aim of this study was to explore the relationship between current risk 
assessment tools namely the Braden and Waterlow risk assessment tools, 
and sub-epidermal moisture measurement. There have been numerous 
studies conducted regarding the validity of risk assessment tools however, 
research regarding the validity of sub-epidermal moisture measurement is 
more limited. This is likely, because the use of sub-epidermal moisture 
measurement is not routine in clinical practice as yet. The writer’s findings, 
therefore, will add to the body of knowledge surrounding the efficacy of risk 
assessment tools and  will also provide information regarding the use of sub-
epidermal measurement, of which no such research has been conducted 
outside of the United States. In this chapter, a brief summary of the writer’s 
findings will be outlined. The study strengths and limitations will be 
discussed. Furthermore, implications of the study findings and 
recommendations for future research will be discussed in detail. Finally, the 
writer will reflect on the study and discuss the lessons learned through the 
research process. 
 
6.2 Key Findings 
Braden and Waterlow scores were calculated weekly for each participant 
over the four week study period. Seven anatomical sites were scanned using 
the sub-epidermal measurement device. Each participant had these seven 
sites scanned twice per week for the four weeks study period. At each visit, 
the seven anatomical sites were also visually assessed according to EPUAP 
guidelines (2014). In total, 1,339 sub-epidermal measurements and visual 
skin assessments were acquired. 
 
According to the Braden scale, 62% of participants were assessed as being 
at high or severe risk of pressure damage. Conversely, the Waterlow score 
determined 79% of participants to be at high or very high risk of pressure 
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damage. Generally, there was agreement between these two scales in just 
48% of cases. Neither Braden nor Waterlow scores were seen to change for 
any participant over the four week study period.  
 
Sub-epidermal values varied significantly for every participant. Considering 
all participants, 90% had at least one elevated sub-epidermal reading over 
the course of the study. Additionally, 54% of these participants had elevated 
measurements for three consecutive readings in more than one anatomical 
site. Furthermore, 15% of these participants had elevated measurements for 
three consecutive readings in more than two anatomical sites.  
 
In the visual assessment of the skin, 2.6% of participants were noted to have 
abnormal visual assessment. These abnormal assessments ranged from 
blanchable erythema to stage II pressure damage. Abnormal visual 
assessments were noted in 41% of all participants. Of all the participants 
noted to have abnormal visual assessment, 66% showed persistent 
abnormal visual assessments. 
 
No relationship was noted between the Braden or Waterlow scores and the 
sub-epidermal measurement readings. A low negative correlation was noted 
between sub-epidermal measurement and Braden scores (r=-0.234), 
however this was not statistically significant (p=0.222). There was no 
correlation noted between sub-epidermal measurement and Waterlow scores 
(r=0.095) however, this finding was also not statistically significant (p=0.624). 
There was a variable relationship noted between visual skin assessment and 
sub-epidermal scores. For example, participant thirteen developed stage I 
pressure damage and this corresponded with sustained elevated sub-
epidermal readings. Conversely, participant twelve had one elevated sub-
epidermal reading and then developed stage II pressure damage with no 
visual abnormalities noted prior to the development of stage II damage. 
 
When the risk assessment tools were assessed in greater detail using their 
individual subscales, some subscales or risk factors were associated with 
sub-epidermal changes. When considering the Braden subscales, the 
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subscales of mobility (Beta = 0.446, 95% CI: -0.035-0.177) and sensory 
perception (Beta = -0.423, 95% CI: -0.284-0.067) were the highest predictors 
of risk however, these were found to be not statistically significant (p=0.176 
and p=0.212 respectively). The Waterlow subscales of mobility (Beta = -
0.474, 95% interval:; -0.126—0.009) and neurological deficit (Beta = -0.612, 
95% CI: -0.071—0.009) were noted to be the highest predictors of risk and 
these findings were statistically significant (p=0.027 and p=0.013 
respectively).  
 
The purpose of the study was to determine the relationship between risk 
assessment tools, namely the Braden scale and the Waterlow score, and 
sub-epidermal moisture measurement. No statistically significant relationship 
was noted however multiple regression analysis of the risk assessment 
subscales determined the highest predictors of risk. Mobility and sensory 
perception were noted to be the highest predictors of risk in the Braden scale 
however these were not statistically significant. Mobility and neurological 
deficit were the highest predictors of risk in the Waterlow score and both of 
these findings were statistically significant. It is interesting to note the 
similarities in predictive subscales and although each result was not noted to 
be statistically significant, these results appear to be in line with current 
research regarding predictive risk factors. In both tools mobility is noted as 
the highest predictor of risk. The subscales of sensory perception and 
neurological deficit are intertwined as many neurological deficits will create 
issues in sensory perception such as diabetes or a stroke.  
 
The inconsistency between the Braden and Waterlow risk status is notable 
and agreement was only found in 48% of cases. This is of concern as 
clinicians usually determine the most effective preventative intervention 
based upon the risk status. An incorrect risk status could lead to unnecessary 
intervention causing an increase in healthcare costs. Significantly, if risk 
status is underestimated, and prevention is not introduced, the clinician risks 
adding to the prevalence of pressure ulcers.  
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Overall, Braden and Waterlow scores determined the participants to be static 
in terms of their risk status over the four week study period yet, sub-
epidermal moisture measurements varied throughout the study. This would 
appear to indicate a lack of sensitivity of the risk assessment tools as the 
minute, yet significant changes seen in sub-epidermal measurement are not 
noted by traditional risk assessment. 
 
6.3 Strengths and Limitations 
A prospective, non-experimental study design was employed by the writer. 
Prospective data collection is employed when a researcher is interested in 
describing the effect of a cause (Parahoo, 2006). The prospective design 
allowed the writer to examine changes in participants’ skin condition over 
time and therefore, analyse the relationship between risk assessment tools 
and sub-epidermal measurement. An experimental design has been 
described as a method of establishing causality (Curtis and Drennan, 2013). 
As the causes of pressure damage have been widely discussed in previous 
research, the writer’s primary concern was not to determine the causes of 
pressure damage. The writers study aimed to determine the relationship 
between traditional risk assessment tools and sub-epidermal moisture 
measurement. Therefore, a non-experimental design was used. The writer 
considers the use of a prospective, non-experimental design to be a strength 
of the study as no previous research has been conducted to determine the 
relationship between risk assessment tools and sub-epidermal measurement. 
As such, this is the first study of this kind. 
 
The writer believed there was a need for such research due to the growing 
prevalence of pressure damage. Worldwide pressure ulcer prevalence is said 
to range from 7-54% (Kim et al., 2012, Page et al., 2011, Chaves et al., 2010 
and Sayer et al., 2008). Alarmingly, Irish prevalence rates are noted to be 
between 12-38% (Gallagher et al., 2008, Gethin et al., 2005, and Moore et 
al., 2000). To date, efforts to reduce prevalence have not been significantly 
effective; in fact, global prevalence has almost doubled between 2001 and 
2009 (Garcia-Fernandez et al., 2013). The aging demographic of our society 
is another cause for concern. Studies have shown that advancing age is an 
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important risk factor in the development of pressure damage (Moore et al 
2013, Shanin et al 2008 and Nixon et al 2006). The Central Statistics Office 
(CSO) Census (2011) showed that 11.6% of the population are 65 years of 
age or older. By 2041, the projected figure for those over 65 years of age is 
22.4% (CSO, 2013). Subsequently, we are at risk of experiencing continued 
increase in pressure ulcer prevalence unless we provide beneficial 
preventative measures. 
 
The main limitation of the study is the small sample size. Sample size was 
determined using a power analysis (Cohen, 1988). With power set at 80% 
and a significance level of 5%, the required sample size was approximately 
forty-seven participants. The writer aimed to recruit fifty participants in case 
of participant withdrawal to ensure adequate sample size. Several issues 
were noted in the recruitment of participants. The study was conducted in a 
residential care of the elderly facility therefore, a large proportion of the 
population were unable to provide informed consent. Only four of the initial 
fifty potential participants were deemed capable of providing informed 
consent. The writer had to obtain assent from the remaining forty-six 
participants’ next of kin before they could be included in the study. Eight of 
the forty-six potential participants had no next of kin and were therefore 
excluded from the study to maintain ethical integrity. Two potential 
participants’ next of kin declined to have their relative partake in the study. 
Sadly, three potential participants passed away during the assent process. 
The remaining thirty-three potential participants’, who were unable to give 
informed consent, had information leaflets provided by the gate keeper, to 
their next of kin. Assent was obtained from twenty-five families over the 
period of eight weeks. The remaining eight participants’ next of kin did not 
attend the study site during the recruitment stage therefore; these 
participants could not be included in the study. Previously, authors have 
discussed such issues in conducting research within a vulnerable population 
(Beck et al., 2003 and Moore et al., 2003). However, the exclusion of these 
participants presents an ethical dilemma in itself (Black et al., 2010) as this 
population is at high risk of developing pressure damage. In order to improve 
the prevalence of pressure ulcers in this population, research is necessary. 
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Therefore, due care was taken to include the participants whose next of kin 
provided assent and to exclude those for whom assent could not be attained. 
Due to this, the writer could not recruit the required sample size and this 
should be considered in reviewing study results. 
 
Another limitation of the study was time. Due to the study being undertaken 
as part fulfilment of a Master’s degree, time was limited. The writer had 
initially planned to assess participants using the sub-epidermal scanner three 
times per week. After a pilot study, it was determined that the study would not 
be completed within the required time frame therefore, assessments were 
reduced to two times per week. If longer time had been allowed, more sub-
epidermal moisture measurements could have been gathered, therefore 
enhancing the study results. Furthermore, had the writer had more time, 
further participants could have been recruited. Unfortunately, there was an 
outbreak of norovirus in the study site during the study which meant that the 
writer could not assess participants for two weeks. This was done to prevent 
the unnecessary spread of the infection around the study site however, this 
added to the time constraint. 
 
The writer did not note the preventative measures in place for each 
participant. This is also a limitation as it would have aided in determining the 
cause of incidence in the study, or may have helped place the changing sub-
epidermal moisture measurement scores into greater context. Although the 
prevention employed within the study site was not the primary concern of this 
research, in hind sight gathering of this information may have provided 
greater clarity as to what was happening with the patients on a day to day 
basis. To do this effectively would require not only examining patients clinical 
care notes, but also observing practice. This is because it is well documented 
that there is a gap between what is recorded in clinical notes and what actual 
care is delivered to patients (Jordan O’Brien and Cowman, 2008). This 
approach was outside the scope of the current project, however, this is an 
important point to consider in future research. 
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There are many strengths of this study worth noting. The writer was the only 
assessor in the study. Risk assessment, visual assessment and sub-
epidermal measurement were completed by the writer for all participants. 
This diminishes the risk of inter-rater bias. Furthermore, both Braden and 
Waterlow scales have been validated for use in the assessment of pressure 
ulcer risk. Visual assessment was conducted based upon EPUAP (2014) 
guidelines. Also, the writer received sub-epidermal scanner training before 
conducting the study therefore reducing user error. Considering these points, 
the writer believes the study assessment provides sufficient reliability and 
validity. 
 
The writer considered use of this population chosen for inclusion in the study 
to be a strength, as older age is a notable risk factor in the development of 
pressure damage (Moore et al 2013, Shanin et al 2008 and Nixon et al 
2006). Furthermore, this population were seen to have limited mobility, 
another key factor in the development of pressure damage (Coleman et al., 
2013, Cowman et al., 2012, Cox, 2011, Moore et al., 2011 and Verschueren 
et al., 2011). Therefore, this population are at increased risk of pressure 
damage and are the most appropriate population to use when researching 
this topic. Furthermore, these results can be applied to other people of similar 
age and mobility status in future research, providing cognisance of the 
limitations of the study is given in any potential application of findings. 
 
The small sample size, as mentioned previously, is the main limitation of the 
study however, the study design and setting were strengths and will allow for 
replication of the study in future research. It is important to note that the 
writer was conducting the study in fulfilment of a Master’s degree therefore, 
time was limited. It is also of note that all planning, research and 
assessments were conducted by the writer. Other studies of this nature had 
several researchers or assessors to conduct the study and they were not 
limited by the same time restrictions. Considering this, the writer feels that, 
although statistical significance cannot be inferred, this study can be used as 
a platform for future research in this area. 
 
126 
 
 
 
 
6.4 Dissemination of Findings 
Research is conducted to benefit patients, health professionals, the health 
service as a whole and also to provide confidence among  the general public 
of the safety and efficacy of health care delivery interventions (National 
Institute for Health Research, 2010). As such, research is imperative in the 
development of nursing practice and is a significant component in the 
provision of evidence-based, high quality care (An Bord Altranais, 2007). In 
order for others to know the results from a given research project, it is the 
responsibility of the researcher to disseminate their research findings to both 
professional and general populations in order to heighten the contribution to 
evidence based practice (Polit and Beck, 2012). 
 
Initially, the writer will composed a report of the study for submission to the 
Royal College of Surgeons in Ireland library where it can be used as a 
reference for future research. A copy of the study will be sent to the tissue 
viability nurse in the study site, and the writer will arrange a meeting to inform 
the staff of the findings and recommendations. The study abstract will be 
submitted to the European Wound Management Association and to the 
European Pressure Ulcer Advisory Panel for consideration for their annual 
conference, 2016. An abstract will also be submitted to the Wound 
Management Association of Ireland for their conference, 2015. Finally, the 
writer will prepare a paper from the study for submission to relevant peer-
reviewed, tissue viability and wound management journals for potential 
publication. 
 
6.5 Implications for Nursing Practice 
The purpose of conducting research is to discover new information in an 
effort to provide the highest standard of care to our patients. It also aids 
clinicians in continual professional development. The purpose of conducting 
this research was to determine the relationship between traditional risk 
assessment tools and sub-epidermal moisture measurement. It has been 
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shown that traditional risk assessment tools have many limitations and this 
appears to agree with current research regarding the efficacy of these tools. 
Clinical staff must be mindful of these limitations when using these tools to 
prevent unnecessary complications for their patients. As professionals, 
nurses are accountable for their actions and omissions (An Bord Altranais, 
2000a), therefore it is their duty to ensure they continually educate 
themselves. The study results should be disseminated to ensure nurses are 
aware of the limitations of current risk assessment tools and are mindful of 
these limitations in their daily practice. 
 
Additionally, the use of sub-epidermal moisture measurement has shown 
promise. Recent research regarding the pathology of cell damage and the 
development of deep tissue damage has shown that tissue damage is not 
always visible on the surface of the skin. Previously, visual skin assessment 
was a key indicator to instigate preventative measures. This will have 
implications for nursing practice as the use of visual assessment will not 
identify all instances of damage. It is imperative that clinical staff realise the 
difference between superficial and deep tissue damage so that instances of 
deep tissue damage can be reduced. If sub-epidermal moisture 
measurement can identify non-visible tissue damage, it could aid the clinician 
in preventing further tissue damage. Further research must be conducted to 
confirm the efficacy of sub-epidermal moisture measurement in the clinical 
area. Nurses must be mindful of new developments in nursing research to 
continually update their knowledge in an effort to provide the highest 
standard of care to their patients. 
 
6.6 Recommendations for Future Research 
The purpose of conducting research is to identify trends and patterns for 
comparative use (Parahoo, 2006). Therefore, the most important 
recommendation for future research is to replicate the study or conduct a 
similar study to verify or refute the study’s findings. The inconsistencies in the 
validity of risk assessment tools have been outlined in both the writer’s study 
and in previous research. Unfortunately, this is the only method available to 
clinicians at present to determine risk. There has been a vast amount of 
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research conducted to determine the validity of these tools yet no consensus 
can be reached in determining their efficacy. As previously stated, this may 
be due to the differing study specialities and the various risk factors included 
for their potential in determining the actual risk of this population. In reality, 
studies which determine the efficacy of a risk assessment tool may not be 
applicable to other clinical environments due to differing populations and 
therefore, different determinant risk factors. Due to this, the writer would 
recommend future research in the area of risk assessment. Consequently, it 
is imperative that clinicians are aware of the shortcomings of the current tools 
and practice caution with their use. Furthermore, more appropriate methods 
should be considered to help minimise the growing prevalence of pressure 
damage. 
 
To date, there have been six studies conducted regarding the use of sub-
epidermal moisture measurement. These studies have shown promising 
results however; further research regarding the efficacy of sub-epidermal 
moisture measurement is needed to verify these results. The writers study 
was unable to clearly determine the role of sub-epidermal moisture 
measurement versus traditional risk assessment. However, given the static 
nature of the risk scores of the participants, versus the fluctuation in sub-
epidermal moisture measurement, it is clear those changes in patients’ 
responses to pressure and shear may not be readily understood using 
traditional risk assessment. However a larger study will provide greater clarity 
to the findings presented here.  
 
The writers study was conducted in a care of the elderly environment. This 
population was appropriate due to their high risk status. However, it is known 
that the elderly population are not the only cohort at risk of pressure ulcer 
development. Indeed, any person of any age could get a pressure ulcer 
providing they are exposed to the prolonged adverse effects of pressure and 
shear forces. Therefore, given the high prevalence of nosocomial pressure 
ulcers among individuals who are acutely ill, or are undergoing surgery, 
future research would benefit from also establishing the validity of sub-
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epidermal moisture measurement in an acute care setting. In this manner, 
other populations and other risk factors may be studied.  
 
This study has attempted to discover the relationship between risk 
assessment tools and sub-epidermal moisture measurement. It has provided 
information which is pertinent to the current use of risk assessment tools but 
more significantly, it has provided information regarding the use of sub-
epidermal measurement in clinical practice. A study of this nature has not 
been conducted previously. In this manner, the writer’s results can be used 
as a basis for future studies and also helps to build upon our knowledge 
regarding sub-epidermal moisture measurement. 
 
6.7 Reflections on the Study 
Schon (1987) described the practice of reflection as a method in which to 
improve practice by contemplating on previous action. In this manner, 
professionals can bridge the theory-practice gap and discover new 
knowledge. Reflective practice can enhance the clinicians’ self-awareness 
and aid the clinician in improving their practice (Johns, 2009). An Bord 
Altranais (2000a) suggests that reflection can encourage evidence based 
practice and therefore; improve patient outcomes. 
 
On reflection, I have found the research process to be challenging in many 
ways. Throughout the process, I have experienced many setbacks and 
frustrations. Initially, I was enthusiastic about the possibility of completing a 
research project, a task I had never attempted before. Soon after beginning 
the process, I realised the tremendous amount of time, effort and hard work 
that goes in to conducting research. It was daunting. I doubted my ability to 
complete the project. Gaining ethical consent, finding an appropriate study 
site, recruiting participants and assessing participants were all larger tasks 
than I realised. These components were difficult and time consuming. I found 
it difficult to manage my time and even more difficult to manage my stress. 
However, despite all of these things, this project has helped me to develop 
both professionally and personally. The process of recruiting and assessing 
participants was the most difficult and exasperating part of the study however 
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it has aided me in improving and developing my personal skills. I feel more 
confident in dealing with a vulnerable population; I also gained invaluable 
experience in communicating with participants families. This will not only 
serve me in conducting future research but also in my own clinical 
environment. Communicating with the staff in the study site has also helped 
me to appreciate the tremendous workload involved in residential care but 
more importantly, I gained an insight into the talents needed to provide 
quality care to this population. The study site staff were patient, caring and 
compassionate. I felt the care provided to the patients in the study site was 
commendable and it has taught me to strive to care for my own patients in 
such a positive and pleasant manner. 
 
In regards to time management and dealing with stress; I was given 
invaluable advice to break the study down into small sections so as not to 
become overwhelmed by the enormity of the task. This method was of great 
assistance to me over the last year and it is something I will carry with me 
going forwards both personally and professionally. I feel I would have lacked 
confidence in reading and critiquing research before this study. I certainly 
was not confident in my ability to write a research study however, on 
reflection, I have gained experience and practice in each of these elements 
and my confidence and ability has grown. Most importantly, I have gained a 
greater understanding of pressure ulcer risk assessment and the challenges 
clinicians face in attempting to control incidence. It is a challenging and 
multifaceted topic and clinicians need every assistance available in reducing 
pressure damage in patients. 
 
If I were to repeat this research study I would consider completing it in a 
different environment. In the environment chosen, the majority of participants 
could not provide informed consent therefore; assent had to be sought from 
the next of kin. Due to the vulnerable nature of the participants, it was difficult 
to meet the required sample size which has affected the quality of the results. 
Further research is needed to confirm the benefits of sub-epidermal 
measurement.  
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I have gained invaluable experience in the process of conducting research. I 
have seen the difficulties and benefits that researchers experience in 
attempting to discover new information and I have huge admiration for the 
work which is done to enhance nursing knowledge and the profession as a 
whole. I have received incredible support, guidance, patience and 
understanding from so many individuals in my personal and professional life 
throughout the research process and I will endeavour to offer others the 
same qualities in times of stress in the future. It has been a tremendous 
learning experience not only in terms of conducting research but also on a 
personal level. It has shown me that, with hard work, I am more capable than 
I thought and I am proud that I have completed such a task. 
 
6.8 Summary 
The writer has discussed the validity of traditional risk assessment methods. 
This is supported by previous research regard risk assessment tools. The 
use of visual assessment shows variability and therefore cannot be relied 
upon. At present, these two methods are the only methods available to 
clinicians in the determination of risk and in understanding whether the 
patient is developing early pressure ulcer damage. The use of sub-epidermal 
moisture measurement has shown promise in previous research and in the 
writers study however, further research is needed to confirm these findings. 
 
The study design was considered to be a strength of the study, as this design 
allowed the writer to follow the participants over a defined period of time. In 
this way, the relationship between risk assessment tools and sub-epidermal 
moisture measurement could be defined. The use of a residential care of the 
elderly population is also considered to be a study strength as this population 
are at high risk of developing pressure damage and will frequently be 
affected by this problem.  
 
Sample size and time restrictions were limitations of the study. The writer 
was unable to recruit the required sample size due to the restrictions in 
consenting vulnerable adults. The majority of the participants were unable to 
provide informed consent therefore; assent had to be provided by their next 
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of kin. This was a difficult task as the writer was dependant on the next of kin 
visiting the study site to obtain assent. Many participants did not have any 
next of kin visits over the duration of the study period and therefore, had to 
be excluded from the study. The writer was completing the study as a 
Master’s degree consequently, time was limited. Sample size and the 
number of assessments could have been increased if the writer had more 
time. Future research regarding sub-epidermal moisture measurement is 
imperative to verify the positive results demonstrated in previous research 
and in the writers study.  
 
Study results will be disseminated locally, in the Royal College of Surgeons 
in Ireland library for reference and for future research. A copy of the study will 
be sent to the study site and the writer will endeavour to formally present to 
the group to inform them of the results and recommendations. The study will 
be submitted for presentation at the European Wound Management 
Association, the European Pressure Ulcer Advisory Panel and Wound 
Management Association of Ireland conferences. The study will also be 
submitted to relevant tissue viability and wound management journals. 
 
On reflection, the writer found the research process to be challenging yet 
much has been gained. The writer has developed professionally and 
personally and has gained confidence in regards to academic ability. These 
are traits that will be carried forward and will aid the writer in improving 
clinical practice. 
 
 
6.9 Conclusion 
The prevalence of pressure damage is a universal issue. Pressure ulcers 
have been described as an unnecessary healthcare complication as they are 
preventable in 95% of cases (Garcia-Fernandez et al., 2013). Despite this, 
the prevalence of pressure ulcers has almost doubled in recent years 
(Garcia-Fernandez et al., 2013). Worldwide prevalence ranges from 7-54% 
(Sayer et al., 2008) with Irish prevalence reported to be as high as 38% 
(Moore and Cowman, 2011). The cost of treating pressure ulcers cannot be 
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underestimated. Approximately 2-8% of global healthcare budgets are used 
in the prevention and treatment of pressure ulcers annually (Bennett et al., 
2008). This is an alarming figure considering the fact that the majority of 
pressure ulcers are preventable. Furthermore, the personal cost of living with 
a pressure ulcer is also of significance. The physical, mental, social and 
financial implications of living with a pressure ulcer should therefore, not be 
underestimated. Those suffering with pressure damage have described 
feelings of anxiety, low mood and social isolation due to their condition 
(Goreki et al., 2009). Furthermore, the pain and immobility associated with 
pressure ulcers contributes to an increased absence from the workplace 
(Goreki et al., 2009). Most notably, people with pressure ulcers are seen to 
have a higher mortality rate than those without pressure ulcers (Bouten et al., 
2003).  
 
Moving into the future, the aging demographic of our society is of serious 
concern. Many studies have shown that increasing age is a predictive risk 
factor in the development of pressure damage (Moore et al., 2013, Shanin et 
al., 2008 and Nixon et al., 2006). The Central Statistics Office census (2011) 
determined that 11.6% of our population was 65 years or above. This figure 
is set to dramatically increase with 22.4% of our population estimated to be 
65 years or older by 2041 (CSO, 2013). This increasing age demographic 
has the potential to worsen the prevalence of pressure damage unless steps 
are taken to control this growing healthcare issue. 
 
The inconsistencies in the validity of risk assessment tools have been 
described in previous research and in the writers study. The lack of 
congruency in this research is of concern and provides many obstacles for 
the clinician in determining the most beneficial tool for their clinical 
environment. At present, the only method of risk assessment is through the 
use of a risk assessment tool which is often combined with a visual 
assessment of the skin. As seen in the writers study, neither method is 
faultless. The lack of sensitivity of risk assessment tools is the writer’s 
primary concern as this method does not appear to detect minute, yet 
significant changes in the condition of the skin. Visual assessment relies on 
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the premise that pressure damage is linear and therefore; is not always a 
reliable indicator of damage. This too was seen in the writers study when one 
participant developed grade II pressure damage with no previous visual 
indicators noted. The writer believes this can be attributed, in part, to deep 
tissue injury. The discovery of the importance of this type of injury is relatively 
recent and research has determined that sustained mechanical loading can 
lead to rapid deep tissue injury (Linder-Ganz et al., 2006). As this occurs 
deep within the muscular layers of the tissue, initial damage will not be 
distinguished by risk assessment tools, nor will it be visible on the skins 
surface and will therefore lack detection on visual assessment. These 
inadequacies are adding to the challenges faced by clinicians in their attempt 
to prevent pressure damage. A more reliable method of assessing the 
condition of the skin is imperative to aid clinicians in reducing the prevalence 
of pressure ulcers. 
 
Current research regarding the use of sub-epidermal moisture measurement 
has shown two promising findings. Firstly, sub-epidermal moisture 
measurement has been found to be concurrent with tissue damage (Harrow 
et al., 2014, Guihan et al., 2012, Bates-Jensen et al., 2008 and Bates-Jensen 
et al., 2007). This means that sub-epidermal moisture measurement 
fluctuates in line with tissue damage and can accurately determine the level 
of tissue damage. In the writers study, this finding could not be verified as the 
sub-epidermal readings fluctuated throughout. The writer believes this is due 
to the effect of intervention therefore, tissue was relieved of pressure due to 
interventions and the sub-epidermal measurement subsequently decreased. 
Although this finding could not be verified in the writers study, it is an 
interesting and promising finding and further research must be conducted in 
order to verify its validity. Secondly, previous research has found that sub-
epidermal measurement is capable of detecting damage before it is visible on 
the surface of the skin (Bates-Jensen et al., 2009, Bates-Jensen et al., 2008 
and Bates-Jensen et al., 2007). In fact, 32% of all grade I damage was 
predicated by elevated sub-epidermal moisture measurement one week 
before visual assessment could determine the presence of damage (Bates-
Jensen et al., 2008). In the writers study, all four incidences of pressure 
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ulcers were predicated by at least one elevated sub-epidermal moisture 
measurement. Although these results were not found to be statistically 
significant, they concur with previous sub-epidermal research and provide 
further confirmation of the promise of sub-epidermal use. Further research is 
imperative to verify the validity of the promising results in the use of sub-
epidermal moisture measurement. If sub-epidermal moisture measurement 
can perform in clinical practice as it has in research, this could be a 
promising avenue in the fight against pressure damage.
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I have been recruited by a person other than the 
researcher. 
Yes    □ No   □ 
I have read the information leaflet/ had the 
leaflet read to me. 
Yes    □ No   □ 
I understand the information contained within the 
leaflet. 
Yes    □ No   □ 
I understand that my participation in this study is 
entirely voluntary and I may withdraw from the 
study at any time, without reason. 
Yes    □ No   □ 
I understand that withdrawing from the study will 
not affect my future medical care. 
Yes    □ No   □ 
I understand that my medical records will be 
viewed by the study author. 
Yes    □ No   □ 
I understand that my identity will remain 
confidential at all times. 
Yes    □ No   □ 
The benefits and risks of participating in the 
study have been clearly explained to me. 
Yes    □ No   □ 
I give permission for unidentifiable data Yes    □ No   □ 
Consent Form  
Study Title 
 
Validity of risk assessment using sub 
epidermal moisture measurement 
compared to traditional risk 
assessment methods – a preliminary 
investigation 
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concerning my person to be stored for possible 
future research subject to research ethics 
committee approval. 
I have been given a copy of the participant 
information leaflet and this consent form. 
Yes    □ No   □ 
I agree to participate in this study. Yes    □ No   □ 
 
 
 
 
 
Participant name (PRINT):  
____________________________________ 
 
 
Participant Signature:  _______________________________ 
 
 
Date: _____________________________ 
 
 
 
Statement of researcher’s responsibility 
I the undersigned have taken the time to fully explain to the above 
patient the nature and purpose of this study in a manner that they 
could understand. I have explained the risks involved as well as 
the possible benefits. I have invited them to ask questions on any 
aspect of the study that concerned them. 
 
Researcher Name (PRINT): 
_______________________________ 
 
 
Researcher Signature: ____________________________ 
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Date: ___________________ 
 
 
 
 
 
 
Further information 
If you want more information, please ask the nurse to contact me. I 
will arrange to speak to you at a time that suits you.  
 
 
My contact details are as follows:  
Ms. Susan Molloy, Phone: 01 2889053. School of Nursing & 
Midwifery, RCSI, 123 St Stephens Green, Dublin 2.  
 
My supervisor’s contact details are as follows: Professor Zena 
Moore, School of Nursing & Midwifery, RCSI, 123 St Stephens 
Green Dublin 2. Tel: 01 4022569. 
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Assent Form 
 
Study Title 
 
Validity of risk assessment 
using sub epidermal 
moisture measurement 
compared to traditional 
risk assessment methods 
– a preliminary 
investigation 
 
 
 
Assent is the expression of approval or agreement. By providing assent for 
your next-of-kin, you are agreeing to allow their participation in this study.  
 
 
I have read the information leaflet/ had the leaflet 
read to me. 
Yes    □ No   □ 
I understand the information contained within the 
leaflet. 
Yes    □ No   □ 
I understand the concept of assent.    Yes    □     No   □ 
I understand that I may withdraw assent at any time 
if I have any concerns for the participant. 
Yes    □ No   □ 
I understand that withdrawing from the study will not 
affect the participant’s future medical care. 
Yes    □ No   □ 
I understand that the participant’s medical records 
will be viewed by the study author. 
Yes    □ No   □ 
I understand that the participant’s identity will remain 
confidential at all times. 
Yes    □ No   □ 
The benefits and risks of the study have been Yes    □ No   □ 
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clearly explained to me. 
I give permission for unidentifiable data concerning 
the participant to be stored for possible future 
research subject to research ethics committee 
approval. 
Yes    □ No   □ 
I have been given a copy of the participant 
information leaflet and this consent form. 
Yes    □ No   □ 
I agree to provide assent to allow the participant be 
included in the study. 
Yes    □ No   □ 
 
 
Name of person providing assent (PRINT):  
____________________________________ 
 
Relationship to participant:  
___________________________________ 
 
Signature:  _______________________________ 
 
Date: _____________________________ 
 
Statement of researcher’s responsibility 
 
I the undersigned have taken the time to fully explain to the above patient 
and party providing assent, the nature and purpose of this study in a manner 
that they could understand. I have explained the risks involved as well as the 
possible benefits. I have invited them to ask questions on any aspect of the 
study that concerned them. 
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Researcher Name (PRINT): _______________________________ 
 
Researcher Signature: ____________________________ 
 
Date: ___________________ 
 
 
Further information 
If you want more information, please ask the nurse to contact me. I will 
arrange to speak to you at a time that suits you.  
 
 
My contact details are as follows:  
Ms. Susan Molloy, Phone: 01 2889053. School of Nursing & Midwifery, 
RCSI, 123 St Stephens Green, Dublin 2.  
 
My supervisor’s contact details are as follows: Professor Zena Moore, 
School of Nursing & Midwifery, RCSI, 123 St Stephens Green Dublin 2. 
Tel: 01 4022569. 
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Appendix D – Participant Information 
Leaflet  
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Participant Information 
Leaflet 
 
Study Title 
 
Validity of risk 
assessment using sub 
epidermal moisture 
measurement compared 
to traditional risk 
assessment methods – a 
preliminary investigation 
 
 
 
You are being invited to take part in a research study which will 
assess your risk of developing a pressure ulcer. This research is 
being undertaken in fulfillment of a Master’s degree at the Royal 
College of Surgeons in Ireland. This work is being undertaken by 
Ms Susan Molloy, post graduate student and is supervised by 
Professor Zena Moore, Professor and Head of Nursing & 
Midwifery, Royal College of Surgeons in Ireland.  
 
Before you decide whether or not you wish to take part, please 
read the information provided below carefully.  
 
Purpose of the Study 
Pressure ulcers (also known as bed sores, pressure sores and 
decubitus ulcers) are areas of injury to the skin, underlying tissue 
or both, usually over a bony area, as a result of pressure, or 
pressure in combination with shear (tissue distortion resulting from 
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squeezing and stretching soft tissues between bony structures and 
the skin). Prevention of pressure ulcers is an important aspect of 
patient care. In order to identify those who require pressure ulcer 
prevention, a risk assessment, using a specifically designed 
questionnaire, is carried out on each patient to determine their risk 
of developing a pressure ulcer. A further method of risk 
assessment is assessment of the skin using a sub-epidermal (just 
beneath the outer layer of the skin) moisture scanner. Please take 
a look at the enclosed picture of the scanner. This is a handheld 
device which measures the moisture content of the skin and 
provides an estimation of this moisture which is indicative of risk of 
pressure ulcer formation. This study aims to understand which 
method of risk assessment is more effective for predicting pressure 
ulcer risk. 
 
What will happen during the study? 
It is planned to assess your risk of developing a pressure ulcer 
using two risk assessment questionnaires. These questionnaires 
will be completed by me; you will not have to complete the 
questionnaires. An inspection of your skin will also be undertaken 
to determine whether or not you have a pressure ulcer. Finally your 
skin will be inspected using the hand-held sub-epidermal moisture 
scanner. This scanner is a painless, non-invasive device that is 
rolled over the skin. Risk assessment and skin assessment will be 
undertaken three times a week for 4 weeks. The assessment will 
be done at a time which is convenient to you, usually before you 
get up in the morning, so as not to disturb or interrupt your daily 
activities. Specifically the following information will be gathered: 
 Your risk of developing a pressure ulcer 
o Your age 
o Your activity and mobility abilities 
o Your nutritional status – this information will be 
obtained from your medical chart 
o Your continence status 
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o Your underlying medical condition – this information 
will be obtained from your medical chart 
 Your skin condition 
 Your skin assessment using the sub-epidermal moisture 
scanner 
 
All information gathered about you will be treated with strict 
confidence. All patients will be assigned a code. Only the 
researcher will know who the patients are. Results from all patients 
who participate will be combined and the combined results may be 
published in relevant journals and presented at conferences. 
Results will also be shared within the organisation. However, 
nobody will be able to identify that it is you have taken part in the 
study. 
 
Any risks involved in the study 
We hope that the study will benefit patients; however, there are a 
few points that you should be aware of: 
 The skin assessment is a painless and non-invasive 
process however it will involve turning and/or rolling in your 
bed. This may cause mild discomfort based on your medical 
history or level of mobility. 
 There will be a small demand on your time as the 
assessment process will take a few minutes. I will try to 
make the process as quick and comfortable as possible. 
 
The possible benefits of the study 
By taking part in the study, you will allow me and the hospital staff 
to have a better understanding of risk assessment for the 
prevention of pressure ulcers. This will help others, involved in the 
care of patients, to more accurately help to prevent pressure ulcers 
from happening. 
 
May I refuse to take part in the study? 
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You may refuse to take part in the study, without giving a reason 
and this will not affect your care in any way. 
 
May I withdraw from the study at any time if I wish? 
You are free to stop being a part of the study at any time, if you 
want to, without giving a reason. This will not affect your clinical 
care in any way.  
 
Who has given approval to complete this study? 
Ethical approval has been sought from the Royal College of 
Surgeons in Ireland Research Ethics Committee. Permission to 
conduct the study has been granted by the Director of Nursing and 
the Medical Director of the hospital. 
 
 
Further information 
If you want more information, please ask the nurse to contact me. I 
will arrange to speak to you at a time that suits you.  
 
 
My contact details are as follows:  
Ms. Susan Molloy, Phone: 01 2889053. School of Nursing & 
Midwifery, RCSI, 123 St Stephens Green, Dublin 2.  
 
My supervisor’s contact details are as follows: Professor Zena 
Moore, School of Nursing & Midwifery, RCSI, 123 St Stephens 
Green Dublin 2. Tel: 01 4022569. 
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Appendix E – Waterlow Score Scoring 
Sheet  
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Appendix F – Braden Scale Scoring Sheet  
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Appendix G – Data Collection Sheet  
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Participant Code: 
Date: 
Visit: 
 
Site: Left Shoulder 
    High  
 
Low 
 
Deviation 
 
      
    
 
 
Site: Right Shoulder 
    High  
 
Low 
 
Deviation 
 
      
    
 
 
Site: Sacrum 
    High  
 
Low 
 
Deviation 
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Site: Left Knee 
    High  
 
Low 
 
Deviation 
 
      
    
 
Site: Right Knee 
    High  
 
Low 
 
Deviation 
 
      
    
 
Site: Left Heel 
    High  
 
Low 
 
Deviation 
 
      
    
 
Site: Right Heel 
    High  
 
Low 
 
Deviation 
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Braden Scale 
Sensory Perception  
Moisture  
Activity  
Mobility  
Nutrition  
Friction/Shear  
 
Total: 
 
 
 
 
Waterlow Score 
BMI  
Continence  
Skin Type  
Mobility  
Sex/Age  
MUST  
Tissue Malnutrition  
Neurological Deficit  
Surgery/Trauma  
 
Total: 
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Appendix I – Sub-Epidermal Moisture 
Measurement Tables  
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SEM Scores 
  
Patient Number 
Sacrum Measurement Number & SEM Result 
1 2 3 4 5 6 7 8 
1 0.2 0.2 0.8 0.7 0.1 0.5 0.4 0.5 
2 0.5 0.4 0.8 0.7 0.1 0.4 0.5 0.5 
3* 0.1 0.2 0.7 0.1 0.3 0.7 0.5 0.6 
4 0.1 0.2 0.4 0.6 0.2 0.3 0.5 0.4 
5 0.3 0 0.4 0.3 0.4 0.2 0.3 0.5 
6* 0.7 0.4 0.5 0.7 0.4 0.5 0.6 0.5 
7 0.2 0.2 0.3 0.4 0.3 0.4 0.3 0.5 
8 0.3 0.4 0.4 0.9 0.6 0.4 0.6 0.1 
9 0.2 0.2 0.4 0.7 0.4 0.3 0.4 0.5 
10 0.4 0.3 0.2 0.4 0.4 0.2 0.4 0.6 
11* 0.5 0.1 0.4 0.1 0.3 0.6 0.5 0.5 
12* 0.5 0.7 0.8           
13* 0.1 0.3 0.5 0.6 0.6 0.6 0.4 0.5 
14 0.3 0.3 0.4 0.1 0.5 0.3 0.5 0.5 
15 0.2 0.2 0.5 0.8 0.3 0.4 0.2 0.6 
16 0.2 0.3 0.2 0.4 0.2 0.4 0.5 0.4 
17 0.4 0.4             
18 0.4 0.4 0.6 0.4 0.5 0.4 0.4 0.5 
19 0.2 0.3 0.4 0.3 0.5 0.3 0.4 0.5 
20 0.4 0.3 0.3 0.4 0.6 0.4 0.2 0.5 
21* 0.1 0.4 0.6 0.5 0.5 0.6 0.4 0.3 
22* 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.5 
23 0.4 0.5 0.3 0.5 0.3 0.2 0.6 0.4 
24 0.4 0.2 0.3 0.6 0.4 0.4 0.4 0.4 
25 0.3 0.4 0.2 0.2 0.3 0.4 0.3 0.5 
26* 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.2 
27* 0.5 0.6 0.5 0.5 0.5 0.2 0.5 0.5 
28 0.3 0.4 0.3 0.4 0.5 0.2 0.5 0.4 
29 0.1 0.5 0.5 0.4 0.5 0.3 0.5 0.5 
*9 patients have elevated SEM readings for 3 days or more 
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Patient Number 
Left Shoulder Measurement Number & SEM Result 
1 2 3 4 5 6 7 8 
1 0.2 0.5 0.4 0.4 0.3 0.3 0.6 0.5 
2 0.5 0.7 0.3 0.4 0.4 0.3 0.5 0.4 
3 0.1 0.1 0.2 0.4 0.3 0.4 0.2 0.3 
4 0.2 0.1 0.3 0.4 0.4 0.2 0.3 0.3 
5 0.4 0.5 0.3 0.3 0.5 0.4 0.4 0.3 
6 0.2 0.1 0.4 0.2 0.4 0.5 0.3 0.5 
7 0.2 0.1 0.3 0.4 0.4 0.2 0.7 0.4 
8 0 0.3 0.2 0.1 0.3 0.6 0.4 0.2 
9 0.2 0.4 0.3 0.7 0.3 0.2 0.5 0.7 
10 0.3 0.1 0.6 0.6 0.2 0.3 0.8 0.6 
11 0 0.3 0.2 0.2 0.4 0.4 0.2 0.5 
12 0.2 0.6 0.2 0.2 0.3 0.1 0.3 0.3 
13 0.4 0.4 0.2 0.2 0.4 0.4 0.2 0.3 
14 0.2 0.4 0.3 0.6 0.4 0.1 0.3 0.4 
15 0.3 0.3 0.3 0.1 0.2 0.4 0.3 0.3 
16 0.2 0.6 0.3 0.4 0.4 0.5 0.1 0.1 
17 0.1 0             
18 0.3 0.3 0.3 0.2 0.4 0.5 0.5 0.4 
19 0 0.5 0.6 0.4 0.4 0.2 0.5 0.3 
20 0.2 0.4 0.6 0.3 0.4 0.3 0.3 0.2 
21 0.3 0.5 0.5 0.1 0.1 0.4 0.3 0.4 
22 0.3 0.5 0.4 0.2 0.4 0.4 0.4 0.3 
23 0.4 0.4 0.3 0.5 0.3 0.4 0.2 0.2 
24 0 0.2 0.4 0.3 0.8 0.4 0.4 0.2 
25 0.5 0.4 0.4 0.2 0.3 0.3 0.4 0.5 
26 0.3 0.3 0.3 0.5 0.4 0.2 0.4 0.7 
27 0.3 0.5 0.3 0.4 0.6 0.4 0.3 0.3 
28 0.2 0.3 0.1 0.3 0.4 0.3 0.3 0.4 
29 0.2 0.5 0.5 0.2 0.2 0.4 0.3 0.2 
No patient has an elevated SEM for 3 days or more 
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Patient Number 
Right Shoulder Measurement Number 
1 2 3 4 5 6 7 8 
1 0 0.3 0.4 0.5 0.5 0.1 0.6 0.3 
2 0.4 0.8 0.3 0.1 0.4 0.5 0.4 0.5 
3 0.1 0.2 0.3 0.3 0.6 0.4 0.4 0.1 
4 0.2 0.1 0.2 0.3 0.1 0.5 0.5 0.1 
5 0 0.1 0.2 0.5 0.1 0.5 0.3 0.2 
6 0.3 0.1 0.2 0.3 0.4 0.2 0.5 0.4 
7 0.4 0.1 0.3 0.1 0.3 0.1 0.3 0.3 
8 0.3 0.3 0.2 0 0.5 0.4 0.5 0.5 
9 0.1 0.5 0.3 0.4 0.3 0.4 0.4 0.5 
10 0.2 0.5 0.4 0.3 0.3 0.4 0.2 0.4 
11 0.1 0.5 0.3 0.3 0.5 0.6 0.1 0.4 
12 0.3 0.4 0.4 0.1 0.4 0.2 0.3 0.4 
13 0.3 0.1 0.4 0.1 0.4 0.2 0.3 0.5 
14 0.1 0.2 0.3 0.3 0.2 0.4 0.4 0.3 
15 0.2 0.3 0.3 0.3 0.2 0.2 0.5 0.3 
16 0.2 0.3 0.6 0.3 0.1 0.3 0.3 0.3 
17 0.3 0.4             
18 0.5 0.1 0.2 0.5 0.3 0.2 0.4 0.4 
19 0.4 0.4 0.2 0.4 0.2 0.2 0.2 0.2 
20 0.1 0.5 0 0.5 0.4 0.2 0.2 0.4 
21 0.5 0.1 0.4 0.4 0.2 0.3 0.3 0.4 
22 0.2 0.7 0.5 0.4 0.4 0.3 0.3 0.1 
23 0.3 0.3 0.5 0.4 0.3 0.4 0.2 0.5 
24 0.1 0.2 0.5 0.3 0.5 0.6 0.4 0.2 
25 0.3 0.5 0.3 0.3 0.2 0.4 0.4 0.3 
26 0.2 0.4 0.3 0.4 0.4 0.4 0.3 0.3 
27 0.4 0.4 0.3 0.4 0.4 0.3 0.2 0.4 
28 0.3 0.4 0.3 0.2 0.5 0.4 0.2 0.3 
29 0.2 0.3 0.3 0.3 0.2 0.3 0.3 0.3 
No patient has an elevated SEM for 3 days or more 
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Patient Number 
L Knee Measurement Number 
1 2 3 4 5 6 7 8 
1* 0.3 0.3 0.5 0.5 0.3 0.5 0.7 0.7 
2* 0.3 0.6 0.3 0.4 0.7 0.6 0.6 0.4 
3 0.5 0.2 0.4 0.2 0.4 0.3 0.3 0.2 
4 0.2 0.1 0.2 0.6 0.6 0.1 0.5 0.3 
5 0.3 0.3 0.4 0.4 0.3 0.3 0.6 0.3 
6 0.7 0.2 0.8 0.4 0.7 0.5 0.4 0.4 
7 0.3 0.1 0.7 0.8 0.4 0.3 0.4 0.1 
8 0.4 0.4 0.4 0.3 0.8 0.9 0.6 0.4 
9* 0.4 0.3 0.9 0.7 0.7 0.1 0.4 0.8 
10 0.5 0.5 0.3 0.8 0.6 0.2 0.6 0.3 
11 0 0.5 0.2 0.1 0.4 0.2 0.4 0.2 
12 0 0.3 0.2 0.3 0.4 0.3 0.2 0.2 
13 0.4 0.5 0.2 0.3 0.2 0.4 0.1 0.4 
14 0.7 0.2 0.7 0.4 0.5 0.3 0.2 0.5 
15* 0.1 0 0.7 0.4 0.6 0.6 0.5 0.6 
16 0.2 0.2 0.2 0.6 0.3 0.4 0.4 0.3 
17 0.1 0.2             
18* 0.6 0.6 0.5 0.6 0.5 0.6 0.4 0.5 
19 0.3 0.8 0.3 0.7 0.4 0.3 0.5 0.6 
20 0.1 0.2 0.3 0.5 0.4 0.8 0.4 0.4 
21 0.3 0.3 0.4 0.6 0.6 0.4 0.4 0.3 
22 0.2 0.7 0.3 0.3 0.4 0.8 0.2 0.4 
23 0.4 0.1 0.8 0.6 0.3 0.1 0.7 0.3 
24* 0.2 0.1 0.7 0.5 0.6 0.4 0.1 0.4 
25* 0.5 0.4 0.7 0.7 0.5 0.4 0.6 0.6 
26 0.2 0.2 0.3 0.3 0.3 0.1 0.3 0.4 
27* 0.6 0.5 0.5 0.3 0.3 0.5 0.4 0.1 
28* 0.6 0.7 0.4 0.5 0.6 0.5 0.4 0.6 
29 0.5 0.1 0.4 0.3 0.4 0.2 0.1 0.3 
*9 Patients have elevate SEM readings for 3 days or more 
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Patient Number 
R Knee Measurement Number & SM Result 
1 2 3 4 5 6 7 8 
1 0.4 0.1 0.4 0.9 0.6 0.3 0.8 0.4 
2 0.5 0.5 0.4 0.3 0.5 0.3 0.7 0.6 
3 0.2 0.5 0.4 0.3 0.4 0.2 0.4 0.2 
4 0.6 0.4 0.5 0.2 0.1 0.4 0.3 0.3 
5 0.2 0.1 0.2 0.4 0.3 0.2 0.6 0.6 
6* 0.6 0.1 0.6 0.6 0.7 0.6 0.2 0.5 
7 0.4 0.4 0.4 0.6 0.8 0.2 0.3 0.2 
8* 0.2 0.2 0.9 0.5 0.9 0.4 0.6 0.1 
9 0.6 0.2 0.4 0.6 0.9 0.4 0.5 0.4 
10* 0.5 0.2 0.6 0.6 0.5 0.3 0.2 0.1 
11 0.1 0.1 0.6 0.2 0.5 0.3 0.4 0.4 
12 0 0.1 0.7 0.5 0.2 0.4 0.5 0.4 
13 0.1 0.4 0.1 0.7 0.4 0.5 0.4 0.3 
14* 0.5 0.5 0.7 0.4 0.4 0.2 0.4 0.1 
15* 0.2 0.3 0.2 0.5 0.6 0.8 0.3 0.4 
16 0.1 0.1 0.4 0.6 0.2 0.3 0.6 0.4 
17 0.1 0.4             
18 0.5 0.3 0.6 0.4 0.5 0.5 0.3 0.2 
19* 0.1 0.5 0.4 0.4 0.4 0.7 0.5 0.6 
20 0.4 0.2 0.5 0.3 0.5 0.7 0.5 0.3 
21 0.4 0.4 0.8 0.4 0.6 0.2 0.2 0.5 
22* 0.5 0.6 0.7 0.4 0.9 0.5 0.5 0.5 
23 0.4 0.2 0.7 0.7 0.4 0.3 0.2 0.4 
24* 0.4 0.1 0.5 0.6 0.5 0.5 0.2 0.5 
25 0.1 0.5 0.6 0.3 0.3 0.4 0.4 0.1 
26 0.5 0.1 0.3 0.4 0.3 0.2 0.5 0.1 
27 0.5 0.6 0.3 0.5 0.4 0.3 0.4 0.4 
28                 
29* 0 0.6 0.2 0.5 0.6 0.5 0.5 0.6 
*9 patients have elevated SEM readings for 3 days or more 
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Patient Number 
Left Heel Measurement Number & SEM Result 
1 2 3 4 5 6 7 8 
1* 0.1 0.3 0.5 0.4 0.5 0.9 0.6 0.5 
2 0.4 0.7 0.2 0.1 0.4 0.2 0.3 0.4 
3 0.3 0.1 0.4 0.1 0.9 0.3 0.5 0.6 
4* 0.4 0.2 0.7 0.6 0.5 0.2 0.4 0.6 
5 0.1 0.3 0.3 0.6 0.5 0.4 0.7 0.5 
6 0.9 0.3 0.4 0.4 0.5 0.4 0.5 0.2 
7* 0.4 0.1 0.7 0.8 0.6 0.3 0.4 0.4 
8* 0 0.4 0.7 0.7 0.7 0.5 0.4 0.1 
9 0.2 0.3 0.8 0.5 0.2 0.2 0.4 0.6 
10* 0.5 0.2 0.6 0.7 0.6 0.6 0.2 0.4 
11 0.3 0.2 0.3 0.7 0.4 0.5 0.2 0.4 
12 0.6 0.3 0.7 0.7 0.4 0.2 0.3 0.2 
13 0.4 0.5 0.4 0.2 0.4 0.2 0.2 0.4 
14 0.3 0.3 0.5 0.6 0.2 0.1 0.4 0.2 
15 0.5 0.2 0.2 0.5 0.2 0.4 0.6 0.1 
16* 0.4 0.3 0.3 0.7 0.7 0.6 0.6 0.6 
17 0.2 0.3             
18* 0.2 0.6 0.6 0.8 0.2 0.6 0.3 0.3 
19 0.1 0 0.3 0.6 0.6 0.3 0.5 0.3 
20 0.3 0.6 0.3 0.2 0.5 0.8 0.3 0.3 
21 0.4 0.3 0.3 0.5 0.3 0.3 0.4 0.1 
22 0.3 0.2 0.8 0.3 0.4 0.3 0.5 0.5 
23* 0.2 0.3 0.8 0.7 0.5 0.3 0.4 0.3 
24* 0.6 0.4 0.8 0.7 0.5 0.4 0.3 0.6 
25* 0.4 0.7 0.5 0.9 0.2 0.3 0.3 0.2 
26                 
27 0.7 0.5 0.2 0.1 0.4 0.1 0.3 0.2 
28                 
29 0.2 0.4 0.4 0.2 0.2 0.3 0.4 0.1 
*10 Patients have elevated SEM readings for 3 days or more 
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Patient Number 
Right Heel Measurement Number & SEM Result 
1 2 3 4 5 6 7 8 
1* 0.5 0.7 0.9 0.7 0.3 0.7 0.6 0.5 
2 0.3 0.9 0.6 0.3 0.5 0.4 0.1 0.4 
3* 0.3 0.3 0.5 0.8 0.3 0.5 0.6 0.6 
4 0.2 0.2 0.5 0.4 0.6 0.5 0.3 0.2 
5 0.3 0.1 0.7 0.7 0.4 0.1 0.5 0.2 
6 0.4 0.3 0.5 0.5 0.4 0.3 0.3 0.4 
7 0.5 0.4 0.7 0.5 0.6 0.1 0.5 0.4 
8* 0.4 0.3 0.6 0.7 0.5 0.8 0.4 0.5 
9* 0.4 0.1 0.7 0.6 0.5 0.9 0.6 0.2 
10 0.3 0.3 0.7 0.5 0.2 0.8 0.5 0.4 
11 0.5 0.4 0.8 0.6 0.3 0.5 0.5 0.4 
12 0.2 0.6 0.6 0.4 0.5 0.5 0.2 0.1 
13 0.3 0.4 0.6 0.3 0.5 0.4 0.2 0.4 
14 0.7               
15* 0.1 0.1 0.4 0.6 0.5 0.5 0.2 0.3 
16 0.4 0.3 0.8 0.4 0.3 0.5 0.2 0.4 
17 0.4 0.3             
18 0.2 0.6 0.3 0.9 0.2 0.8 0.4 0.3 
19* 0.1 0.3 0.6 0.5 0.6 0.5 0.6 0.5 
20 0.2 0 0.1 0.4 0.9 0.5 0.6 0.3 
21 0.6 0.3 0.3 0.3 0.5 0.1 0.4 0.3 
22* 0 0.4 0.8 0.6 0.5 0.2 0.4 0.4 
23* 0.4 0.4 0.9 0.6 0.5 0.3 0.4 0.2 
24* 0.4 0.3 0.6 0.9 0.7 0.3 0.4 0.6 
25 0.4 0.3 0.5 0.6 0.3 0.5 0.6 0.3 
26                 
27 0.5 0.4 0.4 0.2 0.3 0.2 0.3 0.2 
28                 
29 0.3 0.3 0.3 0.3 0.1 0.5 0.3 0.4 
*9 patients have elevated SEM readings for 3 days or more 
Elevated SEMs by Participant Number 
 
 
